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Although no structure morphologically similar to the well-characterised Golgi complex of
mammalian cells can be seen in Saccharomyces cerevisiae (yeast), there is much genetic and
biochemical evidence to suggest the existence of a yeast organelle functionally equivalent to the
mammalian Golgi. The trans Golgi network (TGN) of mammalian cells is characterised, at
least in part, by the presence of serine proteases that process prohormone molecules by
catalysing cleavage of polypeptide chains at pairs of basic residues. Analogous proprotein
processing in yeast is achieved by the action of the Kex2 protease. Kex2p is the best-
characterised resident protein of the yeast Golgi to date, and is believed to reside in a
compartment of the organelle that is equivalent to the mammalian TGN.
In order to further characterise the yeast Golgi, the aim of this project was to prepare vesicles
derived specifically from the Kex2p-containing compartment of the yeast Golgi. This aim was
pursued in two ways. Firstly, a hybrid protein, consisting of IgG-binding domains of the
S. aureus coat protein (protein A) fused to the extreme, cytoplasmically-disposed, C-terminus of
Kex2p was constructed. It was intended that IgG-Sepharose would be used to isolate membrane
vesicles containing the hybrid protein from yeast cell lysates, and that these vesicles would
originate from the Kex2-containing compartment. Unfortunately, this approach was
unsuccessful since preliminary results suggest that the protein is mislocalised to the vacuole.
The second approach that was employed involved the generation of a polyclonal antibody
preparation that specifically recognises the cytoplasmically-disposed C-terminal region of
Kex2p. This was achieved using bacterially-produced hybrid proteins (containing the C-terminal
100 residues of Kex2p) to immunise rabbits, and to affinity-purify Kex2p specific antibodies
from immune serum. Affinity-purified antibodies were bound to fixed S. aureus cells by taking
advantage of the high affinity of protein A for the Fc portion of IgG molecules. The resulting
immunoadsorbent (ImAd) can be used to recover 80% of Kex2 protease activity from a yeast cell
lysate. Kex2p recovered using the procedure established during the course of this project is
contained within intact membrane vesicles as demonstrated by its resistance to externally added
protease and the ability of the ImAd to recover a soluble cargo protein. As well as containing
Kex2p the material bound by the ImAd is enriched for dipeptidyl aminopeptidase A and Kexlp,
both of which reside in the same compartment as Kex2p in the cell, but does not contain
activities of enzymes associated with the endoplasmic reticulum (NADPH cyt c reductase) or the
vacuole (dipeptidyl aminopeptidase B).
The material that has been immunoisolated using the Kex2p antibody will be of use to provide
insights into the structure of the yeast Golgi, as well as being central to the development of
protein transport assays to study the function(s) of this organelle.
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Section 1. The secretory pathway
1.1. Introduction and overview
Eukaryotic cells differ in many ways from their prokaryotic counterparts. One of their
most striking features in this respect is their intracellular compartmentalisation (Alberts
etal., 1989). The existence of organelles, which are created by enclosing various
groups of molecules within membranes of a defined lipid and protein compostion,
allows processes which would otherwise interfere with each other to occur within the
same cell. For example, proteolytic enzymes are contained within the lysosome of
mammalian cells (Alberts etal., 1989) or the vacuole of yeast cells (Wiemken etal.,
1979) away from other cellular components which they would otherwise degrade. In
order for cells to achieve and maintain this compartmentalisation it is vital that new
proteins reach their desired locations so that the function for which they have been
produced occurs in the correct place and not in any other. In other words the cell must
be able to target proteins accurately to their rightful cellular locations.
Proteins destined for many organellar locations, as well as those to be secreted irom the
cell travel through the secretory pathway (for review see Kelly, 1985). Entry into this
pathway is achieved by proteins being translocated across, or inserted into, the ER
membrane. From the ER, proteins travel to and subsequently enter the Golgi
apparatus. This transfer occurs by means of vesicular traffic (Palade, 1975):
membrane buds from the ER to form vesicles entrapping soluble proteins present in the
ER lumen, then delivery of cargo proteins is achieved as these vesicles fuse with the
cis cisternae of the Golgi apparatus, consequently becoming incorporated into its
membrane and delivering any contents inside. Transport through the different cisternae
of the Golgi complex is also mediated by vesicular traffic and proteins leave this
organelle when they are packaged into secretory vesicles which bud from the trans face
of the Golgi. These secretory vesicles can then fuse with the plasma membrane in
order to deliver proteins to the cell surface, or to secrete soluble proteins from the cell;
2
alternatively they may fuse with the lysosomal (or vacuolar) membrane to achieve
delivery of proteins to this organelle. In mammalian cells the fusion of post-Golgi
secretory vesicles with the plasma membrane occurs both constitutively and in a
regulated manner (for review see Burgess and Kelly, 1987). Regulated secretory cells,
such as neurones and cells of the endo- and exocrine glands, are specialised to release,
over a short period of time, large amounts of protein at a much higher rate than they are
synthesised. Cells of the endocrine system concentrate secretory proteins by as much
as 200-fold during their passage from the trans Golgi to secretory vesicles (Salpeter and
Farquhar, 1981). Such proteins are stored in specialised vesicles close to the plasma
membrane until their exocytosis is required. Fusion of these vesicles with the plasma
membrane, and therefore the release of their contents, is triggered by a specific external
stimulus in response to a change in the physiological state of the organism and is
mediated through changes in the concentration of an intracellular messenger such as
calcium (Burgoyne, 1990). In contrast, the constitutive secretory pathway does not
concentrate newly synthesised molecules; there is no post-Golgi storage pool and
secretory vesicles move directly from the Golgi to the plasma membrane where fusion
occurs. The constitutive pathway is thought of as the general route in all cells for the
transport of molecules that are constantly required at the cell's exterior such as growth
factors, extracellular components and enzymes. There is direct evidence that both
regulated and constitutive secretion occur within the same cell. Proteins that are
secreted from a cell constitutively are found in transport vesicles distinct from those
containing protein that is secreted only in response to an external stimulus (Gumbiner
and Kelly, 1982).
Current views of protein traffic favour the theory that proteins entering the ER travel
through the secretory pathway as described above, with no specific sequence being
required for a protein to be moved from the ER to the Golgi, or for entry into post
Golgi secretory vesicles and that it is proteins required at other cellular locations such as
the lysosome or vacuole that carry sequences containing the information necessary to
direct them away from this default pathway (Kornfeld and Mellman, 1989; Pearse and
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Robinson, 1990). Similarly, it is believed that proteins resident to the constituent
compartments of the pathway carry information which prevents them from being
permanently removed from their rightful location by the bulk-flow of membrane traffic.
Our understanding of such information remains limited, soluble proteins resident to the
ER of mammalian cells contain the C-terminal tetrapeptide -KDEL and those resident to
the ER of yeast cells -HDEL (Pelham, 1989). It is believed that these proteins are not
retained, as such, in the ER, but rather are recycled from a post-ER compartment by
virtue of their C-terminal signal interacting with a receptor. The 'bulk-flow' view of
the secretory pathway described above gained support from experiments that followed
the movement of small peptides through the secretory pathway of mammalian cells to
show that fast and efficient export from the cell does not require a specific signal in the
molecule being secreted (Wieland et al., 1987). Small peptides in this system were
found to be secreted from the cell with the same kinetics as a number of secretory
proteins (Helms etal., 1990). However, the transport route of such small peptides
from the ER seems to be dependent on the biological system in which they are used,
since similar experiments in Xenopus oocytes and yeast show that the peptides fail to
be secreted and are transported into the cytoplasm of yeast and the lysosome of the
oocytes (Geetha-Habib etal., 1990: Romisch and Schekman, 1992). Recent work in
yeast questions the idea of the default pathway as described so far, suggesting that the
default pathway for integral membrane proteins in this organism may be delivery to the
vacuole. Evidence for this comes from experiments which show that none of the three
domains of a protein resident in the vacuole carry information to direct the protein there,
and also that the removal of information that directs and keeps a resident Golgi protein
in its compartment results in its localisation to the vacuole (Roberts et al., 1992). Such
recent findings demonstrate that our understanding in this area is far from complete.
As mentioned above, proteins are carried through the secretory pathway by vesicles
which bud off from one membrane bound compartment (the donor) and subsequently
fuse with another (the acceptor). Movement of proteins between the organelles of the
secretory pathway requires accuracy of fusion of these vesicles with their acceptor
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compartments and little is known about how this is achieved within the cell. Assays
that reconstitute certain events in vitro have proved to be useful as tools to aid the
analysis of complicated biological processes, and it is hoped that the reconstitution of
stages of the secretory pathway will aid the biochemical dissection of the pathway and
lead to the identification and subsequent characterisation of components involved in it.
1.2. Investigation of the yeast secretory pathway
Saccharomyces cerevisiae (yeast) is attractive as an experimental organism in which to
study protein transport, a process which has been shown to occur analogously in yeast
and higher eukaryotes (Wilson etal., 1989: Rothman and Orci, 1992). The ease with
which yeast can be manipulated genetically means that it can be used to examine the
pathway not only biochemically (by the development of assays which reconstitute
protein transport events in vitro), but also genetically, an approach that cannot be
considered when working with a mammalian system.
Various stages ofprotein transport in yeast have been identified and defined by the
characterisation of mutant cells which are defective in protein transport at 37°C.
Characterisation of such mutants by Novick and co-workers led to the identification of
twenty three genes whose functions are required for the secretion of proteins (Novick
etal., 1980). At the restrictive temperature of 37°C, cells carrying temperature
sensitive mutations in any one of these genes (sec mutants) accumulate intracellular
pools of secretory proteins not found in the same cells at 25°C. These SEC genes were
grouped, according to morphological studies, in relation to which organelle proliferated
in cells in which their function had been altered. The largest of these groups has ten
members, and a mutation in any of these genes causes cells to accumulate membrane
vesicles 80-100nm in diameter which were proposed to represent secretory vesicles that
would ordinarily fuse with the plasma membrane. A second set of sec mutants has nine
members all of which accumulate an extended ER network as compared to that found in
wild type cells at 37°C. A subset of this second group accumulates 40nm vesicles as
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well, and these are known as class II mutants, whereas class I mutants accumulate the
ER structure alone (Kaiser and Schekman, 1990). Two of the remaining four sec
mutants identified were found to accumulate a membraneous stack which has been
described as 'an exaggerated Golgi-like structure'. The last two sec mutants have not
been placed into the above groups since one (secl9) appears to accumulate all three
types of organelle, and another (sec11) did not appear to accumulate any.
The order of events in the yeast secretory pathway was elucidated by the
characterisation of strains carrying two different see mutations (Novick etal., 1981).
The morphology of the exaggerated organelles accumulated in such cells allowed the
order in which the SEC gene products are required to be assessed. Examination of
precursor forms of accumulated invertase (a protein that is ordinarily secreted from
yeast cells) in sec mutants allowed the order of processing events performed on the
protein to be determined. These studies led to the following model (summarised in
Figure 1-1): Secretory proteins enter the ER where they are modified by the addition of
sugar chains. Nine or more SEC gene products act to transfer secretory proteins to a
second membrane compartment where the glycans they received in the ER are
modified. The products of at least two genes are then required for proteins to move
from this compartment into secretory vesicles. Following this, a further nine or more
gene products are involved in the delivery of the secretory vesicles to their final
destination.
Since the identification of the initial twenty three SEC genes, other genes involved in
protein transport in yeast have been identified. These include genes whose products are
involved in the translocation of proteins across the ER membrane (e.g. SEC61:
Rothblatt et al„ 1989) as well as other genes, mutations in which block the secretory
pathway at the stage(s) in which their products are involved (e.g. BET1 : Newman
and Ferro-Novick, 1987) and genes, mutations in which cause the cell to mislocalise
certain proteins (e.g. vps mutants (Robinson etal., 1988: Rothman etal., 1989)
secrete vacuolar proteins). Genes encoding small GTP-binding proteins that are
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involved in the yeast secretory pathway, such as YPT1 (Segev etal., 1988) have also
been identified, as have suppressor genes that restore growth to cells bearing mutations
in such genes (e.g. SLY2 and SLY12, Dascher etal., 1991: Ossig etal., 1991).
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Figure 1-1
The yeast secretory pathway
Proteins that are secreted by yeast follow a pathway similar to that described in
mammalian systems. Proteins destined for secretion enter the pathway by translocation
across the membrane of the ER after which they are carried through various membrane
bound compartments; all transport is mediated by vesicular traffic. Temperature
sensitive mutations that block this pathway at precise locations have been isolated.
These blocks are reflected in an accumulation of an organelle of the secretory pathway
in cells carrying the mutations at 37°C. This figure indicates the position at which the
wild type gene products of the twenty three SEC genes identified by Novick and his co¬
workers are thought to function (Novick etal., 1980: Novick etal., 1981).
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Section 2. Protein transport assays
2.1. Introduction
Although the use of genetics has yielded much information about the secretory pathway
in yeast, it is important that this information is combined with biochemical methods of
studying protein transport, since many components involved may not be represented
among the products of the known SEC, BET or VPS genes. This is likely to be the
case since molecular analyses of yeast chromosome I has revealed that the majority of
essential genes are not identified in studies that rely on temperature sensitive mutations
(Diehl and Pringle, 1991: Harris and Pringle, 1991). The use of protein transport
assays which reconstitute various stages of the secretory pathway in vitro, combined
with the information gleaned from yeast genetics may aid in the identification of such
components as well as providing an insight into their function in vivo.
Central to the development of a transport assay is the ability to follow the transport step
being investigated. One way in which this can be done is by monitoring a biochemical
change known to occur in a protein as it is moved from one compartment to the next.
Such changes occur as proteins travel through the secretory pathway, being carried out
by specific enzymes that reside in different compartments of the pathway.
2.2. Proteins are modified as they travel through the secretory pathway
Proteins are acted upon by a number of different enzymes as they travel through the
secretory pathway and this results in covalent modification of the nascent polypeptide
chain. It is these modifications that lead to the differences that exist between the
primary translation product of a gene and a mature protein.
Translocation of proteins into or across the ER membrane (for review see Nunnari and
Walter, 1992) usually occurs cotranslationally although there are some examples of
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proteins crossing the membrane posttranslationally (Schlenstedt etal., 1990), a process
more commonly observed in yeast than in mammalian cells (Hansen et al., 1986:
Rothblatt and Meyer, 1986). Genes encoding proteins destined to enter the secretory
pathway encode a signal sequence which usually resides at the extreme N-terminus of
the nascent polypeptide (Blobel and Dobberstein, 1975). This sequence generally
includes 1-3 positively charged amino acids followed by a run of 14-20 uncharged and
predominantly hydrophobic amino acids and is often ended with a glycine or alanine
residue (von Heijne, 1985). When such a signal sequence emerges from a ribosome in
mammalian cells it is bound by a cytoplasmic ribonucleoprotein complex, signal
recognition particle (SRP) (Walter and Blobel, 1981: Kriegetal., 1986), which arrests
any further elongation of the polypeptide chain. SRP, as part of the ribosome-SRP-
nascent polypeptide chain complex, interacts with its receptor in the ER membrane (of
which docking protein is the largest subunit) and thus directs the complex to the
membrane (Meyer etal., 1982: Gilmore etal., 1982). Following this, both SRP and
docking protein are released from the ribosome in a reaction requiring GTP, and the
elongation of the polypeptide chain continues with its translocation across the
membrane having been initiated (Gilmore and Blobel, 1983: Wiedmannera/., 1987).
Although yeast homologues of SRP and docking protein have been identified (Amaya
et al., 1990: Nunnari and Walter, 1992) the role of translational arrest in yeast is less
clearly understood than it is in mammalian cells. This is possibly due to the fact that
there may be more than one translocation route into the ER of yeast cells (Hann and
Walter, 1991). This would also provide an explanation for the observation that
mutations in the SEC65 gene (whose product shows homology to one of the smaller
subunits of SRP) are not lethal (Stirling et al., 1992: Stirling and Hewitt, 1992: Hann
et al., 1992), perhaps because proteins can still enter the ER, and therefore the
secretory pathway, by another route which usually runs in parallel to the SRP system.
In addition to a signal sequence, membrane proteins possess at least one further
hydrophobic region to anchor them in the membrane, but if no such region is present
(as in soluble proteins) the entire polypeptide chain will pass through the membrane and
into the lumen of the ER (Rapoport and Weidmann, 1985).
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The actual mechanism by which a polypeptide chain crosses the phospholipid bilayer of
the ER is poorly understood, but recent studies in both yeast and mammalian cells have
identified several proteins believed to participate in this process. A channel, whose
opening can be detected by the passage of glutamate ions has been identified in the ER
membrane of mammalian cells (Simon and Blobel, 1991). The opening of this channel
depends on ribosome binding to the ER membrane, and can be blocked by the presence
of nascent polypeptide chains. These findings support popular theories which suggest
the existence of a proteinaceous tunnel to provide a hydrophilic environment allowing
the passage of polypeptide chains through the lipid bilayer. The incorporation of
photoreactive probes into nascent polypeptide chains has facilitated the identification
and purification of proteins with which polypeptides come into contact as they traverse
the membrane (Gorlich et al., 1992: and reviewed in Nunnari and Walter, 1992).
Similar work in yeast has shown that nascent chains come into close proximity with the
products of two genes (SEC61 and SEC62) that were identified by virtue of mutations
that disrupt translocation of proteins into the ER (Musch et al., 1992: Sanders et al.,
1992). It is hoped that such approaches will eventually lead to the identification and
purification of all factors involved in the translocation of polypeptide chains across the
ER membrane so that this process can be fully understood.
As a protein enters the ER the signal sequence is usually removed by signal peptidase
(Baker etal., 1986; Evans et al., 1986), the yeast homologue of which is encoded by
SEC11 (Bohni etal 1988: YaDeauera/., 1991). Proteins undergo other modifications
in the lumen of the ER (Hurtley and Helenius, 1989) including the formation of
disulphide bonds between cysteine residues and the addition of oligosaccharide chains
to selected asparagine residues (for review see Kornfeld and Kornfeld, 1985 and also
Tanner and Lehle, 1987). The latter is the initiating step in the formation of the N-
linked glycosylation found in mature glycoproteins. A core oligosaccharide chain built
up from three glucose, nine mannose and two N-acetyl glucosamine molecules
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(MangGk^GlcNAc^ is transferred from the lipid donor dolichol to the amide nitrogen
of an asparagine residue present in a polypeptide chain within the sequence
Asn-X-Ser/Thr (where X can be any residue except proline). Once attached to the
polypeptide chain the Man9Glc3GlcNAc2 moiety is processed by other enzymes located
in the lumen of the ER.
In yeast cells the removal of the glucose residues and of a single a-1,2-Man residue (by
glucosidases and a mannosidase respectively) results in the formation of Man8GlcNAc2
which is subsequently extended by the addition of up to six mannose residues in a
series of reactions catalysed by a mannosyl transferase (for a review of protein
glycosylation in yeast see Kukuruzinska etal., 1987). Similar processing occurs in the
ER of mammalian cells with glucose and oc-l,2-Man residues being removed from the
core structure to form the high mannose type glycans found in mammalian
glycoproteins.
As well as Asn residues found in the consensus sequence mentioned above, certain Ser
and Thr residues found in proteins in the ER of yeast cells are targets for the attachment
of oligosaccharides (Haselbeck and Tanner, 1983). These receive a single mannosyl
residue from a dolichol carrier and this marks the initiation of the O-linked
glycosylation found in yeast glycoproteins. (N.B. This process does not occur in the
ER of mammalian cells, O-linked glycosylation is initiated in the Golgi apparatus of
such cells, Niemann etal., 1982: Johnson and Spear, 1983). No consensus target
sequence for this process has been identified for the attachment of O-linked sugars but
regions rich in Ser and Thr residues do seem to be particularly susceptible to this
modification.
Polypeptide chains fold into their native conformations and, if necessary assemble into
competent strucures by association with other polypeptide chains within the ER lumen.
Chains which fail to do so are prevented from leaving the organelle by resident ER
proteins (e.g. BiP) and in this way the ER acts as a filter at the begining of the secretory
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pathway, preventing invalid proteins from progressing further and reaching their
destinations in a form that may have a detrimental effect on cellular processes (Hurtley
and Helenius, 1989).
Correctly folded nascent glycoproteins leave the ER and travel through the various
distal compartments of the secretory pathway. In mammalian cells some of the high
mannose chains formed in the ER are processed to complex oligosaccharides which
may contain additional GlcNAc residues as well as a variable number of galactose,
sialic acid and fucose residues (Kornfeld and Kornfeld, 1985). This processing
involves further trimming of the original oligosaccharide added in the ER as well as the
addition of further sugars. The oligosaccharide chains linked to Asn residues in yeast
proteins are also modified after they have left the ER, being extended by the addition of
many more mannose residues to form an outer chain structure which may contain
upwards of fifty mannose residues. It is in the Golgi complex of mammalian cells that
proteins receive their O-linked oligosaccharide chains (Niemann et al., 1982: Johnson
and Spear, 1983), a modification carried out by a series of glycosyl transferases which
catalyse the addition of one sugar residue at a time to a protein (up to about ten).
The processes involved in the formation of N-linked oligosaccharide chains are
summarised in Figure l-2a, and Figure l-2b highlights the differences between the




Figure l-2a is a diagrammatic representation of the events which occur in the secretory
pathway leading to the N-linked glycosylation of proteins as described in the text.
(1) During translocation of the polypeptide across the ER membrane an oligosaccharide
moiety is transferred from dolicholpyrophosphate (Dol-P-P) and then processed prior
to the protein leaving the ER: three glucose molecules and two mannose molecules are
removed by the sequential action of a-glucosidase I (2), a-glucosidase II (3) and 1,2-
mannosidase (4). The oligosaccharide chain undergoes further sequential modification
during transit through the Golgi apparatus. In the cis Golgi oligosaccharide side chains
are trimmed by the removal of four mannose residues by a-mannosidase I (5). A
molecule of N-acetyl glucosamine is added by N-acetyl glucosaminyltransferase I (6) in
the medial Golgi, an event which is followed by the removal of one more mannose
residue by a-mannosidase I (7). Finally in this compartment, a second molecule of N-
acetyl glucosamine and a molecule of fucose are added by N-acetyl
glucosaminyltransferase II (8) and fucosyltransferase (9) respectively. In the trans
cisternae of the Golgi complex two molecules of galactose are added by the action of
galactosyltransferase (10) and this is followed by the addition of two molecules of sialic
acid by sialyltransferase (11).
Figure l-2b highlights the differences between the N-linked oligosaccharide chains
attached to the glycoproteins of mammalian cells and yeast cells. Also shown is the site
of action of endoglycosidase H (endo H).
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The containment of degradative enzymes within the lysosome or vacuole was cited
earlier as an example of the importance of compartmentalisation in eukaryotic cells.
Proteins are often synthesised in an inactive form subject to activation as required in
order to prevent inappropriate functioning of the protein. One way in which a cell can
convert an inactive polypeptide to its active form is by the use of proteolytic processing
(Thomas etal., 1988). An example of this is evident in the synthesis of the yeast
mating pheromone a-factor. Yeast cells of mating type a secrete the peptide a-factor
which interacts with cells of mating type a, and is involved in the initiation of diploid
formation (for review see Herskowitz, 1986). The pheromone is synthesised as an
inactive precursor molecule, prepro-a-factor, and the removal of a signal peptide in the
ER generates pro-a-factor which is also inactive (Waters etal., 1988). Complete
maturation of pro-a-factor to the secreted thirteen residue peptide requires cleavage of
the precursor at the carboxyl side of lys-arg sites followed by the removal of N and C
terminal residues from the peptides yielded by these proteolytic cleavages. The primary
cleavages occur after the peptide has left the ER and is carried out by the product of the
KEX2 gene, a Ca2+-dependent, neutral serine protease (Julius et al„ 1984).
Subsequent removal of of the C-terminal basic residues is achieved by the action of the
KEX1 gene product (Dmochowska etal., 1987: Achstetter and Wolf, 1987), with the
product of STE13 being responsible for the removal of an N-terminal spacer through its
action as a dipeptidyl aminopeptidase (Julius etal., 1983). The various events involved
in the biosynthesis of a-factor were elucidated at least in part with the aid of sec




Shown here are the post-translational processing events involved in the maturation of
the product of the MFal gene product, prepro-a-factor. The order of these events was
elucidated by using biochemical and immunocytochemical identification of various
precursor forms of the mature protein (a-factor) and by the analysis of individual
processing enzymes and their genes (see text for details, adapted from Fuller et al.,
1988).






i translocation into the ER, accompanied by cleavageof signal peptide and core glycosylation
transport to the Golgi and modification of core
glycans by the addition of outer chains
Followed by the first processing event of prepro-
alpha factor: cleavage at the C-terminal side of
paired Lys-Arg residues in spacer peptides
by Kex2 endoprotease




i removal of residual C-terminal Lys-Argresidues by Kex1 protease
removal of N-terminal Glu-Ala residues by
X dipeptidylaminopeptidase A and secretion
Mature alpha-factor
KEY:





proteolytic cleavage site I
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The various processing events to which a protein may be subjected as it travels through
the secretory pathway are carried out in a strictly defined order. This sequence of
events has been identified (Palade, 1975) using pulse-chase labelling, autoradiography
and membrane fractionation work and can be used to determine at which stage in the
pathway a particular protein is at any one time. Investigation of the glycosylation state
of a protein, for example, can be used to gain such information (Esmon et al., 1981).
Due to the variability in the size and number of outer chain units added to yeast
glycoproteins after they have left the ER there is marked heterogeneity in their final
molecular weight. It is because of this that gel electrophoresis of such proteins results
in broad smears. Gel electrophoresis of the same protein which had not, for some
reason, progressed from the ER would result in a more defined band representing the
protein whose glycosylation state at this stage in its existence is more homogeneous,
consisting of the core oligosaccharide chain. It is possible to convert the 'broad smear'
form of such proteins to a homogeneous form by treating them with the enzyme
endoglycosidase H (Trimble and Maley, 1984) which removes most of the
carbohydrate moiety (see Figure l-2b). Such approaches can be used to determine in
which organelle a protein is at any one time, and have been used to study the
mechanisms by which proteins are transported between different compartments of the
secretory pathway in transport assays.
2.3. Identification and characterisation of NSF/Secl8p
By monitoring the covalent modification of a protein known to occur as it is transported
from one compartment of the mammalian Golgi to the next (Fries and Rothman, 1980),
Rothman and co-workers identified a protein that is necessary for this transport step.
Cells infected with vesicular stomatitus vims (VSV) synthesise the virally encoded G-
protein (a viral coat glycoprotein) in large amounts. This membrane protein enters the
host's secretory pathway and is subjected to post translational modifications as it travels
through the various compartments of the pathway to the plasma membrane. VSV-G-
protein has been used in a number of transport assays and is useful in such studies
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especially when the donor and acceptor compartments are prepared from different cells
as it can be assured that only the former will contain the protein by preparing it from
cells infected with the virus while the acceptor fraction is prepared from uninfected
cells. Reconstitution of membrane transport between successive cisternae of the Golgi
complex in mammalian cells revealed that the process was energy dependent since the
delivery of VSV-G-protein from a Golgi-enriched donor fraction prepared from a VSV-
infected mutant Chinese hamster ovary (CHO) cell line lacking the glycosyltransferase
N-acetyl glucosaminyltransferase I to an acceptor Golgi fraction prepared from
uninfected wild-type CHO cells requires not only cytosol, but also a supply of energy
in the form of ATP. Membrane transport from the cis compartment of the donor
fraction to the N-acetyl glucosaminyltransferase-containing medial cisternae of the
acceptor was shown to have taken place when the two fractions were mixed together in
the presence of cytosol, an ATP regenerating system, and also UDP-(3H)-G1cNAc (a
substrate for the N-acetyl glucosaminyltransferase), by demonstrating that, after
incubation at 37°C, label was incorporated into VSV-G-protein (Balch etal., 1984:
Braell et al., 1984). The fact that this transport step could be inhibited by treating the
reaction mixture with the sulphydryl alkylating agent JV-ethyl maleimide (NEM) prior to
incubation led to the identification and subsequent purification of NEM-sensitive factor
(NSF), a homotetramer of 76K subunits (Block et al., 1988).
Since its discovery NSF has been shown to be required for a number of membrane
traffic events including the delivery of VSV-G-protein from the ER to the Golgi in
MDCK (Madin Darby canine kidney) cells, an event which can be followed by
monitoring the formation of the form of the protein carrying five mannose residues (a
product of one of the modification events associated with the Golgi complex), in semi
intact cells (Schwaninger etal., 1991). This delivery is sensitive to NEM, as well as to
an anti-NSF antibody (Beckers etal., 1989). Further evidence that the same protein is
involved in the two separate protein transport reactions comes from the fact that the
block introduced by NEM on ER to Golgi transport is reversible by the addition of
NSF purified using the intra-Golgi transport system.
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Studies involving NSF from mammalian cells have been elegantly complemented by
genetic studies using yeast cells and these have furthered our knowledge concerning the
role of this protein in protein transport. Yeast cells bearing a temperature sensitive
mutation in the SEC18 gene accumulate vesicles associated with the ER as well as
intracellular pools of secretory proteins bearing characteristic ER modifications at 37°C
(Novick etal., 1981). The protein product of SEC18 has 48% sequence similarity with
NSF (Wilson etal., 1989), a finding which was initially surprising since at that time
NSF had not yet been shown to be required for transport between the ER and the Golgi
in mammalian cells, and secl8 mutants were only known to be defective in the
transport of proteins from the ER. A cytosolic fraction prepared from yeast cells can
replace NSF in the CHO intra-Golgi transport system, but cytosol prepared from
secl8 cells lacks this ability (Wilson etal., 1989). The belief that the two proteins
carry out the same function gained further backing from the fact that cytosol prepared
from yeast cells overexpressing SEC18 exhibits enhanced NSF activity. It was this
homology, between a protein required for the intra-Golgi transport of proteins and one
required for transport from the ER, that led to the idea that the same factor might be
required at multiple stages in the secretory pathway.
Cells carrying a temperature sensitive seel8 allele fail to transport secretory proteins
past the ER at 37°C, but there is evidence that Secl8p is also required in subsequent
stages of the yeast secretory pathway. This was shown by taking advantage of the
rapid thermal inactivation of Secl8p. The secretory pathway of a temperature sensitive
seel8 strain was preloaded with radioactively labelled proteins prior to the introduction
of the sec block, following which the glycosylation states of the intracellular pool of
secretory proteins were investigated (Graham and Emr, 1991). The pool was found to
contain not only proteins bearing oligosaccharides characteristic of residency in the ER,
but also proteins which had been modified to various extents by processes known to
occur after proteins have left this organelle (including proteins in their mature forms).
Since these proteins had not been secreted, and could be located to more than one
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intracellular compartment by virtue of modifications they had received, it was deduced
that, as would have been expected from its homology with NSF, in addition to its role
in the transport of proteins from the ER, Secl8p is required in subsequent stages of the
yeast secretory pathway. A suprising finding from this work is that Secl8p is not
required for transport of proteins to the vacuole.
It is noteworthy that seel8 mutants exhibit defects in endocytosis (Riezman, 1985), and
also that NSF has been shown to participate in the fusion of mammalian endocytotic
vesicles with endosomes in vitro (Diaz etal., 1989). One assay used to demonstrate
this involves two different ligands which bind to the same receptor located in the
plasma membrane of macrophages (Diaz et al„ 1989). A DNP (di-nitro phenol)
derivative of (^-glucuronidase was incubated with, and subsequently bound to, the
mannose receptor of one population of macrophages, while an anti-DNP antibody was
similarly bound to the same receptor on a second population of the cells. The two cell
populations were homogenised separately, and post nuclear supernatants prepared from
these homogenates were mixed together. The formation of membrane bound antibody-
antigen complex was followed as a measure of endocytotic fusion. Such fusion was
shown to require cytosol and ATP, as well as NSF.
2.4. NSF/Secl8p functions in association with other proteins
In order to achieve maximum NEM inhibition of protein transport in the systems
described it was found to be necessary to treat both membrane and cytosol fractions
with the reagent (Malhotra etal., 1988). From this finding it was deduced that NSF
exists in both soluble and membrane associated forms, consistent with the fact that
Secl8p exists in both soluble and membrane associated forms within yeast cells (Eakle
etal., 1988). The C-terminal two thirds of the protein consists of two repeats
characteristic of ATP binding sites (Wilson etal., 1989). Mutations in either of these
two regions reduces the ATPase activity of the protein and destroys its fusion activity
demonstrating that ATP hydrolysis plays an important role in the protein's ability to
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stimulate membrane fusion (Rothman and Orci, 1992). The sequence of the 76K
polypeptide subunit of NSF suggests that it is a soluble cytosolic protein, lacking any
obvious hydrophobic regions as are found in viral proteins that induce membrane
fusion (Wilson etal., 1989). This may indicate that, rather than it itself being a
'fusogen', NSF promotes some other, as yet unknown, factor to stimulate membrane
fusion, and that its membrane association is facilitated by interaction with some other
component(s).
The active component involved in membrane fusion is believed to be a 20S particle
(Wilson et al., 1992), consisting not only of NSF, but also a, (3 and y SNAPs or NSF
attachment proteins (Clary et al., 1990). It is this complex that is believed to bind to
integral membrane receptors present in the acceptor compartment (Weidman et al.,
1989). The three SNAPs, water soluble proteins (35K, 36K and 39K) are unable to
bind NSF in solution but can do so when bound to a membrane receptor (Goda and
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Pfeffer, 1989). An integral membrane protein has been identified as a SNAPs receptor
in mammalian Golgi membranes and since it has been demonstrated that a- and p-
SNAPs compete for binding to membranes it is likely that they share the same receptor
and have similar functions. y-SNAP appears to bind to its own separate receptor and is
thought to have a function distinct from that carried out by a- and P-SNAPs (Wilson
etal., 1992). Hydrolysis of ATP by NSF results in the disassembly of the 20S particle
(Wilson etal., 1992) which, since the ATPase activity of NSF is required for
membrane fusion, is likely to be related to membrane fusion.
seel 7 cells are defective in the transport of proteins from the ER and accumulate 50nm
vesicles (Kaiser and Schekman, 1990). The product of the SEC17 gene has been
shown to be functionally equivalent to a-SNAP (it can replace the mammalain protein
in a transport assay) and is found in a complex which also contains Secl8p (Griff et
al., 1992). It has been stated in a prominent review that Secl7p is required not only for
transport of proteins from the ER, but at multiple stages throughout the yeast pathway
(Rothman and Orci, 1992). Such a finding would indeed provide evidence that
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a-SNAP may serve to attach NSF to membranes at various stages in the secretory
pathway, but the reference cited in the review to back up this statement does not show
that Secl7p functions at multiple stages throughout the yeast secretory pathway
(Graham and Emr, 1991) and therefore some confusion exists in this area. It is from
results such as those discussed so far that many elaborate models explaining how the
various components identified as being involved in membrane fusion may interact have
been proposed. While such models can be useful it is important to remember that they
are only models and that they must be adapted as new results demand and that they
alone should not be used to cast doubt on any data which question their validity.
2.5. GTP-binding proteins are involved in membrane traffic events
The yeast genes SEC4 and YPT1 encode proteins that are required for the fusion of
secretory vesicles with the plasma membrane and the transport of proteins from the ER
respectively (Novick etal., 1981: Segev etal., 1988). The discovery that both Sec4p
and Yptlp are homologues of the GTP-binding, transforming protein ras (Gallwitzef
al., 1983: Salminen and Novick, 1987: Wagner etal., 1987: for a review of the ras
superfamily see Bourne etal, 1990, and also Valencia etal., 1991) led to an
investigation into the role of GTP-binding proteins in membrane trafficking events (for
a recent review on this field see Pfeffer, 1992 and also Gruenberg and Clague, 1992).
In vitro transport of VSV-G-protein in the two mammalian systems that were described
earlier (Section 2.3) is inhibited by the non hydrolysable analogue of GTP, GTPyS as
well as by NEM (Melangon et al., 1987). The inhibition exerted by GTPyS leads to the
accumulation of coated vesicles, and coated buds are evident on Golgi membranes
(Melan^on et al., 1987). NEM inhibition on the other hand leads to an accumulation of
uncoated vesicles (Malhotra et al., 1988). It is evident that the GTPyS block precedes
that imposed by NEM since the presence of both inhibitors results in an accumulation
of coated vesicles of the type associated with the GTPyS block (Orci et al., 1989).
These observations have led to a model of membrane traffic (Figure 1-4) in which
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coated membrane vesicles bud from the donor compartment and are uncoated in an
energy requiring process before docking on to, and finally fusing with the acceptor
membrane. It is in this final fusion event, a Ca2+-dependent process which causes the
vesicles to deliver their contents to the donor compartment, that NSF was initially
believed to be involved (Malhotra etal., 1988: Beckers etal., 1989: but see Section
2.6).
The isolation of coated vesicles from a GTPyS blocked in vitro protein transport system
(set up using mammalian components) led to the identification of cytoplasmically
disposed proteins believed to be responsible, at least in part, for the formation of coated
vesicles from donor membranes during secretion (Malhotra et al., 1989; Serafini et al.,
1991a). These coat proteins (COPs) which are present in coated vesicles in
stoichiometric proportions, include a, 3, y and 5-COP as well as the small GTP-
binding protein ARF (Serafini et al., 1991b). Immunocytochemistry has been used to
show that, as well as being associated with the coated vesicles defined by the GTPyS
block, p-COP and ARF both exist in cytoplasmic forms but are not associated with the
vesicles that accumulate upon inactivation of NSF (Duden et al., 1991b; Orci et al.,
1991b). Many models, in trying to explain the mechanics of membrane traffic events,
invoke the association and dissociation of various complexes such as the formation of
vesicle coats from their constituents (Waters et al., 1991). Models of this type are
attractive since they introduce a number of levels at which events can be controlled.
Such a consideration is likely to be important in a system where insufficient control
could result in incorrect fusion which could have drastic results. The apparent absence
of any of the COPs from Golgi membranes (except concominant with bud formation)
has led to the idea that the coats observed on the vesicles are assembled from cytosolic
subunits prior to budding and the presence of P-COP and ARF in the cytosol supports
this idea.
It was mentioned in Section 2.1 that the 'ER-blocking' sec mutants can be divided into
two classes (Kaiser and Schekman, 1990); those that accumulate 50nm vesicles, and
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those that do not (classes II and I respectively). Whereas mutations in the class II
genes {SEC18, 17 and 22) inhibit the fusion of the 50nm vesicles with their target
organelle, mutations in the class I genes, SEC12, 13, 16, 21 and 23, prevent the
budding of membrane from the donor organelle to form the vesicles. The gene
products of both SEC13 and SEC23 are involved in complexes found in the cytosol
(Hicke and Schekman, 1989: Pryer et al., 1990: Hicke et al., 1992) and it is thought
(Rothman and Orci, 1992) that they may be components of a coat similar to that
observed in mammalian systems (although no such coat has been observed in yeast due
to the limited use of electron microscopy with this organism). However, the
mammalain homologue of Sec23p is restricted to a cytoplasmic zone between the ER
and the Golgi complex in mammalian cells (Orci etal., 1991a) suggesting that its role is
confined to vesicle budding from the ER. The 50nm vesicles associated with the
secl8 block (and that imposed by mutations in SEC17 and SEC22) are predicted to be
uncoated since they are accumulated as a result of the equivalent of the NEM block in
mammalian cells (Rexach and Schekman, 1991).
Since NSF/Secl8p has been found to be required for a number of different membrane
transport steps it is unlikely to be involved in controlling the specificity of membrane
fusion. Such specificity is of central importance to the secretory pathway: to ensure
that proteins travelling along it are correctly processed; to ensure that proteins are
accurately targetted as required; and to prevent random membrane fusion events which,
if allowed to occur, could prove catastrophic to the cell. The identification of a number
of YPTl/SEC4-like genes in mammalian systems (Zahraoui et al., 1989: Chavrier et
al., 1990), many of whose products have been localised to distinct compartments, and
the fact that GTPyS inhibits multiple stages of the secretory pathway (Melangon et al.,
1987: Tooze etal., 1990: Rexach and Schekman 1991: D'enfert etal., 1991) support
the proposal that each step of membrane transport is controlled, at least in part, by a
protein belonging to the ras superfamily. It has been suggested that these GTP-binding
proteins (or rab proteins) ensure that transport vesicles fuse only with the appropriate
membrane compartment using a mechanism similar to that used by EF-Tu as it ensures
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codon-anticodon fidelity (Bourne et al., 1990). GTP-binding proteins operate in many
cellular systems as molecular switches. These proteins adopt different conformations
(and thus have different activities) depending on which nucleotide they have bound
(GTP or GDP). EF-Tu binds tightly to amino acyl-tRNAs in its GTP bound state, and
codon recognition by the tRNA triggers GTP hydrolysis. With GDP bound the factor
is no longer able to participate in the complex and is released leaving the tRNA bound
to the ribosome. This process prevents the misincorporation of amino acids into a
growing polypeptide chain since only a correct codon-anticodon match will bind the
EF-Tu-amino acyl tRNA complex to the ribosome for a sufficient period of time, until
the tRNA is released by EF-Tu.
Perhaps one of the most direct lines of evidence for the involvement of a member of the
ras superfamily in membrane fusion events comes from observations that the
dissociation of rab3A from synaptic vesicles correlates with exocytosis of glutamate
from synaptosomes in vitro (Fischer von Mollard et al., 1991). Conversely,
repolarisation of these membranes leads to the reassociation of rab3A with the vesicles,
an association mediated by a post-translational covalent modification of the protein.
This demonstration of the reversible dissociation of a GTP-binding protein from
membranes undergoing fusion supports models which suggest that the cycling of such
proteins between membrane bound and cytosolic states offers control over membrane
fusion (Pfeffer, 1992).
Subcellular fractionation has determined that 15% of Sec4p forms a cytosolic pool in
wild type cells, with most of the other 85% being associated with the plasma membrane
and some with secretory vesicles (Goud et al., 1988). The membrane association of
Sec4p is characteristic of it being an integral membrane protein and since SEC4 doesn't
encode a signal peptide, or any obvious hydrophobic domains which could serve to
anchor the protein in the lipid bilayer it is believed that Sec4p undergoes a post
translational modification in order to acheive its membrane association. Ras proteins
are subjected to the addition of a isoprenyl unit to a Cys residue found within the C-
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terminal sequence Cys-Cys, Cys-X-Cys, Cys-Cys-X-X or Cys-Cys-X-X-X; where X
represents any residue (Farnsworth etal., 1991: Khosravi-Far etal., 1991). Sec4p
has the C-terminal sequence of Ser-Asn-Cys-Cys which may serve the same function
as the Cys containing sequences found in rab proteins. Yptlp has the C-terminal
sequence Gly-Gly-Cys-Cys and it has been shown that the Cys residues within this
sequence are essential for its function (Molenaar et al., 1988). The gene BET2 was
initially identified as being required for transport of proteins from the ER of yeast cells
(Newman and Ferro-Novick, 1987). Its product is required for the membrane
attachment of Sec4p and Yptlp, a fact demonstrated by the observation that there is an
increase in the soluble pools of these proteins in cells bearing a mutation in BET2
(Rossi etal., 1991). Bet2p is homologous to Ramlp, a component of a protein
prenyltransferase that modifies ras allowing its membrane attachment (Kohl et al.,
1991). Although no isoprenylation of either Sec4p or Yptlp has been detected it is still
believed that such a modification is responsible for their membrane attachment. This
theory is supported by evidence which shows that mutant cells in which the synthesis
of the isoprenoid precursor mevalonic acid is blocked have an increased pool of soluble
Sec4p (Rossi etal., 1991). The failure to detect isoprenylation of either Sec4p or
Yptlp may be due to technical difficulties in that S. cerevisiae does not incorporate
externally added mevalonic acid into proteins. Recent studies have demonstrated that
the fission yeast Schizosaccharomyces pombe will incorporate label into several
proteins (20-26kD) following incubation with tritiated mevalonic acid (Giannakouros
etal., 1992) and such work may lead to the demonstration of isoprenylation of small
GTP-binding proteins in yeast.
Reconstitution of intra Golgi transport of VSV-G-protein in vitro requires fatty acyl
CoA (Pfanner et al., 1990). Palmityl CoA is required after coated vesicles have budded
from the donor membrane, moved to the acceptor membrane, uncoated and bound NSF
(as depicted in Figure 1-4). It is tempting to speculate that fatty acyl CoA is required in
order to acylate some component which could then promote membrane fusion by, for
example perturbing the lipid bilayers or anchoring other fusion components in the
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membrane. Palmitate binds to proteins via a thioester or oxyester linkage both of which
can be easily hydrolysed by specific esterases (Schultz et al., 1988). It can be
envisaged that the control of acylation and deacylation of a component would offer a
level of control of membrane fusion events. The budding of coated vesicles also
requires fatty acyl CoA (Pfanner et al., 1989) and thus it is thought that proteins with a
covalently bound hydrophobic moiety may play a crucial role in both the budding of
transport vesicles, and in their fusion with the relevant acceptor membrane. The small
GTP-binding protein ARF found in the 20S NSF-containing particle is N-terminally
myristylated (Kahn et al., 1987) and is required for the budding of vesicles from Golgi
membranes. Myristylated ARF with GTP bound is capable of inserting into lipid
bilayers but the absence of GTP strips the protein of this ability (Kahn et al., 1987).
One theory of ARF's involvement in budding suggests that, as it binds GTP, ARF
inserts into the membrane of the donor organelle allowing COPs to form the coat
complex around it and anchors them in the membrane once the coat is fully formed
(Rothman and Orci, 1992). GTP hydrolysis occuring on encounter with the target
membrane would destabilise the coat and dissociate it from the membrane, recycling its
constituents to the cytosol.
Whereas the myristylation of ARF and the prenylation of rab proteins may explain their
membrane association, they do not explain their organelle specific distributions. Rab
protein sequences are most divergent in their C-terminal sequences and it has been
shown that the location of rab5 can be changed to that of rab7 by transplanting the C-
terminal thirty four amino acids of the latter onto the former (Chavrier etal., 1991).
Overexpression of rab proteins does not lead to their mislocalisation but to their
cytoplasmic accumulation (Gorvel etal., 1991) an observation which is consistent with
the existance of saturable rab receptors suggesting that the specificity of rab localisation
may be achieved in this way.
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Early endosome fusion detected in an assay similar to that described above (Section
2.3) has been found to be sensitive to GTPyS and can be inhibited by the addition of
cytosol prepared from a mutant cell line which overexproduces a mutant form of rab5
(that is unable to bind GTP). The fusion is stimulated by cytosol prepared from cells
overexpressing wild type RAB5 and is specifically inhibited by the addition of anti-rab5
antibodies (Gorvel et al., 1991). The specificity of these small GTP-binding proteins is
demonstrated by the fact that antibodies against other members of the same family of
proteins do not impare the function of rab5 in endosome fusion. Similar work has been
carried out using rablb which has been localised to the ER and the Golgi. Antibodies
against this ras homologue inhibit transport between these two compartments in semi-
intact cells (Plutner etal., 1991). The time at which these antibodies inhibit this
transport is consistent with ras homologues being required for vesicle targetting
(similarly antibodies against Yptlp block transport between the ER and the Golgi after
vesicle formation) as is the accumulation of vesicles in yeast cells harbouring sec4
mutations (Rexach and Schekman, 1991: Segev, 1991).
In addition to vesicle targetting and fusion, GTP hydrolysis appears to be needed for
vesicle budding (Beckers and Balch, 1989: Toozeetal., 1990: Goda and Pfeffer
1991), but is not necessary for all vesicle formation processes since GTPyS causes the
accumulation of transport vesicles (see above: Melangon et al., 1987). Direct evidence
for the involvement of GTP-binding proteins in the formation of transport vesicles has
come from work involving a suppressor of seel2 mutations, SARI. Sarlp is a GTP-
binding protein required for transport between the ER and the Golgi (Nakano and
Muramatsu, 1989) and the SARI suppression of seel2 has been reconstituted in vitro
(Oka etal., 1991) as has a direct biochemical interaction between Sarlp and Secl2p
that is required for the formation of transport vesicles from the ER (D'enfert et al.,
1991).
There is also evidence for the involvement of heterotrimeric GTP-binding proteins (the
type involved in signal transduction at the plasma membrane) in membrane trafficking
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events (for review and proposed models of how such proteins may be involved see
Barr etal., 1992 and also Pfeffer, 1992). It has been known for some time that such
proteins are found, not only on the plasma membrane, but also on some intracellular
membranes, such as the ER (Audigier et al., 1988) and the Golgi complex (Ercolani et
al., 1990) suggesting that they may be involved in the regulation of some function(s)
of these organelles. The retardation of secretion of proteoglycan from cells treated with
pertussis toxin (Stow etal., 1991) and the inhibition of secretory vesicle formation
from the Golgi complex by A1P in vitro (Barr etal., 1991) both suggests that trimeric
GTP-binding proteins are involved in these membrane trafficking events (pertussis
toxin ADP-ribosylates the ajg-subunit of trimeric G-proteins and A1P is known to
activate trimeric G-proteins but has no effect on G-proteins of the ras superfamily:
Higashijimaetal., 1989: Kahn, 1991).
From the above discussion it can be seen that cell free systems in which various stages
of the secretory pathway have been examined in isolation have played a crucial role in
the identification of factors involved in the pathway. Models of how these components
might act in the cell are then proposed, often takL.g into consideration information
gleaned from work utilising yeast mutants, and later modified, hopefully becoming
closer to reality, as more and more information about the secretory pathway is gathered.
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Figure 1-4
A model of intra Golgi vesicular traffic
Summarised here is a working model for vesicular transport between Golgi
compartments proposed by Rothman and co-workers (Rothman and Orci, 1992). The
membrane on the left (blank) represents a portion of Golgi membrane from which COP
coated vesicles bud. These then fuse with the target membrane (shaded), of the
subsequent Golgi compartment Specific targetting of the coated vesicles is proposed
to be initiated by an unknown component present in/on the acceptor membrane. The
vesicle is then uncoated and the NSF-dependent fusion pathway is triggered.
Components of the coated vqsicle include a complex of COPs (black squares) and ARF




2.6. Reconstitution of protein transport within the yeast system
Experiments involving the reconstitution of pro-ot-factor transport from the ER to the
next stage in the yeast secretory pathway (Baker et al„ 1988) demonstrate how the
genetic approach used to study secretion in yeast has been used in conjunction with a
biochemical/cell biology approach similar to that used to study the same system in
higher eukaryotic cells.
Messenger RNA can be translated in yeast lysates to generate a 19K form ofprepro-a-
factor, and it is possible to use such a system to produce 35S-met-labelled prepro-a-
factor which can be used to study protein transport. The labelled precursor can be
translocated post-translationally into either yeast microsomes or the ER of
permeabilised spheroplasts resulting in the protein being core glycosylated and yielding
a radioactive protein with an apparent molecular weight of 30K. The transport of core
glycosylated pro-a-factor to the next compartment of the yeast secretory pathway can
be followed by monitoring the formation of a form of the protein that migrates slowly
in gel electrophoresis and is recognised by a-1,6 mannose specific antibodies. The
formation of this more heavily glycosylated pro-oc-factor from the 30K form of the
protein requires the addition of ATP, cytosol and membranes to a system containing the
core glycosylated form sequestered in the ER. The addition of outer chain carbohydrate
was found to be accompanied by the movement of the radiolabelled protein from
rapidly sedimenting membranes to a population that sediment more slowly and which
are depleted of NADPH-cytochrome c oxidoreductase (an ER marker). This was one
criterion that was used to demonstrate that protein transport was being observed rather
than the fusion of two compartments, a phenomenon which may have given similar
results. The fact that GTPyS inhibits the appearance of the form of the protein
recognised by the a-1,6 mannose antibodies but not the formation of the 30K form also
provides evidence that two separate events are being followed here, and that transport
of the protein between the two compartments involves a GTP binding protein. The
transport system is also inhibited by NEM suggesting the involvement of Secl8p at this
stage in the pathway.
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This cell-free system was established using wild type yeast cells, but has also been
used to demonstrate that the transport could be detected between membranes prepared
from sec23 cells (which are deficient in the transport being measured) if they were
supplemented with cytosol prepared from SEC23 (wild type) cells (cytosol from sec18
cells also failed to support the reaction in agreement with the block imposed by NEM).
SEC23 encodes an 84K protein but the above system has been used to demonstrate that
it exerts its effects on the acceptor compartment of the reaction by associating with the
cytoplasmic face of the membrane as part of a 400K complex (Hicke and Schekman,
1989). This demonstrates the power of in vitro transport assays to aid the
understanding of the molecular mechanisms involved in protein transport.
Standard genetic techniques were used to identify and isolate BOS1 (Newman et al.,
1990), a gene which has been shown to suppress mutations in two genes which disrupt
the above transport system (SEC22 and BET1). Because of its ability to suppress these
mutations it was thought that the product of this gene must function in the transport of
proteins from the ER and the ability to follow the transport ofpro-a-factor as it travels
through the yeast secretory pathway has provided evidence to support this.
Transport ofpro-a-factor from the ER as described above has been divided into three
separate events that can be followed in the assay (Rexach and Schekman, 1991): (1)
vesicle budding from the ER; (2) targetting of these vesicles to the acceptor membrane;
and (3) fusion of the transport vesicles with the acceptor membrane. Vesicle budding
from the ER can be followed by monitoring the appearance of slowly sedimenting
membranes (which fractionates to a medium speed supernatant or MSS) containing core
glycosylated pro-a-factor (the ER, as 'characterised' by the marker enzyme NADPH-
cytochrome c oxidoreductase sediments rapidly). Vesicle targetting was followed by
monitoring the sedimentation of core glycosylated pro-a-factor in a sucrose density
gradient to the same fraction as membranes containing outer chain glycosylated pro-a-
factor (it had been shown that the transport vesicles containing core glycosylated pro-
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a-factor sedimented to a different fraction from the highly glycosylated form). Vesicle
fusion was followed by monitoring the conversion of core glycosylated pro-a-factor to
the highly glycosylated form of the protein in a MSS. The differential inhibition of
these three stages involved in the transport reaction by mutant SEC gene products and
chemical inhibitors has led to the model shown in Figure 1-5 to be proposed. The way
in which this system has been used demonstrates how genetics and cell biology can
work together to identify and characterise components involved in protein transport.
The results depicted in Figure 1-5 suggest that Secl8p is not involved in the actual
membrane fusion event, but rather serves as a docking protein to bring the two
membranes into close proximity since the ER to Golgi transport defect displayed by
yeast secl8 mutant lysates is apparently restricted to targetting. The Ca2+ dependent
vesicle fusion intermediate can be produced in a seel8 lysate at the permissive
temperature and can be used to show that fusion proceeds at both 25°C and 37°C upon
addition of Ca2+ and ATP (Rexach and Schekman, 1991). This has been taken to
indicate that Secl8p may not participate directly in membrane fusion (Schekman, 1992)
as discussed in Section 2.5. However, these findings do not rule out the possiblity that
Secl8p participates in the fusion reaction since it is possible that once assembled into a
fusion-competent form the fusion activity of the mutant form of Seel 8p may not be
thermosensitive, but its ability to assemble into such a form is. Such a scheme fits with
recently reported results which demonstrate that, although required for the formation of
functional vesicles (in an assay similar to that used by Balch etal., 1984), the NEM
sensitive function of NSF is not required for the attachment of these vesicles to the
acceptor compartment or their subsequent fusion with the acceptor membrane
(Wattenberg etal., 1992). If NSF does have a role in membrane fusion, as discussed
in Section 2-5, these results indicate that it is incorporated into vesicle membranes
during vesicle formation and carried to the site of membrane fusion in this way.
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Figure 1-5
A yeast cell free transport system
Depicted here is a breakdown of transport of pro-a-factor from the ER in yeast cells to
the next compartment in the secretory pathway. Inhibition of various stages of the
transport of pro-a-factor by mutant sec gene products and chemical inhibitors in
permeabilised spheroplasts has led to the formation of the following model explaining
how a number of components may function in protein transport (MSS/P; medium speed












Section 3. The Golgi complex
3.1. Introduction
The structure and distribution of the organelle first described by Camillo Golgi at the
end of the last century (Golgi, 1898) has been described in many eukaryotic cell types
(for review see Mellman and Simons, 1992). A text book description of the
morphology of the Golgi complex might talk of a system of distinct but interconnected,
flattened, membrane-bound compartments (sacs or cisternae), located close to the
nucleus of the cell. This organelle is apparent throughout the cell cycle, except in
premitotic cells where it appears to fragment prior to distribution between the two
daughter cells (Lucocq et al., 1987). Although stacked cisternae can be seen in the
fission yeast S. pombe (Chappell and Warren, 1989), no such structure is visible in
S. cerevisiae (Redding etal., 1991), but there is evidence, some of which is discussed
below, for a compartment of the yeast secretory pathway believed to be analogous to
the mammalian Golgi apparatus.
In mammalian cells the Golgi complex or apparatus is commonly thought of as being
made up of at least three sub-compartments each containing their own sets of unique
enzymes (Dunphy and Rothman, 1983: Duden et al., 1991b). Although
immunocytochemistry provides evidence for this (Roth and Berger, 1982: Slot and
Geuze, 1983: Roth et al., 1985) in that antibodies which recognise different enzymes
seem to recognise different compartments within cells, results obtained using such
procedures are often difficult to interpret and ultimate proof requires that double
labelling techniques are perfected. The compartment closest to the nucleus, which
receives transport vesicles from the ER is known as the cis compartment and it is here
that proteins are modified by mannosidase I (Kornfeld and Kornfeld, 1985: Pelham,
1989) before being moved by vesicular traffic to the medial Golgi where GlcNAc
transferase I catalyses the addition of N-acetyl glucosamine to sugar chains (Dunphy et
al., 1985). The final compartment(s) of the Golgi complex, together with associated
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tubules is(are) known as the trans Golgi network (TGN: Griffiths and Simons, 1986:
Geuze and Morre, 1991) which contains enzymes that complete the processing of many
oligosaccharide chains, for example galactosyltransferase and sialyltransferase (Roth
et al., 1986). The compartmentalisation and polarisation of the Golgi complex were
originally suggested as a result of conventional electron microscopy observations
(Farquhar and Palade, 1981) and additional evidence has since been provided by
biochemical studies (e.g. differential gradient centrifugation can be used to separate
enzymes associated with the organelle, suggesting that they reside in distinct membrane
bound compartments) and immunocytochemistry (Goldberg and Kornfield, 1983:
Dunphy and Rothman, 1983).
In addition to being the 'carbohydrate factory' of the cell, gathering substrates to be
used in the modifications of oligosaccharide chains from the cytosol the Golgi complex
is also the site where a number of other biosynthetic processes occur, including the
formation of glycolipids, and in plants it is in this organelle that extracellular
polysaccharides are produced (Mellman and Simons, 1992). It is from the TGN that
proteins are sorted to their various cellular destinations (Griffiths and Simons, 1986)
such as the lysosome, secretory vesicles or specific plasma membrane domains
(Huttner and Tooze, 1989).
3.2. Evidence for the existence of a Golgi apparatus in yeast cells
Various modifications of the N-linked glycans that are attached to proteins in the ER of
yeast cells that convert them to the form found in secreted proteins have been shown to
be carried out by a membrane fraction that is distinct from the ER (Esmon etal., 1981:
Kukuruzinska etal., 1987). The similarity of these modifications to those carried out
by enzymes located in the Golgi apparatus of mammalian cells suggests that they occur
in an organelle present in yeast cells that is equivalent to the Golgi complex found in
mammalian cells.
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Although no structure with morphology similar to the mammalian Golgi has been
observed in yeast cells, temperature-sensitive mutations in either SEC7 or SEC14 cause
cells to accumulate exaggerated structures that resemble stacked cisternae at the
restrictive temperature (Esmon et al., 1981: Novick et al„ 1981). At 37°C these cells
also accumulate intracellular pools of secretory proteins with characteristic post-ER
modifications of oligosaccharides.
The well characterised processing of the mating pheromone a-factor (see Section 2.2)
makes it a useful tool with which to study protein transport in yeast. It is possible to
detect two of the modifications that pro-oc-factor undergoes as it travels through the
yeast secretory pathway, namely, the addition of outer chain carbohydrate to core
glycans received in the ER and its maturation to a-factor following cleavage by the
Kex2 protease. Work with sec mutants has established that both of these events occur
after the protein has left the ER and before it enters secretory vesicles. In sec7 cells the
addition of outer chain carbohydrate to pro-a-factor can be detected at 37°C, but there
is a substantial reduction in the rate of maturation of the pheromone (Franzusoff and
Schekman, 1989). This indicates that these reactions occur in different, distinct,
cellular compartments, transport between which requires Sec7p. This conclusion is
supported by the fact that intracellular vesicles containing the Kex2 protease sediment in
density gradients to a position distinct from those containing mannosyltransferase I (an
enzyme responsible for the addition of outer chain carbohydrate to glycoproteins)
(Cunningham and Wickner, 1989). These observations have led to the belief that
proteins travelling through the yeast secretory pathway encounter more than one
compartment after leaving the ER and before being packaged into secretory vesicles as
is the case when proteins travel through the Golgi complex of mammalian cells.
Further evidence for compartmentalisation of a yeast organelle taken to be functionally
analagous to the mammalian Golgi comes from pulse-chase labelling experiments
carried out using sec7 cells. At 37°C these cells accumulate a spectrum of N-linked
oligosaccharide structures (ranging from core glycosylation to nearly mature
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carbohydrate) associated with the ordinarily secreted glycoprotein invertase. If the
modifications leading to the various forms of the protein all occurred in a single
compartment then only the mature form of invertase would be expected to accumulate
intracellularly (Franzusoff and Schekman, 1989). Not only do these results support the
existence of different compartments in the organelle, but they also indicate that Sec7p is
required for transport of proteins between the different compartments.
3.3. Visualisation of the yeast Golgi
The absence of a structure analagous to the mammalian Golgi complex in yeast has led
to the cellular distribution ofproteins associated with the yeast Golgi to be investigated
in order to gain some insight into the morphology of this organelle.
Immunofluorescence studies indicate that Kex2p is located at multiple, discrete sites
within wild type yeast cells (between 1-5 per cell) and is not concentrated at a
perinuclear location as may have been expected (by analogy of the organelle in which it
resides with the mammalian Golgi complex) (Redding et al., 1991).
The pattern of Kex2p distribution as determined by immunofluorescence in sec18 cells
at 37°C resembles that seen for a resident ER protein. This is very different from the
pattern observed in the same cells at 25°C, which is the same as that observed in wild
type cells. The distribution of Kex2p in seel cells (which accumulate secretory vesicles
at 37°C) is as that observed in wild type cells at both 37°C and 25°C.
Immunofluoresence has been used to show that secretory proteins accumulate in the
bud of seel cells at 37°C, and the lack of localisation of Kex2p to this area of these
cells demonstrates that the protein does not enter secretory vesicles. Taken together,
these obsevations (Redding etal., 1991) demonstrate that ordinarily the Kex2 protein
progresses from the ER but is not incorporated into secretory vesicles, a conclusion
consistent with its localisation to a stage in the secretory pathway between the ER and
secretory vesicles. Immunofluorescence studies reveal that Sec7p (a protein whose
malfunction leads to the accumulation of exagerated Golgi like structures and
40
intracellular pools of secretory proteins bearing post ER modifications) has the same
cellular distribution as that observed for Kex2p (Franzusoff etal., 1991).
From all the above evidence it seems reasonable to refer collectively to the cellular
compartments encountered by proteins travelling through the yeast secretory pathway
after they leave the ER and before they are packaged into secretory vesicles as the yeast
Golgi. This recently described organelle is currently receiving much research interest,
including work involving the two genes, SEC7 and SEC14 which have Golgi-related
functions (Schekman, 1992). The Kex2 protein resides in a compartment of this
organelle that is encountered by proteins after they have received covalent modifications
carried out in other compartments of the organelle, before they are packaged into
secretory vesicles which are targetted to either the vacuole or the plasma membrane
(Franzusoff and Schekman, 1989: Graham and Emr, 1991).
3.4. Protein transport assays involving the yeast Golgi
Emr and his colleagues have demonstrated that Secl8p is required at multiple stages in
the yeast secretory pathway by showing that individual events in the maturation of ce¬
faclor require the protein, as indicated in Figure 1-6 (Graham and Emr, 1991). The
same rationale of preloading the secretory pathway of a cell with radiolabelled protein
prior to the introduction of a rapid sec block (described in Section 2.3) has been used to
show that Sec23p is required for the addition of a-1,6 mannose to the core
glycosylated form and the addition of a-1,3 linked mannose to the a-1,6 mannosylated
form but not for the Kex2p dependent proteolytic processing of the a-1,3
mannosylated form or the secretion of the mature peptide from the cell. These results,
taken in conjunction with the knowledge that Secl8p/NSF is required for vesicle
mediated transfer of proteins between individual compartments, provide evidence that
each of the events in the maturation of a-factor described above occurs in a separate
membrane bound compartment.
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The vacuolar protein carboxypeptidase Y (CPY) is synthesised as an inactive precursor
pro-CPY which carries information that results in its localisation to the yeast vacuole
where it is proteolytically processed to the mature form (mCPY). It is possible to
observe the transport of this protein to its final destination in permeabilised spheroplasts
prepared from cells that have been radioactively labelled under conditions that
kinetically trap precursor forms of CPY bearing post translational modifications
characteristic of residency in the Golgi apparatus (Vida et al„ 1990). Transport can be
followed by monitoring the appearance of mCPY, an event which requires the action of
vacuolar proteinase A (PEP4 gene product). Transport has been shown to require ATP,
cytosol and it has proved impossible to reconstitute the transport in spheroplasts
prepared from certain vps mutants confirming that the products of VPS15, 33 and 34
are required for the transport of proteins to the vacuole.
The gene encoding proCPY (PRC1) has been used to construct a hybrid gene which
encodes a CPY-oc-factor-invertase fusion protein (Graham and Emr, 1991). Cells
expressing the hybrid gene secrete the invertase portion of the protein while the CPY
portion remains inside the cell. From this, it is concluded that proteins are sorted to the
vacuole after they have encountered the Kex2 protease which is responsible here for
cleaving the fusion protein.
Taken together the above findings (Vida et al., 1990: Graham and Emr, 1991) have led
to a model for the compartmental organisation of post-translational modification and




A proposed compartmental organisation of the yeast Golgi
This model for the compartmental organisation of various posttranslational modification
and vacuolar protein sorting events in the yeast Golgi complex has been described by
Emr and his co-workers. Shown travelling through the pathway are pro-a-factor (pro
a f) and the vacuolar protein CPY. The latter is depicted in the various precursor forms
in which it is found as it travels through the Golgi (pi and p2, p; precursor, m;
mature). Also shown are the positions at which the gene products of SEC18 and





























3.5. The importance of the lipid composition of organelles
SEC14 is essential for the secretory function of a late Golgi compartment in yeast and
has been shown to encode a phosphatidylcholine/phosphatidylinositol (PC/PI) transfer
protein (Bankaitis et al., 1990). Phospholipid transfer proteins move specific
phospholipids from the outer leaflet of one membrane bilayer to that of another. This
finding has implicated phospholipid biosynthesis and exchange in the functioning of the
secretory pathway (Cleves et al., 1991a). Since secl4 cells can function normally if
they also contain mutations in genes encoding enzymes involved in PC synthesis
(Cleves et al., 1991b) it has been proposed that efficient transport through the Golgi
complex depends on a high PI:PC ratio in the cytosolic leaflet of Golgi membranes.
This proposal predicts that incubation in choline-deficient medium should rescue secl4
mutants but this does not appear to be the case and this area remains unclear (as
discussed by various authors in Trends in Cell Biology. Volume2, pages 69-72).
PI is a glycolipid with a large polar head group that gives the molecule an overall
conical shape. PC on the other hand is zwitterionic and has a more cylindrical shape.
A membrane with a high PI/PC ratio in its outer leaflet would have a very curved
structure. Such a structure may be necessary for the formation of secretory vesicles
from membranes. It can be seen that vesicles do bud from highly curved regions of the
mammalian Golgi (i.e. the rims of Golgi saccules) which consists of otherwise planar
membranes (Farquhar and Palade, 1981). Such a theory predicts that post-Golgi
secretory vesicles will have a higher PI/PC ratio than their donor membrane (such a
prediction will only be able to be tested following the isolation of such secretory
vesicles and their donor organelle). Rather than exerting its effect through structural
means, the correct phospholipid composition of membranes may be important in
secretion by providing the correct environment for the functioning of proteins involved
in facilitating the various stages involved in the secretory pathway. There are many
examples of proteins requiring specific lipid environments to function optimally: it may
be envisaged for example that the nucleation of COPs could require a high PI/PC ratio.
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The exciting discovery of the function of Secl4p will undoubtedly lead to a revival of
interest in the lipid composition of cellular organelles and in the lipid requirements of
components involved in membrane traffic. The latter may be investigated by the
incorporation of such components into liposomes containing a soluble cargo protein,
delivery of which to an acceptor compartment could then be followed. Such a scheme
would be able to demonstrate whether all the components involved in a protein
transport step had been identified.
Section 4. Immunoisolation of subcellular organelles
4.1. Introduction
From the work and ideas discussed so far in this chapter a number of places are evident
where the ability to separate one organelle from all other cellular components would be
advantageous, section 3.5 for example. This would allow interpretation of results from
transport assays to be made with less confusion as implied by the quote 'don't waste
clean thinking on dirty enzymes' (Efraim Racker, quoted in Romberg, 1990). The
technique of immunoisolation allows this to be achieved. An antibody that has been
covalently bound to a solid support (to form an immunoadsorbent or ImAd) can be
used to isolate its antigen and any associated structures from a cell lysate or other
biological preparation. Direct immunoisolation involves the addition of a preformed
ImAd to the preparation from which the desired cellular component is to be isolated.
During incubation in the preparation under appropriate conditions the ImAd will bind
the antigen against which its antibody was raised. The ImAd can then be recovered,
either by centrifugation, if for example agarose beads were chosen as the solid support,
or by magnetism if magnetic beads had been used. Such quick and easy recovery
procedures allow the TmAdrantigen and associated structures' complex to be washed
free of any material which may bind to the complex non-specifically. Indirect
immunoisolation involves the addition of free antibody to a system, after which a
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matrix that will bind the antibody (as part of an antigen:antibody complex) is added (see
Figure 1-7).
4.2. Immunoisolation of membranes
Equilibrium density gradient centrifugation is often used to separate membranes that are
derived from different organelles, with the various fractions being identified by
assaying for the activities of various marker enzymes. This technique has been used to
prepare fractions enriched in various organelles which have subsequently been used as
donor or acceptor fractions in protein transport assays (e.g. Balch et al., 1984). The
Golgi fraction used by Rothman and co-workers in their intra-Golgi transport assay is
reported to have been between 30 and 40% pure (Balch et al., 1984). The use of less
contaminated fractions in such a system would offer many advantages in analysing
results and although it is likely that a purer preparation could be obtained using standard
techniques this is likely to be more time consuming than the preparation of such a
fraction by immunoisolation. Immunoisolation takes advantage of an antigen's
localisation to a particular cellular structure in order to purify that structure by using the
antigen as a handle. Since it relies on the specific interaction between an antibody and
its antigen this technique offers advantages in the purification of membrane fractions
over more traditional methods of isolating such fractions which rely on physical
differences between membranes in that membranes of a higher purity may be obtained
in a shorter period of time.
When membranes are required to study protein transport, immunoisolation offers an
advantage over equilibrium density gradient centrifugation in that it facilitates recovery
of the membrane fraction after the transport assay has been carried out. This may be
useful as it allows the analysis of the fraction before and after the reaction and can be
used to study any changes which may have occured during the reaction.
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Figure 1-7
Immunoisolation of cellular structures
A diagramatic representation of the theory behind the technique of immunoisolation
shown here comparing direct and indirect forms of the technique.
preparation containing
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The technique also allows the 'sidedness' of membrane vesicles to be chosen. This can
be achieved using an antibody that specifically recognises its antigen through a domain
known to be located on a particular side of a membrane (Figure 1-8).
The plasma membrane of epithelial cells is divided into two distinct domains, with
different protein compositions. Transport vesicles that deliver proteins from the TGN
of such cells to the plasma membrane are targetted either to the apical domain or the
basolateral domain. VSV-G-protein is targetted to the basolateral plasma membrane of
MDCK cells, whereas a membrane protein of influenza virus, haemagglutin A is
targetted to the apical domain of the same cells. Antibodies raised against cytoplasmic
domains of the two virally-encoded proteins have been used to demonstrate that these
two proteins are packaged into distinct sets of transport vesicles in cells infected with
the two viruses (Wandingeret al., 1990). The two sets of vesicles, immunoisolated
using the antibodies immobilised on agarose beads from a gradient purified membrane
fraction prepared from virally infected cells, both contain a subset of proteins present in
the fraction from which they were isolated. Some of these proteins are present in both
types of vesicles and are believed to be involved in budding and/or fusion events,
whereas proteins that are unique to one type of vesicle may be involved in specific
recognition events such as protein sorting or vesicle targetting.
Antibodies that recognise the cytoplasmic domain of G-protein have also been used to
immunoisolate endocytotic intermediates from extracts prepared from cells whose
endocytotic pathways had been allowed to proceed for various lengths of time
(Gruenberg et al., 1989). Both of the examples outlined above allowed the
characterisation of the isolated intermediates.
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Figure 1-8
Immunoisolation of membrane vesicles
This figure demonstrates how an antibody which recognises a specific domain of a
membrane protein whose orientation is known may be used to isolate vesicles of
known sidedness derived from the membrane in which the antigen resides.
population of membrane vesicles
containing both inside-out (A) and
outside-out (B) vesicles derived from
the organelle of interest
immunoisolation using an antibody
that recognises a cytoplasmically
disposed domain of a protein will
purify right-side out vesicles
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Vesicles involved in protein transport are often present in cells in very small amounts,
and are short lived intermediates. Incubation of sec mutants at their restrictive
temperature can increase the cellular population of functional transport vesicles, and this
fact has been taken advantage of in the purification of post-Golgi secretory vesicles
from yeast from blocked sec6 cells (Walworth and Novick, 1987). This purification,
involving gel filtration chromatography as well as various forms of centrifugation,
allowed the characterisation of these vesicles and led to the identification of two
membrane proteins associated with them. It may be possible to use this information to
develop a procedure which would allow these same vesicles to be immunoisolated.
Such a procedure would offer an advantage over the purification procedure described,
in that it would allow the vesicles to be added to, and then later removed from cell free
systems with ease, allowing their function to be studied.
4.3. Immunoisolation in conjunction with protein transport assays
SEC7 encodes a phosphoprotein with a molecular weight of 230K (Achstetter et al.,
1988) that is required at a number of stages in the secretory pathway (Franzusoff and
Schekman, 1989). Sec7p is present in wild type yeast lysates in approximately equal
proportions of soluble and membrane associated forms. Antibodies raised against the
protein have the ability to block the formation of the highly glycosylated form of pro-ce¬
faclor in the transport assay described in Section 2.6 (Franzusoff et al., 1992). The
addition of the antibodies did not affect the budding of vesicles from the ER, since the
core glycosylated form of the protein still appeared in the medium speed supernatant
(MSS-that does not contain the ER) in their presence, but this did not receive outer
chain glycosylation indicating that delivery to the Golgi had been blocked. The
transport assay has been used to show that the Golgi present in a MSS treated with the
Sec7p antibodies is competent as an acceptor compartment, but the transport vesicles
containing core-glycosylated pro-a-factor are incompetent for fusion. Protein A-
Sepharose added to such a MSS results in the recovery of membrane vesicles devoid of
marker enzymes characteristic of the ER (Franzusoff etal., 1992). Examination of this
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immunoisolated fraction by electron microscopy reveals that it contains vesicles similar
in size to those accumulated by class II ER-accumulating sec mutants. This technique
has opened a way to the characterisation of these vesicles, although since Sec7p has
been shown to be required at multiple stages in the yeast secretory pathway the
preparation may contain other vesicles apart from those derived from the ER and this
must be taken into consideration. Initial characterisation studies (from elecron
microscopy) have been taken to suggest that Sec7p may be involved in the formation of
a coat around these transport vesicles a theory which fits with its involvement in
multiple stages of the secretory pathway.
Section 5. Ouline of the project
The aim of this project was to investigate the use of immunoisolation procedures for the
purification of specific membrane fractions from yeast. More specifically, a polyclonal
antiserum was to be raised against the cytoplasmically disposed C-terminal domain of
the Kex2 protease which could then be used to isolate membranes derived from the
compartment of the yeast Golgi containing this protein. The isolation of such
membranes would allow the characterisation of the Kex2p compartment with respect to
its structure, by examining the composition of immunoisolated material, and also its








2.1. Chemicals, enzymes and antibodies.
All chemicals were obtained from Sigma Chemical Co. or BDH Chemicals. Trans-
label [3^S]-met (1136 Ci/mmol) was from ICN Radiochemicals. DNA modification
enzymes were from BRL. Taq polymerase was from Promega limited. Zymolyase
100T was from the Seikagaku Kogyo Co. Japan, lysozyme was from Sigma Chemical
Co. Antibodies not produced during the course of this project were obtained from the
Scottish Antibody Production Unit (unless otherwise stated), the anti-ampicillinase
antibodies were from 5 prime-3 prime Inc. Enhanced chemiluminescence (ECL) kit
and Hyperfilm-MP were from Amersham International. Pansorbin (Staphylococcus
aureus cells, standardised) was from Calbiochem. The synthetic substrate for the Kex2
assay (b-QRR MCA) was from the Peptide Institute Inc., Japan. Nitrocefin was from
BBL Microbiology Systems. IgG-Sepharose (Fast Flow) was from Pharmacia LKB.
Affi-gel 10 was from Bio-Rad Laboratories, as were the Poly Prep chromatography
columns. Media components were from Difco Laboratories.
2.2. Bacterial and yeast strains
The strains of E. coli and S. cerevisiae used in this study are listed in Table 1 (see
Appendix). Derivatives of these are not listed, but are described in appropriate text.
Transformants are denoted by listing the strain, followed by the plasmid with which it
has been transformed in parenthesis.
2.3. Media
Bacterial cultures were grown in complete medium (Luria broth; L-broth) containing
1% (w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast extract and 0.5% (w/v) NaCl.
Antibiotics were added to this as required. Bacto agar was added to the above to 1.5%
(w/v) when solid medium was required.
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Yeast cultures were grown in either rich medium (YPD; containing 1% (w/v) Bacto
yeast extract, 2% (w/v) Bacto peptone and 2% glucose) or minimal (selective) medium
(SD; containing 0.67% (w/v) Bacto yeast nitrogen base without amino acids and 2%
(w/v) glucose) to which the following were added, to the following final
concentrations, as required; histidine (20(ig/ml), leucine (30|ig/ml), tryptophan
(20fig/ml), uracil (20|ig/ml). Where stated, the carbon source supplied in the medium
was galactose which was added to the above in place of glucose to make (YPG and
SG). 2% (w/v) Bacto agar was added, to 2% (w/v), to the above when solid medium
was required.
Sporulation media consisted of 0.1% (w/v) Bacto yeast extract, 1% potassium acetate
and 0.05% (w/v) glucose.
2.4. Plasmids




All general DNA manipulation techniques, including restriction endonuclease cleavage,
extraction with phenol, precipitation in ethanol, ligation and PCR were performed as
described by Maniatis etal (1982) and Sambrook (1989).
Gel electrophoresis, for the separation and visualisation of DNA fragments, was
routinely carried out using agarose gels of between 0.6 and 1.2% (w/v) agarose; the
size of fragments of DNA was estimated by comparing their mobility through an
agarose gel with that of fragments of known size liberated by digestion of phage X.
DNA with either Pstl or 5.vtEII.
2.6. Transformation of bacterial and yeast cells
DNA was transformed into bacterial cells which had been treated with CaCl2 as
described by Maniatis etal (1982). Yeast cells were made competent for transformation
by using LiOAc as described by Ito etal. (1983).
2.7. Preparation of yeast genomic DNA
A 5ml of culture of yeast cells was grown overnight in YPD. Cells were harvested
from this and resuspended in 0.5ml 1M sorbitol, 0.1M EDTA (pH7.5). Zymolyase
was added to 20|ig/ml and the cells were incubated at 37°C for 1 hour. Spheroplasts
were harvested by centrifugation for 2 mins at 4000g and resuspended in 50mM
Tris.HCl (pH7.4), 20mM EDTA. 50|il 10% SDS was added prior to incubation at
65°C for 30 mins, after which 200(il 5M potassium acetate was added. The sample
was incubated on ice for 1 hour and then centrifuged at 10 OOOg for 5 mins. An equal
volume of isopropanol was added to the resulting supernatant, and after 5 mins
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incubation at room temperature the sample was centrifuged for 10 mins at 10 OOOg.
The pellet thus obtained was air-dried and then resuspended in 300(il TE buffer (lOmM
Tris.HCl (pH8.0), ImM EDTA). 30|il of 3M NaOAc (pH5.2) and 200|ll isopropanol
were added and the sample was centrifuged for 5 mins at 10 OOOg. The final pellet was
resuspended in 200|il TE buffer.
2.8. Determination of yeast mating type
To establish whether a yeast strain was MATa or MATa, cells were mixed separately
with the strains DC 14 and DC 17 under conditions that select for the formation of
prototrophic diploids. MATa strains formed such diploids with DC 14 and MATa
strains with DC 17.
2.9. Electrophoretic separation of proteins
Electrophoretic separation of proteins was performed using SDS polyacrylamide gels
following the basic procedures described by Laemmli (1970) using the v iious
solutions detailed below.
Separating gel buffer: 0.75M Tris.HCl (pH8.8), 0.2% (w/v) SDS
Stacking gel buffer: 0.25M Tris.HCl (pH6.8), 0.2% (w/v) SDS
Acrylamide solution: 44% (w/v) acrylamide, 0.8% (w/v) N;N'-methylene-
bisacrylamide
Electrophoresis buffer: 0.125M Tris. 0.2M glycine, 0.1% (w/v) SDS
(gives pH8.3 without adjustment)
SDS sample buffer: 0.0625M Tris.HCl(pH6.8), 20% (w/v) glycerol,
4% (w/v) SDS, 5% (w/v) p-mercaptoethanol
Routinely, either a 12% (w/v), 10% (w/v) or a 6% (w/v) separating gel, with a 5%
(w/v) stacking gel, was used to achieve separation of proteins.
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Following electrophoretic separation, protein bands were visualised by staining with
Coomassie blue: the gel was allowed to equilibrated with a solution of 0.25% (w/v)
Coomassie Brilliant Blue dissolved in 50% (v/v) methanol, 7% (v/v) acetic acid.
Destaining of the gel was achieved by gently agitating the gel, immersed in 10% (v/v)
methanol, 7% acetic acid.
2.10. Preparative SDS-PAGE and electroelution
The sample from which the desired protein was to be purified was subjected to
electrophoretic separation using an appropriate polyacrylamide gel with a single well
(capable of holding 1ml of sample) across its top. Following staining of the gel with
Coomassie blue a slice of the gel containing the protein of interest was excised. The
protein was extracted from this gel slice by dividing it into small fragments (approx
2mm x 2mm) and placing them into a length of dialysis tubing containg 5ml
electrophoresis buffer. Electroelution was achieved by placing the sealed dialysis
tubing containing the gel in an electrophoresis tank containing electrophoresis buffer
and applying a voltage of 125V for 5 hours. Following this, the buffer into which the
protein had been eluted was dialysed, at 4°C, against distilled water.
2.11. Fluorography
Following electrophoretic separation of radiolabelled proteins on an appropriate
polyacrylamide gel the gel was incubated on a shaking platform in 25% methanol, 7%
acetic acid for 1 hour. The gel was then washed (4x10 mins) in distilled water, before
being incubated in 1M sodium salicylate for 1 hour. The gel was washed as before,
prior to being vacuum dried onto blotting paper. X-ray film was exposed to the dried
gel at -70°C.
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2.12. Transfer of proteins onto nitrocellulose
2.12a. Semi-dry electroblotting
Where required, proteins that had been separated on polyacrylamide gels were
transferred onto nitrocellulose by a semi dry blotting procedure (using an LKB semi
dry blotting apparatus). Six pieces of 3MM paper and one piece of nitrocellulose were
cut to the same size as the gel to be blotted. Two of the pieces of 3MM paper were
soaked in anode buffer 1 (0.3M Tris.HCl (pH10.4), 20% (v/v) methanol, 0.1% SDS)
and placed, one on top of the other, on the anode plate. A piece of 3MM paper soaked
in anode buffer 2 (25mM Tris.HCl (pH10.4), 20% (v/v) methanol, 0.1% (w/v) SDS)
was placed on top of these, followed by the nitrocellulose which had been soaked in
water and then the gel which had been soaked in cathode buffer (25mM Tris.HCl
(pH9.4), 20% (v/v) methanol, 0.1% (w/v) SDS, 40mM 6-amino-rc-hexanoic acid).
The remaining 3 peices of 3MM paper were soaked in cathode buffer and layered on
top of the gel. The cathode plate was placed on top of the stack and transfer was
achieved by applying a current of 0.8mA per cm2 gel area.
2.12b. Wet electroblotting
For the detection of Ste2p on immunoblots it was necessary that the buffers used did
not contain methanol. When this protein was to be detected the proteins were
transferred using a wet blotting apparatus. The SDS-polyacrylamide gel containing the
separated proteins was placed next to a sheet of nitrocellulose that had been cut to the
same size as the gel and was then sandwiched between two sets of three sheets of 3MM
paper that had been soaked in blotting buffer (125mM Tris.HCl (pH7.4), 200mM
glycine). Transfer was achieved by placing this sandwich in a tank containing blotting
buffer and a current of 0.8 amps was applied for 2 hours (with the nitrocellulose closest
to the anode).
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2.12c. Dot blotting assay: screening culture supernatants
(for monoclonal antibody production)
Yeast lysate (diluted to 0.2mg/ml and solubilised with 0.05% Triton X-100) was
applied to a sheet of nitrocellulose (soaked in distilled water) using a Biorad Bio-Dot
microfiltration apparatus by passive filtration. Unfilled sites on the nitrocellulose were
blocked with 0.5% Tween-20 in TBS (1 hour). The nitrocellulose membrane was put
back in the dot-blotting apparatus with the positions of the dots corresponding to the
wells. The apparatus was sealed and various culture supernatants were added to the
wells. Following overnight incubation, the filter was processed as described for
immunoblot analysis (2.13.), using anti-mouse-IgG and anti-mouse-IgM antibodies.
2.12d. Ponceau S staining
The presence of proteins on nitrocellulose filters was detected using Ponceau-S. The
nitrocellulose was immersed in 0.2% (w/v) Ponceau-S in 3% (w/v) TCA. Destaining
was achieved by washing the nitrocellulose with distilled water and the staining was
reversible upon washing the filter with TBS (lOmM Tris.HCl (pH7.4) 1.5M NaCl).
2.13. Immunoblot analysis
Unfilled sites on a nitrocellulose filter onto which proteins had been transferred were
filled by gently agitating the filter in blocking buffer (5% (w/v) non-fat dried milk, 1%
Tween-20 in TBS; lOmM Tris.HCl (pH7.4) 150mM NaCl) for 1 hour. The filter was
then exposed to primary antibody for one hour with gentle agitation. Antibody
preparations were presented to the filter, diluted in blocking buffer as described in the
text.
Following exposure to primary antibody , the filter was washed, once for 15 mins and
then 3 times for 5 mins with washing buffer (1% (v/v) Tween-20 in TBS). Where
required, the filter was then exposed to secondary antibody (routinely, a donkey anti-
rabbit IgG-HRP conjugate used at a dilution of 1 in 5000 in blocking buffer for the
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detection of rabbit antibodies; and either an anti-mouse-IgG (whole molecule) or an
anti-mouse-IgM (|i chain specific) antibody for the detection of mouse antibodies) for
20 mins. For the detection of protein A fusion proteins only one antibody (a rabbit
anti-bovine IgG-HRP conjugate was used at a dilution of 1 in 10 000 in blocking
buffer) was required, and the filter was exposed to this for 20 mins. Prior to the
detection of the HRP-conjugated antibody, the filter was washed as before, and then
once briefly with TBS.
Two different methods of detecting HRP conjugated antibodies on immunoblots were
used in this study. Immunoblots presented in the first part of Chapter 3 (up to and
including Figure 3-7) were developed using 4-chloro-l-naphthol. This was achieved
by placing the filter in developing solution (containing 20ml of a solution of 4-chloro-l-
naphthol (3mg/ml in methanol) and 20ml of a 30% (w/v) H202 solution per 100ml) and
watching for the appearance of a dark brown precipitate indicating the presence of HRPV
on the filter. The reaction was stopped by washing the filter liberally with distilled
water and then storing in TBS in the absence of light. It was important that
immunoblots developed in this way were photographed as soon as possible as the
colour tended to fade fairly rapidly.
Immunoblots presented later in this study were developed using enhanced
chemiluminesence (ECL) with ECL reagent in accordance with the manufacturers
instructions.
N.B. In order to include molecular weight marker proteins on immunoblots, the
nitrocellulose filter was stained with Ponceau S prior to immunoblot anlysis. This
revealed the positions of marker proteins which had been separated on the gel, these
positions were then marked on the filter using indelible ink.
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2.14. Production of hybrid proteins from E. coli
2.14a. Induction of expression from the lacZ promoter
A culture of bacteria harbouring a plasmid containing a gene under the control of the
lacZ promoter (e.g. pKpra) was grown in selective medium to an OD60q of 0.8.
Expression was induced by the addition of IPTG to a final concentration of 0.25mM
and the culture was left growing at 37°C for a further 4 hours.
2.14b. Induction of expression from the PR promoter
A culture of bacteria harbouring a plasmid containing a gene under the control of the PR
promoter (e.g. a pEX vector) was grown at 30°C in selective medium to an OD60q of
0.4. Expression was induced by incubating the culture at 42°C for 4 hours.
2.14c. Fractionation of a bacterial culture by differential centrifugation
(Preparation of inclusion bodies)
Cells were harvested by centrifugation (5 mins at 5000rpm in a Beckman JA-20/JA-14
rotor), washed once with, and then resuspended in, one twentieth of the culture volume
lOOmM Tris.HCl (pH7.4). Lysozyme was added to a final concentration of lmg/ml
and the cells were left on ice for 20 min. Cell lysis was achieved using sonication (5
bursts of 30 seconds with 2 min cooling intervals on ice). The lysate was clarified by
centrifugation in a Beckman JA-20 rotor (3000rpm for 5 mins), to yield the pellet P3.
The resultant supernatant was subjected to further centrifugation in the same rotor (20
mins at 20 OOOrpm) to yield the soluble S20 and the insoluble P20 fractions. For
comparison of the protein composition of the various fractions, both the P3 and the P20
were resuspended in one twentieth of the original culture volume lOOmM Tris.HCl
(pH7.4) before subjection to electrophoretic separation.
2.14d. Use of IgG-Sepharose in the purification of Spa-fusion proteins
A soluble fraction (of volume V) was prepared from an appropriate bacterial culture
(Chapter 3) and was incubated overnight at 4°C on a rotating wheel to allow gentle
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mixing with IgG-Sepharose (V/10) which had been equilibrated, by washing, with
TST buffer (50mM Tris.HCl (pH7.4), 150mM NaCl, 0.05% Tween-20). The IgG-
Sepharose was washed eight times with TST buffer before being resuspended in
elution buffer (V/5) (0.5M acetic acid adjusted to pH3.4 with ammonium acetate).
Elution of material bound to the IgG-Sepharose was achieved by gentle mixing at 4°C
for 20 mins. A second elution was performed for a further 10 mins and the two eluates
were pooled and dialysed against distilled water.
2.15. Production of polyclonal antibodies from rabbits
2.15a. Immunisation of rabbits and collection of serum
For immunisation with spa fusion proteins, lOOpg of the protein (in a 250pl volume)
was emulsified with an equal volume of Freund's complete adjuvant. This material
was administered to young New Zealand white rabbits by subcutaneous injection. Six
weeks after the initial injection a subcutaneous booster of the same amount of the
protein was administered in Freund's incomplete adjuvant. A second boost was
administered in this way six weeks after the first, 10 days after which, 5ml of blood
was collected from the animal. Serum was prepared from this blood sample by
allowing it to stand at room temperature for 1 hour and then at 4°C for 24 hours. The
serum was separated from clotted material by centrifugation (10 mins at 10 OOOrpm in a
Beckman JA-20 rotor) and was passed through a 0.22pm Millipore filter. After it had
been ascertained that the serum contained the desired antibodies (e.g.by checking for
recognition of the appropriate (3gal fusion protein) the animal was sacrificed (provided
that it was less than 14 days after the last boost) and serum was prepared from the
blood obtained. Serum was stored in 1ml aliquots at -20°C.
2.15b. The use of Pgal fusion proteins to affinity purify antibodies
2ml (slurry volume) Affi-gel 10 was washed once with 10ml water and once with 10ml
0.1M Hepes (pH7.4), the Affi-gel was allowed to settle out by gravity, on ice, in
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between these washes. Routinely, 500)ig of the appropriate fusion protein,
resuspended in 10ml 0.1M Hepes (pH7.4) was bound to the matrix by allowing gentle
mixing at 4°C for 2 hours or overnight. The affinity matrix was washed using 0.1M
Hepes (pH7.4) until the A280 of the buffer after washing was zero. Any remaining
reactive groups on the Affi-gel were quenched by gentle mixing with 10ml 0.2M
glycine HC1 (pH8.0) for an hour at 4°C. Following two washes with 0.1M Hepes
(pH7.4), the affinity matrix was gently mixed with elution buffer (0.2M glycine HC1
(pH2.8) for 5 min at room temperature. After restoration to pH7.4 using the 0.1M
Hepes buffer, the affinity matrix was incubated at 4°C on a rotating wheel for 2 hours
or overnight with 5ml immune serum (raised against the appropriate protein) before
being packed into a 10ml Poly Prep chromatography column. The column was washed
with 0.1M Hepes (pH7.4) until the buffer coming through the column had an A280 = 0
(approx. 5 bed volumes). Elution of antibodies bound specifically to the column was
achieved using 0.2M glycine HC1 pH2.8. Fractions (1ml) were collected into tubes
containing 75)0.1 1M Tris.HCl (pH8.0) (to give a final pH 7.4) with A28q being
monitored. Using this procedure, generally it was the first 5 fractions eluted from the
column which were pooled giving a 5ml sample with an A280 = 0.05. This was
divided into aliquots (lOOpl) and stored at -20°C following the addition of sodium
azide to 0.1%.
2.16. Production of antibodies from mice
A six week old mouse was immunised subcutaneously with 100|ig Spa-Pmalp fusion
protein (Chapter 3). Three weeks later it was immunised with a similar dose of the
same antigen intraperitoneally, a procedure that was repeated once more three weeks
later again. Three days after the final immunisation the mouse was bled to death. 2ml
sera was prepared from the mouse in the same way as described for the preparation of
rabbit sera. The mouse's spleen was removed under sterile conditions and was used to
prepare hybridoma cell lines by Dr J. Haywood (as described in Tugal, 1991).
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The supernatants from these cell lines were tested for reaction with the Pmalp in yeast
cell lysates during the course of this study.
2.17. Preparation of yeast cell lysate/homogenate
Where a lysate was required for the preparation of membrane vesicles all cell breakages
were achieved in the presence of 0.8M sorbitol.
2.17a. Yeast cell glass bead lysate
Cells were harvested (by centrifugation for 5 mins at 5000rpm in a Beckman JA-20/JA-
14 rotor) from yeast cultures that had been grown to an OD600 of 0.7-1.0, washed once
in distilled water and resuspended to 100 OD units/ml in lysis buffer (200mM
Tris.HCl (pH7.4), 0.7M sorbitol, 2mM EDTA.) containing protease inhibitors (ImM
PMSF, 0.4mg/ml each of pepstatin, leupeptin, chymostatin and antipain, ImM EDTA,
ImM EGTA.). Glass beads were added to the level of the meniscus and the tubes were
vortexed 4 x 30 seconds (with two minute cooling intervals on ice). The cell lysate was
collected by centrifugation, through the glass beads, at 3000g for 10 mins. This step
resulted in a pellet of unlysed cells and cell debris and a supernatant of cell lysate.
2.17b. Yeast cell homogenate
Cells were harvested as above, washed and then resuspended in spheroplast buffer
(1.4M sorbitol, 50mM potassium phosphate (pH7.4), lOmM NaN3, 40mM (3-
mercaptoethanol) containing zymolyase (5mg/ml). Cell wall digestion was achieved at
25°C, and this incubation was carried out until at least 80% of the cells present had
been converted to spheroplasts (normally 30 mins; see 2.17c below). Spheroplasts
were harvested (2 mins at 4000g), washed once in spheroplast buffer before being
homogenised (7 strokes) on ice in 1 ml/100 OD units of the original culture
homogenisation buffer (0.8M sorbitol, lOmM triethanolamine, ImM EDTA, brought to
pH7.4 with acetic acid) containing protease inhibitors (as above). The homogenate was
cleared of cell debris by centrifugation (2 mins at 4000g) before use.
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2.17c. Spheroplast assay
To estimate the proportion of cells in a sample that had had their cell wall digested 10[il
of the sample was diluted to 1ml in distilled water and 10(il to 1ml in spheroplast
buffer. The OD600 of the two diluted samples was recorded and an index of the
proportion of cells in the sample that had been converted to spheroplasts was taken as;
OD600in spheroplast buffer - OD6qq in distilled water X 100
OD600 in spheroplast buffer
2.18. Fractionation of yeast cell extracts by differential centrifugation
Yeast cell lysates/homogenates were fractionated using differential centrifugation by
subjecting them to a one hour centrifugation at 10 OOOOg to yield a high speed
supernatant (S100) and a membrane pellet (P100). This was performed using a
Beckman TL100-3 rotor (55 OOOrpm for 1 hour).
2.19. Radiolabelling of yeast proteins
A 100ml culture of the yeast strain to be radiolabeled was grown in selective medium
to an ODgoo °f approximately 0.5. A 10ml aliquot of this was removed and had 10|iCi
of 35S-methionine added to it. Both the 10ml aliquot, and the remaining 90ml culture
were allowed to grow for a further 1 hour. After this time, the 10ml aliquot was
returned to the culture, which was harvested for subsequent analysis as desired.
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2.20. Immunoisolation techniques
2.20a. Preparation of Kex2-Immunoadsorbent (Kex2-ImAd)
All steps described here were carried out at 4°C. Following all washes and incubations
the cells were pelleted by centrifugation for 2 mins at 4000g. After an initial wash in
binding buffer (20mM Hepes pH7.2, 2mM MgCl2, 150mM KC1) standardised
Pansorbin cells were resuspended in blocking buffer (binding buffer containing
lOmg/ml bovine serum albumin) using lml/50p.l original 10% (w/v) cell suspension
volume used and placed on a rotating wheel for 1 hour. The blocked cells were washed
for 15 mins in binding buffer before the addition of affinity-purified anti-Kex2C
antibody. For the production of the standard ImAd which was used throughout this
study, lp.1 of affinity purified antibody (5|ig protein) was added for each jul of cell
suspension used and the sample volume was made up to 500|il with binding buffer.
After incubation on a rotating wheel for 3 hours or overnight the ImAd was washed
once (15 minutes) in binding buffer and once with lysis buffer or homoginisation
buffer, as appropriate, prior to use.
2.20b. Recovery of a Kex2-ImAd bound fraction from yeast
Kex2-ImAd was reususpended using, routinely 300|il (approximately 300|J,g protein)
freshly prepared yeast cell lysate (prepared using either glass bead lysis or
homogenisation) and was left to incubate on a rotating wheel at for 3 hours to allow
gentle mixing. The ImAd was retrieved from these samples by centrifugation (4000g
for 2 mins) and was washed 3 times (twice by simple resuspension and 1x15 mins on
the rotating wheel) with lysis buffer or homogenisation buffer as appropriate (all steps
described here were carried out at 4°C).
2.20c. Recovery of an IgG-Sepharose bound fraction from yeast
The procedure described for the preparation of a Kex2-ImAd bound fraction from yeast
was followed using 50p.l (slurry volume) IgG-Sepharose in place of Kex2-ImAd.
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2.21. Enzyme assays
2.21a. Kex2 activity assay
The sample being assayed for Kex2 protease activity was added to 50|il Kex2 assay
mix (200mM Hepes (pH7.0), ImM CaCl2, 0.5mM PMSF, O.lmM L-l-tosylamido-2-
phenyl-ethyl chloromethyl ketone, 1% (w/v) Triton-X-100, lOOmM r-butoxycarbonyl-
Gln-Arg-Arg-4-methylcoumarin-7-amide (bQRR-MCA)). Reaction mixtures were
incubated at 37°C for 30 mins after which time the reaction was terminated by the
addition of 0.9ml 125mM ZnS04 and 0.1ml of a saturated Ba(OH)2 solution. The
precipitate formed upon the addition of the Ba(OH)2 was removed by centrifugation in
a microcentrifuge for 1 min. The amount of Kex2 protease activity in the sample was
determined by detecting free 7-amino-4-methylcoumarin (AMC) released from bQRR-
MCA following cleavage by Kex2 (after the pair of arginine residues). The amount of
AMC in the sample at the end of the assay was determined fluorimetrically,
X(excitation) = 385nm, X(emission) = 465nm. Assay results are expressed in arbitary
units of fluorescence.
2.21b. (3-lactamase (ampicillinase) activity
5mg nitrocefxn was dissolved in 0.5ml DMSO before being diluted to 0.5mg/ml with
0.1M sodium phosphate (pH7.0). 50|il of this stock nitrocefin solution was added to
900|il 0.1M sodium phosphate (pH7.0) in a cuvette. The sample to be assayed was
added to this cuvette in a 50|il volume and the increase in A490 was followed.
2.21c. Carboxypeptidase Y assay
50|il of the sample to be assayed was added to 1ml of assay mix containing,
0.125mg/ml L-amino acid oxidase, 0.2mg/ml peroxidase, 0.5mM MnCl2, O.lmg/ml
dianisidine.HCl and 5mM peptide substrate (/V-carbobenzoxy-L-phe-L-leu) in 0.1 M
potassium phosphate buffer (pH7.0). The complete mixture was incubated at 37°C for
90 mins after which time the A405 of the mix was read against a blank of the reaction
mix that had been incubated with 50(il distilled water.
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2.21d. Dipeptidyl aminopeptidase assay
Total DPAP activity in a sample was assayed by adding the sample, in a 20Qil volume,
to 250|il 400mM Tris.Hepes (pH7.0) and 50jil of a 3mM solution in 25% methanol of
the substrate X-pro-pNA and incubated at 37°C for 30 mins. The reaction was stopped
by the addition of 500pl ZnS04 and 100(il 7.5% Ba(OH)2, this led to the formation of
a precipitate which was removed by centrifugation for 10 mins in a bench top
microfuge. The A405 of the supernatant was read against a blank to which 200|il
distilled water had been added in place of the sample. The activity of DPAP A (which
is heat stable) was assayed by heating the sample to 65°C for 15 mins prior to its
addition to the assay (being allowed to equilibrate to 37°C following this heat treatment)
and the activity of DPAP B was estimated by subtracting the amount of heat stable
DPAP activity in a sample from the total amount of DPAP activity in that same sample.
2.21e. NADPH:Cytochrome c oxidoreductase assay
Two identical aliquots of the sample to be assayed were each added, in 20pl volumes to
970jil of reaction mix containing 1.5mg/ml cytochrome c in 300mM potassium
phosphate buffer (pH7.4) in matched quartz cuvettes. 10(il NADPH (16mg/ml in the
phosphate buffer) was added to one of these samples and the change in A550 was
followed.
2.21f. Assays for a-factor
Two assays were used for the detection of the mating pheromone; both are based on the
inhibition of growth of a yeast strain that is sensitive to a-factor (RC631).
2.21fl. Halo assay for secreted a-factor
A growing culture of RC631 was diluted to a density of 106 cells/ml in YPD containing
0.8% (w/v) Bacto agar (no warmer than 50°C) and was poured immediately onto a
YPD plate to create a lawn of sensitive cells. After the plate had been dried the strains
to be tested for a-factor secretion were patched onto the seeded lawn (this was achieved
by harvesting 10ml of a growing culture of the strain, resuspending it in as small a
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volume as possible and dropping this onto the lawn, taking care that the plates had
dried before continuing with the procedure). The plate was incubated at 25°C for
approximately 36 hours, until the sensitive strain had grown and halos of growth
inhibition could be seen around patches of yeast cells known to secrete a-factor (e.g.
JRY188).
2.21fii. Bioassay for secreted a-factor
A growing culture of RC613 was diluted to a density of approximately 105 cells/ml
using YPD. IOOjj.1 of this was added to 100(ll of the supernatant to be assayed for the
presence of the pheromone (or a suitable dilution of the same) contained within a well
of a microtitre assay plate. The plate was incubated overnight (for approximately 18
hours) at 30°C after which the density of the sensitive cells was measured by removing
the contents of the well from the plate and diluting it with 800|il distilled water in a 1ml
cuvette and measuring the OD^ of this. A lower OD^ corresponds to a higher
concentration of a-factor in the supernatant.
2.21g. Determination of protein concentrations
Protein concentrations were estimated using the method of Bradford (Bradford, 1976)
using solutions containing known concentrations of BSA as standards.
2.22. Digestion of proteins using proteinase K
Proteinase K was added to samples to be treated (containing 2mM CaCl2) to 50|ig/ml.
Digestion was allowed to proceed for 60 mins (on ice), after which the reaction was
stopped by the addition of PMSF (to 3mM).
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Chapter 3
The use of bacterially-synthesised hybrid proteins
in the production of affinity-purified antibodies
that specifically recognise Kex2p
3.1. Introduction
Central to the development of an immunoisolation procedure is the availability of an
antibody that will bind to an antigen located in the structure of interest. For the
purposes of this project antibodies that specifically recognise the cytoplasmically-
disposed C-terminal domain of Kex2p were required.
In this project bacterially-produced fusion proteins were used to raise antibodies against
various yeast proteins including Kex2p. This strategy of raising antibodies was chosen
over the immunisation of rabbits with the proteins purified from yeast since it obviates
the need to purify the various antigens and offers the advantage that antibodies against
specific domains of the individual proteins may be obtained. In order to raise
antibodies against various yeast proteins as part of this study, a gene fusion was
constructed consisting of the part of the yeast gene encoding the region of the protein
against which antibodies were desired, fused to a portion of DNA encoding IgG-
binding domains of S. aureus protein A (Uhlen etal., 1984). The gene fusions were
then expressed in bacteria and the resulting protein products were purified and used as
immunogens. Such a stategy was chosen for a number of reasons. Firstly, the IgG
binding domains of protein A (included in the fusion protein) allow affinity purification
of the protein (Nilsson etal., 1985). This affinity of protein A for IgG (Langone,
1982) is also useful in screening for the synthesis of the fusion protein using
immunoblot analysis. Also, it is thought likely that the repetitive structure of the
protein A moeity enhances the immune response to the fusion protein (Lowenadler
etal., 1986).
This chapter describes, in detail, the production of affinity-purified antibodies that
specifically recognise the cytoplasmically disposed C-terminal domain of Kex2p for use
in immunoisolation of the yeast Golgi. Included here, as an appendix to this chapter, is
a description of the production of antibodies against other yeast proteins, that are also
used in this work.
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3.2. The Spa-Kex2C fusion protein and its use as an immunogen
The use of gene fusions made it possible to ensure that only antibodies against the C-
terminus of Kex2p were raised by ensuring that this was the only portion of the protein
that the immune system of the rabbit was exposed to.
The plasmid pKpra (Figure 3-1) carries a segment of DNA (derived from the spa gene)
encoding two of the IgG-binding domains of protein A and has a multiple cloning site
to allow the insertion of DNA fragments adjacent to this. The spa-KEX2C gene fusion
had been created by P. Whitley in the plasmid pKpraKex2C (Figure 3-1). This plasmid
was constructed by cloning the 1.25kb fragment liberated upon digestion of pGA714
(Figure 3-1) with EcoRI and BamHl into pKpra to create an in-frame gene fusion
predicted to encode a protein A fusion protein (Spa-Kex2C) with a molecular weight of
29K.
The spa DNA contained within pKpra is under control of the E.coli lac promoter,
expression from which can be induced by the presence of IPTG (Brown, 1991). The
two plasmids pKpra and pKpraKex2C were transformed separately into the E.coli
strain NM522 to create NM522(pKpra) and NM522(pKpraKex2C) respectively. The
effect of the addition of IPTG to growing cultures of these strains upon their pattern of
protein synthesis was investigated. Figure 3-2 shows that, as expected, pKpra encodes
a protein with an apparent molecular weight of 23K (220 residues) which reacts with
rabbit IgG, and that pKpraKex2C encodes a protein A fusion protein with an apparent
molecular weight of about 40K. The Spa-Kex2C fusion protein is predicted to have a
molecular weight of 29K (made up of 165 residues encoded by spa DNA and 100
residues encoded by the portion of KEX2 used to create the gene fusion), but the
protein detected in Figure 3-2 has an apparent molecular weight more than 10K higher
than this. This discrepancy can be explained by the high net negative charge carried by
the amino acid sequence of the C-terminal tail of Kex2p. When this portion of the
protein is deleted the resulting shift in mobility of Kex2p in SDS polyacrylamide gels is
greater than expected (Fuller et al., 1989). From this, it is reasonable to accept that the
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use of this portion of Kex2p in the construction of Spa-Kex2C has caused the fusion
protein to run aberrantly in SDS polyacrylamide gels.
When large amounts of recombinant proteins are expressed in E. coli, as from the lac
promoter, large insoluble aggregates of protein, known as inclusion bodies, often form
(Maniatis et al., 1982). In order to take advantage of protein A's affinity for IgG in the
purification of Spa-Kex2C it was important to determine whether any of the fusion
protein was present in a soluble form available for binding to IgG. This was
investigated using differential centrifugation to remove insoluble material from lysed
cells taken from a bacterial culture that had been induced to synthesise Spa-Kex2C and
screening the various fractions obtained by this procedure for the presence of the fusion
protein. As can be seen from Figure 3-3, a substantial amount of the fusion protein
encoded by pKpraKex2C is found in the soluble fraction of a cell lysate. On the basis
of this observation it was decided that IgG-Sepharose should be used in the purification
of Spa-Kex2C. Comparison of Figure 3-3a with Figure 3-4a (i.e. comparison of a
Coomassie-stained polyacrylamide gel of the soluble fraction prepared from a culture
of NM522(pKpraKex2C) producing the fusion protein with that of the material
recovered from this using IgG-Sepharose) shows that although the use of IgG-
Sepharose has been successful in recovering Spa-Kex2C the sample obtained also
contains other proteins.
It has been ascertained that, as indicated on Figure 3-4a, two of the contaminating high
molecular weight proteins are DnaK and GroEL (Ellis and van der Vies, 1991 - this
was shown to be the case by using affinity-purified antibodies, supplied by J. Zueco,
against both proteins in immunoblot analysis, data not shown) and that another
contaminating protein is the heavy chain of IgG (confirmed using the observation that
this protein reacts with anti-rabbit IgG antibody in immunoblot analysis, data not
shown) which has become detached from the Sepharose during elution of the bound
material. The lower molecular weight contaminants are degradation products of the
fusion protein, as suggested by the fact that they react with rabbit IgG in immunoblot
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analysis (data not shown). Due to the presence of these contaminating proteins it was
decided to include preparative SDS-PAGE as a final purification step in order to obtain
a homogeneous preparation of the fusion protein (Figure 3-4b) for the immunization of
rabbits.
The purified fusion protein was injected into rabbits from which immune sera putatively
containing antibodies directed against the C-terminal domain of Kex2p were collected.
Starting with a 500ml culture of NM522(pKpraKex2C) a typical yield of Spa-Kex2C
fusion protein obtained by following the procedure laid out here would be 800-1000|ig
(as determined by the method of Bradford).
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Figure 3-1
Creation of the spa-KEX2C gene fusion
both plasmids were digested
with BamHI and EcoRI and the
fragment thus liberated from




A protein A fusion protein produced by NM522(pKpra-KEX2C)
100ml cultures of both NM533(pKpra) and NM522(pKpraKEX2C) were grown in
selective medium (L-broth containing 50jlg/ml kanamycin) at 37°C to an OD600 of
0.8. Both cultures were then split in half. IPTG was added to one half of each
culture to a final concentration of 0.25mM and the cultures were all left growing at
37°C for a further four hours. The half of each culture to which IPTG had been
added was labelled as 'the induced culture'. 1.0ml samples were taken from each
of the now four cultures. Cells were harvested from these and boiled in lOOp.1 SDS
sample buffer for 5 mins. The cell extracts thus prepared were analysed by 12%
SDS-PAGE and immunoblot analysis using a rabbit IgG-HRP conjugate.
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Analysis of an induced culture of NM522(pKpraKEX2C)
Cells from a 50ml 'induced culture' - (see Figure 3-2 legend) - were harvested,
washed with 10ml Tris.HCl (pH7.4) and resuspended in 10ml of the same.
Lysozyme was added to a final concentration of lmg/ml and the cells were left on
ice for twenty minutes. Cell lysis was achieved using sonication (4 x 30 seconds
on ice with two minute intervals on ice to avoid excess heating). A 100fll sample
was taken and labelled as 'whole cell extract' (WCE) before unlysed cells and cell
debris were removed by centrifugation at 300g for 5 mins. The pellet from this was
labelled as 'P3' and the supernatant was centrifuged for 20 mins at 25 OOOg to clear
the cell lysate of any insoluble material yielding a soluble fraction, the 'S25', and
'the inclusion body preparation' or 'P25'. Both the P3 and the P25 were
resuspended in 10ml Tris.HCl (pH7.4). All of the fractions obtained using the
above procedure were run on two identical 12% polyacrylamide gels. One of these
was stained with Coomassie blue (Figure 3-3a) and the other was used to transfer
the samples to nitrocellulose to allow immunoblot analysis using a rabbit IgG-HRP
conjugate to be performed (Figure 3-3b).
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Figure 3-3a
MWt WCE S25 P25 P3
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Figure 3-3b
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Figure 3-4
Purification of the Spa-Kex2C fusion protein
A 500ml culture of NM522(pKpraKex2C) was induced to express the Spa-Kex2C
fusion protein as described in the legend for Figure 3-2. A soluble fraction was
prepared from this culture (see the legend for Figure 3-3 for details). 1ml (slurry
volume) IgG-Sepharose was added to this and left on a rotating wheel at 4°C
overnight. The IgG-Sepharose was recovered and washed six times in TST to
remove non-specifically bound material. Elution of the bound material was
achieved by washing the IgG-Sepharose (once for 20 mins and once for 5 mins)
with 0.5M HAc(CH3COOH) adjusted to pH3.4 with NH4Ac. These washes were
pooled and dialysed against distilled water overnight at 4°C, before being freeze
dried and resuspended in 0.5ml distilled water. An aliquot (10|il) of this was
subjected to 12% SDS-PAGE and stained with Coomassie blue (Figure 3-4a). An
identical gel was used to transfer the samples to nitrocellulose and the band
indicated as Spa-Kex2C was shown to react with rabbit IgG by immunoblot
analysis (data not shown).
The fraction eluted from the IgG-Sepharose was run on a 12% preparative SDS-
poly acrylamide gel. The gel was lightly stained using Coomassie blue and a strip
of the gel containing the band corresponding to the Spa-Kex2C fusion protein was
cut out and placed in sealed dialysis tubing along with 5ml electrophoresis buffer.
The protein was electroeluted (lOOmV for 5 hours) into the buffer contained within
the dialysis tubing. This buffer was dialysed against distilled water before being
freeze-dried. The lyophilised material was resuspended in 0.5ml distilled water.
An aliquot of this (10|ll) was subjected to 12% SDS-PAGE and stained with
Coomassie blue (Figure 3-4b). The band indicated as the Spa-Kex2C fusion








3.3. Production of a (3gal-Kex2C fusion protein
When working with polyclonal antiserum it is advantageous to be able to separate
antibodies that specifically recognise the antigen of interest from other components of
the serum. This is because the serum will contain antibodies that may recognise and
bind to other proteins present in the preparation containing the antigen, and this would
obviously be undesirable in an antibody preparation to be used for immunoisolation.
Immunisation of a rabbit with Spa-Kex2C allowed immune serum containing
antibodies that recognise the C-terminal 100 amino acids of Kex2p to be collected. In
order to isolate these antibodies from the immune serum, a second Kex2p fusion
protein was prepared. This time, the same portion of Kex2p that had been used in the
construction of Spa-Kex2C was fused to Pgal creating a pgal-Kex2C fusion protein.
This was achieved by using the fragment of DNA from pGA714 (Figure 3-1) that had
been used in the construction pKpraKex2C to create an in-frame gene fusion with the
lacZ gene in the plasmid pEXl 1 (Figure 3-5). This gene fusion resulted in the
construction of the plasmid pNB21 and was predicted to encode a pgal-Kex2C fusion
protein (Pgal-Kex2C) with a molecular weight of 127K.
Transcription of the lacZ gene in the pEX vector family, of which pEXl 1 is a member,
is under control of the PR promoter of bacteriophage lambda (Kusters et al., 1989).
Regulated expression can be achieved in a host strain of E.coli (such as pop2136)
which harbours lysogenised lambda carrying the thermosensitive cI857 allele. At 30°C
the repressor is functional whereas at 42°C it is not; this means that a shift to 42°C of a
growing culture of pop2136 cells containing a pEX vector allows expression of the
gene under control of the PR promoter.
pop2136 cells were transformed separately with both pEXl 1 and pNB21 creating
pop2136(pEXl 1) and pop2136(pNB21) respectively. Growing cultures of both these
strains were shifted from 30°C to 42°C for four hours. Figure 3-6 examines the effect
of such a temperature change upon the pattern of proteins produced by these strains.
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There is a protein present in the extract prepared from pop2136(pEXl 1) cells that had
been shifted to 42°C, which is not present in that prepared from cells that had been left
at 30°C, corresponding to the pEXl 1 Pgal product (117K). Similarly, there is a
protein present in the lane containing pop2136(pNB21) extract prepared from cells that
had been shifted to 42°C which is not present when the same cells were left at 30°C
and this band is taken to be the |3gal-Kex2C fusion protein (127K).
Examination of cells producing the (3gal-Kex2C fusion protein by light microscopy
suggests that they contain inclusion bodies (they adopt a filamentous morphology with
a refractile body at one end: both of these characteristics are typical of cells containing
inclusion bodies). These inclusion bodies were partially purified using differential
centrifugation to separate them from soluble material present in the cells, and
immunoblot anlysis using affinity-purified anti-(3gal antibody (supplied by J. Zueco) as
primary antibody was carried out on the various fractions yielded by this procedure.
Figure 3-7 demonstrates that essentially none of the (3gal-Kex2C fusion protein is
present in a soluble form in the cell extract.
Pgal-Kex2C is easily identifiable on a Coomassie-stained gel in the lane containing
whole cell extract prepared from an induced culture of pop2136(pNB21)-(Figure 3-7a).
It was decided that preparative SDS-PAGE should be used to obtain a sample of the
fusion protein from such cell extracts since attempts at solubilizing the inclusion bodies
(Maniatis et al., 1982) with the eventual aim of purifying the fusion protein by affinity
chromatography proved unsuccessful.
Whole cell extract prepared from an induced culture of pop2136(pNB21) was subjected
to electrophoretic separation on a 10% polyacrylamide gel. After Coomassie-staining, a
gel slice containing the fusion protein was excised and the protein was recovered from
this by electroelution.
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3.4. Affinity purification of anti-Kex2C specific antibodies
Pgal-Kex2C purified as described was bound to Affi-gel 10 (Frost etal., 1981) and
used to purify antibodies that specifically recognise the C-terminal domain of Kex2p
from immune sera raised against the Spa-Kex2C fusion protein. Routinely, from 5ml
immune sera obtained from a rabbit that had been immunised using Spa-Kex2C
approximately 25mg (as estimated by the method of Bradford) of affinity purified




Construction of the (3 gal-KEX2C gene fusion
EcoRI and BamHI, and the 1.25kB fragment






Proteins produced by pop2136(pNB21)
100ml cultures of pop2136(pEXl 1) and pop2136(pNB21) were grown at 30°C in
selective medium (L-broth containing 100|lg/ml ampicillin) to an OD^ of 0.5.
Both cultures were then spht in half with 50ml of each being left at 30°C and the
other 50ml of each being moved to 42°C for four hours. The half of each culture
that was moved to 42°C was labelled at the 'induced culture'. 1.0ml aliquouts were
taken from the now four cultures and the protein composition of cells from these



















A [3gal-Kex2C fusion protein produced by pop2136(pNB21)
Cells from a 50ml culture of pop2136(pNB21) which had been induced to produce
the (3gal-Kex2C fusion protein as in the legend for Figure 3-6 were treated in the
same way as those from an induced culture of NM522(pKpraKex2C) were as
described in the legend for Figure 6-3 yielding whole cell extract (WCE), P3
(unlysed cells and cell debris), P25 (inclusion bodies), and S25 (soluble material).
These fractions were run on two 10% polyacrylamide gels one of which was
stained with Coomassie blue (Figure 3-7a) with the other being used to transfer the
samples to nitrocellulose for immunoblot analysis using affinity-purified anti-(3gal
antibody as primary antibody (Figure 3-7b).
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Figure 3-7a
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Appendix to Chapter 3
Other antibodies produced during the
course of this work
3A.1. Introduction
In addition to the anti-Kex2 antibody, it was desirable to obtain antibodies against other
yeast membrane proteins in order to evaluate the purity of material immunoisolated
using the anti-Kex2p antibody. To demonstrate the purity of a membrane fraction it is
necessary to show that it is free from contamination by membranes derived from
organelles other than the one of interest. This can be achieved by showing that the
fraction does not contain activities of enzymes associated with potential contaminating
organelles. However, such information can be misleading since few enzyme assays are
absolutely specific for the particular marker enzyme that is being monitored. For
example, the assay used throughout this study to follow Kex2 protease activity does
not detect the activity of just the Kex2 protease. Cell extracts prepared from yeast cells
in which the KEX2 gene has been disrupted (PWYS3) cleave the fluorogenic peptide
used in the assay albeit at a rate twenty times slower that an extract prepared from cells
in which theKEX2 gene is intact (JRY188). Th&KEX2 gene of PWYS3 has been
disrupted in such a way that the portion of DNA known to encode the catalytic domain
of Kex2p has been removed. Immunoblot analysis performed on the same extracts
using a polyclonal antibody raised against Kex2p detects a protein with an apparent
molecular weight of 135K present in the extract prepared from JRY188 but not in that
prepared from PWYS3. From these results (Whitley, 1990), it can be concluded that
the cleavage of the peptide by the PWYS 3 extract is due to an activity distinct from that
of Kex2p.
Antibodies that recognise a number of yeast proteins were raised as part of this work,
and their production is described in this appendix. In each case, methods similar to
those used for the production of the anti-Kex2C antibodies were used.
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3A.2. Antibodies that recognise Ste2p
3A.2a. Preparation of anti-Ste2p antibodies
Antibodies were prepared against the product of STE2 (the receptor for the mating
pheromone a-factor - Burkholder and Hartwell, 1985), for two reasons. Firstly, these
antibodies were to be used to demonstrate whether material immunoisolated using the
anti-Kex2C antibody contained any plasma membrane derived material (the receptor is
an integral membrane protein located in the plasma membrane). Secondly, the
antibodies were raised specifically against the cytoplasmically-disposed C-terminal
domain of the protein so that they could be of use in the future to immunoisolate inside-
out plasma membrane vesicles (such vesicles could be used to develop a protein
transport assay involving the fusion of post-Golgi secretory vesicles with the plasma
membrane). A spa-STE2 gene fusion was created by cloning a portion of DNA (about
400 base pairs) from the coding region of the STE2 gene (Nakayama etal., 1985)
contained within the plasmid pAB510 into pKpra (Figure 3-1). In order to create an in-
frame gene fusion as required the cloning strategy outlined in Figure 3A-1 was
undertaken. It was predicted that the spa-STE2 gene fusion contained within pNB4
should encode a protein A fusion protein with a molecular weight of 40K (comprised of
165 residues encoded by pKpra DNA and 135 residues encoded by STE2 DNA) and
this was shown to be the case (data not shown). It was ascertained that the Spa-Ste2p
fusion protein produced by NM522(pNB4) did not form inclusion bodies (data not
shown) and therefore it was possible to purify the fusion protein using IgG-Sepharose.
The purified fusion protein was injected into a rabbit from which immune serum was
subsequently collected.
In order to separate antibodies specific to the C-terminal 135 residues of Ste2p from
other antibodies present in immune serum raised against the Spa-Ste2p fusion protein,
a [3gal-Ste2p fusion protein was prepared whereby the same 135 residues of Ste2p that
were used in the construction of Spa-Ste2p were fused to pgal. This was achieved by
cloning the same portion of DNA from pAB510 that was used in the construction of
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pNB4 into pEXl 1 to create the plasmid pNB 13 containing an in-frame gene fusion.
pNB13 is predicted to, and was shown to, encode a (3gal fusion protein of molecular
weight 13 IK (data not shown). This fusion protein was purified from a culture of
pop2136(pNB 13) and was used to affinity purify antibodies specific to the C-terminal
135 amino acids of Ste2p (anti-Ste2p).
3A.2b. Demonstration of the specificity of anti-Ste2p
In order to demonstrate the specificity of anti-Ste2p for the pheromone receptor, a yeast
strain containing a unique, inducible copy of the STE2 gene was created. In order to
create such a strain the plasmid pIH2-4, which harbours a copy of STE2 under the
control of the GAL1 promoter, was transformed into the diploid yeast strain, NBY10
(in which haploid specific genes under mating type control are not expressed; i.e. it
does not produce Ste2p, or a-factor) to create NBY10(pIH2-4).
Two cultures of NBY10(pIH2-4) were grown: one using galactose as a carbon source,
(the cells in this culture will produce Ste2p); and the other using glucose as a carbon
source. The cells in the culture which had been grown on glucose will not express
STE2 because such growth conditions repress the GAL1 promoter.
Due to the hydrophobicity of Ste2p (it contains seven transmembrane spans) it was
found that the protein could not be detected using anti-Ste2p against yeast cell lysates
that had been boiled in SDS sample buffer prior to separation by SDS-PAGE and
transfer to nitrocellulose (a procedure often used for the preparation of samples to detect
proteins in this way). Instead, a crude preparation of membranes was obtained from
each culture and solubilised with detergent before being subjected to SDS-PAGE and
immunoblot analysis (Konopkaera/., 1988) (N.B. it was found that the protein could
only be detected by immunoblot analysis if buffers not containing methanol were used
throughout the transfer of proteins to the nitrocellulose filter). As can be seen from
Figure 3A-2 the affinity-purified antibodies react with the sample prepared from the
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cells supplied with galactose as their sole carbon source but not with that prepared from
cells that had been exposed to repressing concentraions of glucose.
From the published sequence of the STE2 gene the predicted molecular weight of the
protein is 47 794. Figure 3A-2 shows that the antibody recognises two bands in the
sample prepared from the culture that had been induced to produce Ste2p which are not
present in the sample prepared from cells which had not been induced to produce the
protein, this pattern is similar to that found in another study involving the detection of
Ste2p by immunoblot analysis (Konopka etal., 1988). The lower of the two bands has
an apparent molecular weight of between 50 and 55kD and is taken to be the
monomelic form of STE2p. One reason for the fact that this is of a higher apparent
molecular weight than might have been expected from the gene sequence is that the
protein is glycosylated. The higher molecular weight material migrates to an area of the
gel corresponding to about lOOkD and may be accounted for by the likelihood that




Construction of the spa-STE2 gene fusion
(1) The 1.6kb fragment, containing the STE2 gene, yielded upon the digestion of
pAB510 with //mdin was cloned into the Hindlll site of pK19 to create pNBl.
Clones containing the Hindlll fragment in the desired orientation were identified as
those which a) produced a 1.6kb fragment upon digestion with Hindlll and b) produce
a 1.6kb fragment upon digestion with Sail.
(2) The largest Hae EI fragment (0.8kb) from pNBl, which is also the only Haelll
fragment from pNB 1 that contains a Sail site, was cloned into the Smal site of pUC18
to create pNB2. Clones containing the correct fragment in the desired orientation were
taken as those which could be digested with Hindlll to give a 0.6kb fragment and with
Sail to give a 0.3kb fragment.
(3) pNB2 was digested with Kpnl and BamHl and the 0.8kb fragment thus liberated
was directionally cloned into pKpra to create pNB3 with positive clones being
identified as those which a) released the cloned BamHl, Kpnl fragment upon digestion
with the two enzymes, b) are linearised upon digestion with each of Sail, Pstl and
Hincll, and c) yield two fragments, of 2.8kb and l.Okb, upon digestion with Hindlll,
the smaller of which contains both a Pstl and a Hincll site.
(4) pNB3 was linearised by digestion with Sail and the cohesive ends thus created were
filled in using Klenow fragment. A blunt end ligation created pNB4 containing a
spa-STE2 gene fusion. Positive clones were screened for by checking for the
disappearance of the Sail site.
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Figure 3A-2
Recognition of Ste2p by affinity purified anti-Ste2p antibodies
Two 50ml cultures of NBY10(pIH2-4) were grown in selective medium, one was
supplied with galactose as its sole carbon source (Gal), and the other was supplied
with glucose (Glucose). The cultures were grown to early log phase after which
the cells from both were harvested, washed once with water, and resuspended in
0.5ml lOmM Tris.HCl (pH7.5), ImM EDTA. The cells were disrupted by
vortexing in the presence of glass beads and the resultant extracts were centrifuged
(10 OOOOg) for 30 mins. The pellet thus obtained was extracted with 1%
deoxycholate, lOmM Tris.HCl (pH7.5) on ice for 30 mins. Solubilised material
was mixed with an equal volume of SDS sample buffer containing 8M urea
(prewarmed to 65°C). The samples were incubated at 65°C for 10 mins before
being resolved by electrophoresis on a 12% polyacrylamide gel and then transferred
to nitrocellulose (it was important that no methanol was present in the buffers used
during the transfer of the samples to nitrocellulose). Immunoblot analysis was
performed on the filter using affinity-purified anti-Ste2p as primary antibody at a
dilution of 1 in 1000.
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NBY10(pIH2-4)






3A.3. Antibodies that recognise the yeast plasma membrane H+-ATPase
Antibodies that specifically recognise a second yeast plasma membrane protein , Pmalp
were also raised during the course of this project. Pmalp, the product of the yeast
PMA1 gene, is a H+ -translocating ATPase (Serranoet al., 1986).
The oligonucleotides 5'-CTCTTGGTGGATCCATACATGG-3' and
5'-TGGCCCGGGCTAAGAAACAAGCCATTGTTC-3' were used as primers for PCR
to generate a fragment of DNA that encodes from Ala354 to Asp534 of Pmalp using
genomic DNA prepared from NBY10 as template DNA. The product of this reaction
(which had been shown to be the desired product, since it could be digested by FcoRI
to give two fragments, 288bp and 273bp) was digested with Srnal and BamHl and
cloned into similarly digested pAXl 1 to form a spa-PMAl gene fusion contained
within the plasmid pNB75, and also into pEXl lthat had also been digested with Smal
and BamHl to form pNB76. The fusion protein encoded by the spa-PMAl gene fusion
was purified from bacteria producing it (using IgG-Sepharose) and was used to
immunise mice. It was decided to raise antibodies in mice in this case for two main
reasons: Firstly, it has been reported that mouse antiserum tends to recognise fewer
proteins in yeast non-specifically (V. Bankaitis - personal communication); and
secondly mice are cheaper and easier to keep than rabbits.
The immune serum obtained from one of the mice was found to recognise the (3gal-
Pmalp fusion protein encoded by pNB76, but not the (3gal-Kex2C fusion protein
encoded by pNB 11 (this was ascertained by immunoblot analysis using the serum as
primary antibody against whole cell extracts prepared from induced cultures of
pop2136(pNB76) and pop2136(pNBl 1) that had been electrophoretically separated on
a 10% polyacrylamide gel - data not shown). This serum was then tested for reaction
with a yeast cell lysate and with membrane and cytosol fractions prepared from this by
differential centrifugation. Figure 3A-3 shows that the serum reacts with the crude
lysate prepared from the yeast strain NBY10 and also with the membrane (P100)
fraction, but not with the cytosolic (S100) fraction. Pmalp is predicted to have a
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molecular weight of approximately 100K. Figure 3A-3a demonstrates that the
antiserum reacts with an area of the immunoblot corresponding to proteins with
apparent molecular weights ranging from approximately 90K to approximately 200K
that are present in a cell lysate and enriched in the PI00.
At the same time as blood from the immunised mice was obtained, the spleen from one
was removed and used to produced hybridoma cell lines by J. Haywood. Culture
supernatants from these cell lines were tested for reaction with yeast cell lysates.
Primary screening was carried out by dot-blot analysis. Supernatants that reacted with
yeast extract were then tested for reaction with the pgal-Pmalp fusion protein (using
immunoblot analysis against bacterial whole cell extract prepared from an induced
culture of pop2136(pNB76) that had been electrophoretically separated on a 10%
polyacrylamide gel - data not shown). Those that recognised the Pgal-Pmalp fusion
protein, but showed no reaction with the Pgal-Kex2C fusion protein were finally tested
for recognition of a protein corresponding to Pmalp in a membrane fraction prepared
from yeast cells. Figure 3A-3b shows the reaction of supernatant from the cell line
B/lA1 with a protein present in the PI00 prepared from a yeast cell lysate, which has
an apparent molecular weight of approximately 150K. Such an apparent molecular
weight is consistent with the protein recognised here being Pmalp (by comparison of
the immunoblot shown in figure 3A-3b with one presented in Serrano et ai, 1986)
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3A-3.
Immunoblotting of the yeast plasma membrane H+-ATPase (Pmalp)
A cell lysate prepared from the yeast strain NBY10 was fractionated by differential
centrifugation to yield a P100 and a S100. These were electrophoretically separated
on a 10% polyacrylamide gel and were subsequently transferred to nitrocellulose.
Figure 3A-3a shows an immunoblot that was performed against these samples
using antiserum from a mouse that had been immunised with the Spa-Pmalp fusion
protein as primary antibody, and anti-mouse IgG-HRP and anti-mouse IgM-HRP
(both at a dilution of 1 in 3000) as secondary antibody.
Figure 3A-3b shows an immunoblot performed against a P100 and an S100 (as
above) using supernatant from the cell line B/1A1 at a dilution of 1 in 5 in blocking
























3A.4. Antibodies that recognise HMG-Coenzyme A reductase
PCR using the oligonucleotides 5'-GAATGCTGCTAGAATTCATACCAG-3' and
5' -CGGGATCCAATGACGTATGACTAAGTTTAGG-3' and genomic DNA prepared
from NBY10 gave rise to a fragment of DNA that encodes part of the integral ER
membrane protein HMG-CoA reductase (from He524 to Ser1054 - Basson etal., 1988),
encoded by HMG1 (Hmglp). The DNA obtained as a result of this reaction was
shown to be the desired fragment by digesting it with HindUl, this yielded three
fragments, 867bp, 548bp, and 22bp. The PCR product was cloned, as an EcoRl,
BamHl fragment, into the plasmid pAX12 to form pNB72, and also into pEX12 to
create pNB73.
The Spa-Hmglp fusion protein encoded by pNB72 was purified from an induced
culture of NM522(pNB72) using IgG-Sepharose and was used to immunise a rabbit
from which immune serum was subsequently collected. This serum was found to
recognise the Pgal-Hmglp fusion protein encoded by pNB73, but not the Pgal-Kex2C
fusion protein (by using the serum as primary antibody in immunoblot analysis against
induced cultures of pop2136(pNB73) and pop2136(pNB21) separated on a 10%
polyacrylamide gel). HMG1 encodes a protein with an apparent molecular weight of
115K (Wright etal., 1988). It can be seen, from Figure 3A-4a that the immune serum
raised against the Spa-Hmglp fusion protein does not recognise a protein of this
molecular weight in either a yeast cell lysate, or a P100 prepared from this when used
in immunoblot analysis against these fractions.
Hmglp is predicted to have seven transmembrane spans (Basson etal., 1988), and
therefore it was thought that the lack of detection of the protein with the antiserum may
be due to problems similar to those encountered during initial attempts to detect Ste2p
by immunblot analysis. A sample prepared using conditions that allow the detection of
Ste2p was tested for reactivity with the antiserum. Figure 3A-4b shows that this has
allowed the detection of some high molecular weight material that was not detected in a
PI00 that had been placed in a boiling water bath for five minutes prior to
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electrophoretic separation. Attempts at affinity-puriying Hmg lp-specific antibodies
using the (3gal-Hmglp fusion protein encoded by pNB73 proved unsuccessful,
perhaps due to a low titre of such antibodies in the serum.
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Figure 3A-4.
Detection of HMG-CoA reductase by immunoblot analysis
A cell lysate prepared from the yeast strain NBY10 was fractionated to yield a PI00
and a S100. These were electrophoretically separated on a 10% polyacrylamide gel
and transferred to nitrocellulose. Figure 3A-4a shows an immunoblot that was
performed against these samples using antiserum from a rabbit that had been
immunised with the Spa-Hmglp fusion protein as primary antibody.
Figure 3A-4b shows an immunoblot that was performed using the same serum
against a sample that had been prepared as described in the figure legend for Figure
3A-2 (i.e. a crude preparation of membranes extracted with detergent prior to
electrophoretic separation).
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Figure 3A-4a Figure 3A-4b
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Chapter 4
The use of affinity-purified anti-Kex2p antibodies
in the immunoisolation of Kex2p
from yeast cells
4.1. Introduction
This chapter describes how antibodies directed against the cytoplasmically-disposed
C-terminal domain of Kex2p (anti-Kex2C; preparation described in Chapter 3) were
used to isolate membrane vesicles derived from the Kex2-containing compartment
of the yeast Golgi. This was achieved using the technique of immunoisolation the
theory of which is outlined briefly in Chapter 1.
The purity of material obtained through immunoisolation depends largely on the
specificity of the antibody used in the formation of the immunoadsorbent (ImAd).
It is therefore important to use an antibody which recognises only the antigen of
interest in the preparation from which material is to be isolated. For this reason it is
common for affinity purified antibodies to be used, since they tend to recognise less
non-specific material than do crude sera. Figure 4-1 demonstrates that anti-Kex2C
recognises only Kex2p in a yeast cell extract.
For an antibody to be of use in recovering material it is necessary for it to be
attached to a solid support to allow recovery of any bound material from biological
preparations. There are a number of matrix materials which may be used for this
purpose. The matrix must be inert, showing no reaction with the system in which it
is to be used, and obviously it must be capable of binding antibody molecules. For
indirect immunoisolation (Chapter 1), agarose or magnetic beads carrying chemical
groups (e.g. tosyl groups) that will covalently bind proteins under defined
conditions can be used to preform the ImAd. Alternatively, a matrix carrying an
antibody that will recognise and bind the antibody used for the immunoisolation
may be used; if this method is used it is desirable that the second antibody
recognises the Fc portion of the first, as this will ensure that the antigen binding
sites of the first antibody are free to bind antigen. Such orientation of the antibody
can also be ensured if binding to the matrix is achieved through the S. aureus coat
protein, protein A, which has high affinity for the Fc portion of rabbit IgG
molecules (Langone, 1982), but cannot be ensured if the antibody is attached to the
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matrix through, for example, tosyl groups which will bind to any available amino
group (Nilsson and Mosbach, 1984) in the antibody molecule and may lead to its
being attached to the matrix through an antigen binding site, thus rendering it unable
to bind antigen due to steric hinderance, and resulting in the formation of an
inefficient ImAd. Matrices which bind antibody as a result of specific recognition,
such as those carrying protein A, can be used in either direct or indirect
immunoisolation (Chapter 1), whereas those which bind antibody molecules
through amino groups are obviously restricted to use in direct immunoisolation. It
was such considerations that led to the choice of matrix used here namely, fixed
S. aureus cells (Pansorbin).
4.2. Preparation and use of a Kex2-Immunoadsorbent
Affinity purified anti-Kex2C was bound to Pansorbin to form a Kex2-
immunoadsorbent (Kex2-ImAd). Rabbit IgG binds to protein A through the Fc
portion of the immunoglobulin and therefore it is envisaged that the antigen binding
sites of the antibody remain free to bind to any available antigen. Figure 4-2
demonstrates that Kex2-ImAd can be used to recover functional Kex2p from a cell
lysate prepared from the yeast strain NBY10(pGA714), whereas none is recovered
using Pansorbin to which no antibody has been attached. Kex2p recovered in this
way is detectable by immunoblot analysis (Figure 4-2a), and the fact that the
recovery can be blocked (Figure 4-3) by preincubation of the ImAd with (3gal-
Kex2C fusion protein (which will occupy antigen binding sites of antibodies that
recognise the C-terminal domain of Kex2p) confirms that the observed recovery is
mediated by specific antibody-antigen interaction. No such block of recovery is
seen when the preincubation is carried out using an unrelated fusion protein, |3gal-
Ste2p. Since the two fusion proteins used carry the same (3gal derived portion, it
can be concluded that the inhibition of Kex2p recovery is due to the Kex2 derived
portion of the Pgal-Kex2C fusion protein occupying antigen binding sites present in
the ImAd and thus destroying its ability to bind Kex2 protein from the cell lysate.
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Figure 4-1.
Specificity of affinity-purified anti-Kex2C antibody
Glass bead extracts were prepared from growing cultures of NBY10,
NBY10(pGA714) and PWYS3. These were subjected to electrophoretic separation on
a 10% polyacrylamide gel and then transferred to nitrocellulose. Affinity-purified anti-
Kex2C was used as primary antibody in immunoblot analysis of the lysates on this
filter. This figure shows that anti-Kex2C recognises a single protein of apparent
molecular weight 135K in extracts from NBY10 and NBY10(pGA714), but does not
recognise any component of the PWYS3 extract (the KEX2 gene of PWYS3 cells has
been disrupted). The extract prepared from NBY10(pGA714) contains a higher
amount of the 135K protein than that prepared from NBY10 (an equivalent amount of
protein from the two extracts was loaded on the gel that was used for this immunoblot),
this is due to the presence of pGA714 which causes the cells to overexpress Kex2p.
This, taken with the absence of this protein from PWYS3 cells identifies the 135K
protein recognised by anti-Kex2C as Kex2p.
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Binding of Kex2 protein by a Kex2-Immunoadsorbent
Kex2-ImAd was prepared using 10|J.l anti-Kex2C (50|lg protein) and 10(0.1 Pansorbin
(10% w/v S. aureus cell suspension). This was resuspended in 300jol of cell lysate
(equivalent to 30 OD units of NBY10(pGA714) cells) and incubated on a rotating
wheel, to allow gentle mixing, for 3 hours. The ImAd was then recovered by
centrifugation (2 mins at 4000g) and washed 3 times (twice briefly by simple
resuspension and once for 15mins on a rotating wheel) in lysis buffer. All steps were
carried out at 4°C. The material thus recovered (ImAd bound) was resuspended either
in 50|il Kex2 assay mix in order to assay the amount of Kex2 activity present (Figure
4-2a), or in SDS sample buffer to allow immunoblot analysis using anti-Kex2C as
primary antibody following electrophoretic separation on a 10% polyacrylamide gel
(Figure 4-2b). In both cases an aliquot of the yeast cell lysate (30(il, equivalent to 10%
of that presented to the ImAd) was treated in the same way as the bound fraction
(lysate). A control experiment was carried out in which lOfll Pansorbin to which no
antibody had been bound was used in place of the ImAd (control bound).
N.B. Prior to the analysis of bound material by electrophoretic separation the samples
were boiled for 5mins before the S. aureus cells were removed by centrifugation. The
smear of immuno reactivity on the immunoblot in lanes containing samples of bound










Inhibition of Kex2p recovery by (3gaI-Kex2p
The procedure described in Figure 4-2 was used to recover Kex2p from an
NBY10(pGA714) cell lysate using Kex2-ImAd that had been treated in one of three
ways; prior to addition of the cell lysate the ImAd was incubated for 30 mins with a
solution of one of two bacterially-produced (3gal fusion proteins ({3gal-Kex2C or (3gal-
Ste2p; in both cases 500|il of a lmg/ml solution was used), or with PBS (control).
The amount of Kex2 activity bound by the different preparations was assayed and













4.3. Optimisation of the recovery of Kex2p by immunoisolation
Under the conditions used for the preliminary experiments described above
approximately 10% of the total Kex2 activity present in the lysate was bound by the
ImAd (Figure 4-2). In an attempt to increase the recovery of Kex2p increasing
amounts of anti-Kex2C were bound to Pansorbin in the formation of ImAd. From
Figure 4-4 it can be seen that increasing the number of antigen binding sites in the
ImAd above that achieved using lOjil (50|ig) anti-Kex2C antibody appears to have
no effect on the yield of Kex2p. In order to rule out the most obvious explanation
for this result (that is, that not all of the antibody had bound to the Pansorbin, even
though the amount added was within its binding capacity of 2mg/ml), it was
confirmed that in each case all of the antibody added to the Pansorbin had indeed
been incorporated into ImAd by showing that the supernatant remaining after the
formation of the ImAd contained no anti-Kex2C (using immunoblot analysis; data
not shown). Two other possible explanations for the observed result were
considered. Firstly, it may be that only 10% of the Kex2 activity detectable in the
lysate is capable of binding to the antibody, with the remaining 90% being in an
inaccessible form. Alternatively, since it is expected that the antibody-antigen
interaction in these experiments is resulting in the recovery of membrane vesicles
containing the transmembrane Kex2 protein, it may be that these vesicles are of
such a size that once a certain number (containing approximately 10% of total Kex2
activity) have bound to the ImAd, the S. aureus cells become completely coated
with vesicles leaving no room for any more to bind even though there may be
unfilled antigen binding sites.
It was shown that if Kex2-ImAd was used to recover Kex2 protease activity
equivalent to 10% of the total from a cell lysate, and then that same, now depleted,
lysate was exposed to an identical ImAd, then the second aliquot of ImAd also
bound Kex2 activity (again equivalent to approximately 10% of the original total
activity of the lysate), leaving a supernatant with a Kex2 activity equivalent to 80%
of that assayed in the original crude lysate (Figure 4-5). This procedure could be
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repeated until about 80% of the original Kex2 activity had been removed from the
lysate demonstrating that about 80% of the Kex2 activity in a crude lysate is able to
bind to ImAd, and thus ruling out the first explanation for the limitation upon Kex2
yield.
In order to test the second explanation given above, that the surface area of the
ImAd is the factor limiting the amount of Kex2 protein recovered, the amount of
Pansorbin used in the formation of the ImAd was increased. Figure 4-6a shows
that by increasing the amount of Pansorbin used in ImAd formation in order to
increase the total surface area of the ImAd (as well as increasing the amount of anti-
Kex2C used, rather than binding a fixed amount of antibody to increasing amounts
of Pansorbin, in case the amount of antibody also became a limiting factor in the
amount of Kex2p recovered), it is possible to recover more than 10% of the activity
present in a lysate in one round of binding, with an apparent maximum of 14%
being recovered here. Suprisingly, increasing the surface area of the ImAd further
(along with a concominant increase in the number of antigen binding sites) did not
seem to lead to a further increase the amount of Kex2 activity recovered, but
seemed to have the opposite effect (Figure 4-6a-bound). This observation did not
agree with the results obtained from immunoblot analysis of the same material
(Figure 4-6b) which indicate that the use of an increasing amount of ImAd leads to
an increasing amount of Kex2p to be recovered from a lysate. The amount of
activity left in the lysate following treatment with ImAd was assayed and when this
data was analysed a discrepancy was found in that when these results were added to
the amount of Kex2 activity assayed attached to the ImAd a total of less than 100%
was obtained (i.e. activity recovered from, and activity left in, the lysate did not
add up to 100%). The assays carried out on the supernatants remaining after
treatment of lysates with ImAd show that up to 80% of Kex2 activity is removable
from these lysates in a single round of binding (Figure 4-6a-unbound). Thus it
appears that the presence of Pansorbin interferes with the Kex2 protease activity
assay that was used in this study (Figure 4-7).
116
Figure 4-4.
An apparent maximum amount of Kex2p in a cell lysate can bind to
Kex2-ImAd
A number of different Kex2-ImAd preparations made using 10(ll Pansorbin and
various amounts of anti-Kex2C (from 0-100|il; 0-500|ig protein). These preparations
were individually mixed with, and subsequently recovered from, NBY10(pGA714) cell
lysates as described in Figure 4-2. The amount of Kex2 protease activity bound was
assayed, expressed as a percentage of the total Kex2 activity present in the lysate, and
plotted against the amount of anti-Kex2C used to prepare the ImAd.
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Figure 4-5.
Most of the Kex2 activity in a cell lysate can be bound by Kex2-ImAd
ImAd prepared using 10|il Pansorbin and lOpl anti-Kex2C (50|ig protein) was used to
recover 30 units of Kex2 activity from an NBY10(pGA714) cell lysate, leaving 270
units of activity in the supernatant. This depleted lysate was then exposed to an
identical second aliquot of ImAd. The amount of Kex2 activity recovered by this was
assayed, as was that remaining in the lysate. The lysate was exposed to further rounds
of binding using fresh ImAd until the addition of such an ImAd led to no recovery of





Optimisation of Kex2p recovery
ImAd prepared using 500p.l Pansorbin and 500|il anti-Kex2C (2.5mg protein) was
divided into 7 portions (150, 100, 50, 25, 10, 5 and 2(il), each of which was used to
bind Kex2 protein from an NBY10(pGA714) lysate as described in Figure 4-2. Kex2
activity bound by each portion of the ImAd was assayed (Figure 4-6a, ImAd bound),
as was that remaining in the lysate following the removal of the ImAd (Figure 4-6a,
ImAd unbound). The same procedure was carried out using an equivalent amount of
Pansorbin to which no antibody had been bound in place of ImAd. This set of control
experiments demonstrated that up to 150p,l of Pansorbin alone, in place of ImAd, led to
no recovery of Kex2 activity and no depletion of activity from the supernatant (data not
shown).
Identical samples were prepared in parallel and processed for immunoblot analysis
using anti-Kex2C as primary antibody as described in Figure 4-2 (Figures 4-6bi and
4-6bii). Two exposures of the immunoblot are shown in order to highlight the different
amounts of Kex2 recovered from identical lysates by different amounts of ImAd. No
detectable Kex2p was present in the material bound using Pansorbin alone in place of



















































Pansorbin inhibits the Kex2 assay
The amount of Kex2 activity in 30(ll of an NBY10(pGA714) cell lysate (equivalent to 3
OD units) was assayed in the absence of, and in the presence of increasing amounts of
Pansorbin. 2, 5, 10, 25, 50 and 100(ll of Pansorbin were washed with lysis buffer
before being resuspended in 30|il NBY10(pGA714) lysate. The amount of Kex2
protease activity present in these samples was assayed, as was that present in 30(il of
lysate that had not been exposed to Pansorbin (control value).
Equivalent amounts of Pansorbin were resuspended in 30)0.1 lysis buffer. No Kex2
activity was detected in these samples.
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If the assumption is made that the activity removed from the lysates has been bound
by the ImAd then it can be seen from Figure 4-6a that 80% of assayable Kex2
activity in an NBY10(pGA714) cell lysate can be removed using Kex2-ImAd. This
result agrees with data presented in Figure 4-5 and therefore it can be concluded that
80% of the Kex2 activity detected by the assay used here in a NBY10(pGA714) cell
lysate is in a form that can be recovered using Kex2C-ImAd.
From Figure 4-6 it can be seen that at least lOOjil of a now standard Kex2-ImAd
(prepared using 1ml (5mg) anti-Kex2C per ml Pansorbin (10% w/v S.aureus cell
suspension)) is required to recover 80% of the Kex2 protease activity detectable in
an NBY10(pGA714) cell lysate which seems to be the maximum amount of activity
that can be removed from such a sample by the procedure used here (Figure 4-5).
For all binding experiments reported so far, ImAd and cell lysates were incubated
together for three hours prior to recovery of the ImAd for examination of material
bound to it. Since it is hoped that material bound by Kex2-ImAd will be used to
reconstitute protein transport, it was thought to be desirable to determine the
shortest period of time with which the ImAd can be incubated with a cell lysate and
recover Kex2p. Figure 4-8 demonstrates that it is necessary to incubate the ImAd
with the cell lysate for at least 150 minutes in order to bind 80% of the Kex2 protein
present in the lysate.
On the basis of the results presented in this chapter it was decided that in
subsequent experiments where a fraction bound from a yeast cell lysate by Kex2-
ImAd was required, the material which would be used would be that bound by
lOOfll ImAd (prepared using l(ll anti-Kex2C antibody (l|ig protein) per p.1 (10%
w/v S.aureus cell suspension) Pansorbin) from 300jil yeast cell lysate (equivalent
to 30 OD units of yeast cells taken from a growing culture of 00^=0.5-1.0).
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Having optimised the conditions for binding Kex2p from an NBY10(pGA714)
lysate, it was decided to investigate the possibility of recovering Kex2p from
lysates prepared from cells expressing the protein at wild type levels. It was found
to be necessary to use 100|il Kex2C-ImAd (prepared as described above) to remove
all the Kex2p (detectable by immunoblot analysis) from 300(1,1 of an NBY10 lysate.
Figure 4-9 demonstrates that using half of this amount of ImAd results in
incomplete removal of Kex2p from the lysate.
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Figure 4-8.
Time course of Kex2p binding
ImAd prepared using 1ml Pansorbin and 1ml anti-Kex2C (5mg protein) was divided
into 10 identical aliquots, each of which was resuspended in 300|il NBY10(pGA714)
lysate (equivalent to 30 OD units). These samples were incubated on a rotating wheel
at 4°C for various times after which the ImAd was recovered by centrifugation and the





Binding of Kex2p from a lysate containing normal levels of the protein
lOOpl Kex2-ImAd (prepared using 5(ll anti-Kex2C antibody (5|ig protein) per pi (10%
w/v S.aureus cell suspension) Pansorbin) was reuspended in 300pl of an NBY10 glass
bead lysate (prepared from 30 OD units of yeast cells taken from a growing culture of
00^=0.5-1.0). The ImAd was removed after 3 hours incubation at 4°C on a rotating
wheel and the remaining lysate was subjected to electrophoretic separation on a 10%
polyacrylamide gel prior ro immunoblot analysis using anti-Kex2C as primary








Characterisation of material immunoisoiated from
yeast cells using an affinity-purified
anti-Kex2p antibody
5.1. Introduction
This chapter describes the characterisation of material recovered from yeast cells by
immunoisolation based on the affinity of anti-Kex2C for the C-terminal domain of
Kex2p. It is demonstrated here that the material contains the Kex2 protease in intact
membrane vesicles, and that the material is enriched for marker enzymes of the yeast
Golgi but does not contain markers associated with the ER or the vacuole.
5.2. Enzyme activities present in ImAd-bound material
Based on experimental evidence (discussed in Chapter 1) that defines Kex2p as a
resident membrane protein of a late compartment of the yeast Golgi the assumption was
made that material recovered from yeast using Kex2-ImAd would be enriched in
membranes derived from this organelle but not in those derived from other organelles
such as the ER or the vacuole. It is envisaged that the most likely contaminating
membranes in a preparation of Golgi membranes obtained using immunoisolation
would be those derived from the ER since it will contain resident Golgi proteins, such
as Kex2p, en route to their destination. To investigate the composition of the material
bound by Kex2-ImAd from yeast cells, the activities of biochemical marker enzymes
were assayed to screen for the presence of ER and vacuolar membranes (NADPH
cytochrome c oxidoreductase activity was used as a marker for the presence of ER
membranes (Schekman in Strathern etal., 1982), and CPY activity (Schwencke etal.,
1983) and DPAP B activity (Bordalloetal., 1984) were used as markers for the
presence of vacuolar membranes). Figure 5- la shows that material bound by Kex2-
ImAd from a lysate prepared from the yeast strain NBY10 using glass bead breakage
(containing 80% of the cellular Kex2 activity) contains negligible amounts of these
enzymes (less than 0.5% of that present in the lysate presented to the ImAd).
The heat stable dipeptidyl aminopeptidase (DPAP A), encoded bySTE13 is responsible
for the N-terminal maturation of a-factor following its cleavage by Kex2p and C-
terminal maturation by Kexlp (Fuller et al., 1988), and is commonly used as a marker
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for the presence of yeast Golgi membranes. The ImAd bound material was found to
contain little heat stable (Julius etal., 1984) DPAP A activity (less than 2% of that
present in the lysate presented to the ImAd), little more than was bound from the same
cell lysate using Pansorbin alone. Although it has been suggested that DPAP A resides
in a different cellular compartment from Kex2p (due to the presence of several Lys-Arg
sites in the sequence predicted to form its catalytic domain; Fuller et al., 1988), it has
recently been reported that immunofluorescence studies produce a staining pattern
similar to that observed for Kex2p (T. Stevens - quoted in Seeger and Payne, 1992).
This, taken with the fact that the two enzymes act in the maturation of a-factor,
suggests that Kex2p and DPAP A might reside in the same cellular compartment.
Taking such evidence into account, it was perhaps suprising that the material bound by
Kex2-ImAd, known to contain the vast majority of cellular Kex2p from a lysate, was
not enriched in DPAP A activity. The lysate from which the ImAd-bound fraction had
been recovered was prepared by vortexing yeast cells in the presence of glass beads.
This method of lysis can be considered harsh, and is likely to cause considerable
disruption to internal cellular structures. It was suspected that during glass bead lysate
preparation, the Kex2p-compartment had become fragmented to such an extent that
even if DPAP A and Kex2p do both reside in the same compartment, the occurrence of
the two in the same vesicle (derived from the Kex2p-compartment) was rare.
In order to investigate this hypothesis a more gentle method of lysis was used to
generate the cell extract from which a Kex2-ImAd bound fraction could be obtained, in
the hope that less disruption to internal membranes would lead to the isolation of a
fraction more representative of the Kex2p-compartment using Kex2-ImAd. Figure 5-2
demonstrates that a yeast cell lysate prepared by homogenisation of spheroplasts
contains a higher proportion of a secretory protein in a cryptic form (i.e. requiring the
addition of detergent for its detection) than a lysate prepared from the same cells using
glass bead breakage. In a glass bead lysate prepared from the yeast strain
JRY188(pYJS50) which secretes the bacterial enzyme (3-lactamase only 30% of the
detectable activity is present in a cryptic form. An extract prepared from the same cells
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by homogenisation of spheroplasts in a hypertonic buffer contains over 90% of the
enzyme in such a form (Figure 5-2) suggesting that the method of homogenisation
described is less disruptive to internal membranes than glass bead lysis.
A Kex2-ImAd bound fraction was therefore recovered from yeast cells that had been
lysed by homogenisation in hypertonic media following removal of their cell wall and
was found to contain 25% of the DPAP A activity that had been in the homogenate
(Figure 5- lb). The activity of both the vacuolar and the ER marker enzymes in this
fraction was negligible. As well as providing evidence that Kex2p and DPAP A do
reside in the same cellular compartment, these findings suggest the possibility that
Kex2p and DPAP A reside in separate domains of that compartment. It is envisaged
that these domains are physically separated by the harsh method of glass bead lysis
whereas the more gentle lysis technique of homogenisation allows them to remain in the
same membrane structure more often.
On the basis of these results, it was decided that all future Kex2-ImAd bound fractions
should be prepared from cell extracts prepared by homogenisation, since it is
considered that they are more likely to be representative of the organelle in which
Kex2p resides in the cell.
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Figure 5-1.
Enzyme activities associated with ImAd-bound material
The activities of various enzymes were measured in cell extracts, material recovered
from these extracts using Kex2-ImAd, and the material remaining following treatment
with ImAd. This figure compares the amount of activiy of each of these enzymes
recovered from an NBY10 glass bead lysate using Kex2-ImAd (Figure 5-la) with
those recovered in the same way from a homogenate of the same cells (Figure 5-lb).
The activities recovered by the ImAd are expressed as a percentage of the total activity
found in the extract from which the bound fraction was obtained.
The same assays were performed on material recovered using Pansorbin alone,
revealing that Pansorbin alone recovers negligible amounts of activities of any of the
enzymes assayed here (data not shown).
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Glass bead lysis is more disruptive than homogenisation
Two extracts were prepared from the yeast strain JRY188(pYJS50) which actively
secretes the bacterial enzyme (3-lactamase. One extract was prepared using glass bead
lysis and the other by homogenisation of spheroplasts. The activity of ^-lactamase in
5(0.1 of each extract (equivalent to 0.5 OD units of original culture) was assayed in
0.8M sorbitol both in the presence and absence of 0.1% Triton X-100 in order to
determine what proportion of the enzyme was contained within membrane structures.
The activity measured in the presence of detergent was taken as the total amount of
activity present in the extract (the total amount of activity in the two extracts was
found to be the same) and the activity measured in the absence of detergent was
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138
5.3. ImAd recovers Kex2p in sealed membrane vesicles
It is hoped that the material recovered by Kex2-ImAd from a yeast cell homogenate will
be used to reproduce functions that are carried out in the cell, such as the fusion of
transport vesicles with, and budding of transport vesicles from the Kex2p-containing
compartment, and therefore it is important to establish whether it contains intact
membrane vesicles derived from that organelle.
The ability of Kex2-ImAd to recover intact membrane vesicles from a yeast cell
homogenate was initially demonstrated by the fact that it could be used to recover a
soluble cargo protein from a homogenate prepared from cells that are actively secreting
the protein. (3-lactamase, a soluble protein secreted by JRY188 cells harbouring the
plasmid pYJS50 can be recovered using Kex2-ImAd in such a form that its presence
can only be detected under conditions associated with membrane disruption (Figure
5-3).
To demonstrate that the Kex2 protein recovered by Kex2-ImAd is itself contained
within membrane vesicles, the susceptibility of the protein to externally added protease
was examined. An affinity-purified antibody that recognises the N-terminal 120 amino
acids of Kex2p (anti-Kex2N; produced by P. Whitley: Whitley, 1990) was used to this
end. Intact vesicles bound to ImAd through the C-terminal domain of Kex2p will carry
the region of the transmembrane protein recognised by anti-Kex2N inside them. Figure
5-4 shows that when material bound from a yeast cell homogenate by Kex2-ImAd is
treated with protease prior to immunoblot analysis using anti-Kex2N as primary
antibody, the protein detected is of an apparent molecular weight consistent with the
cytoplasmic domain of Kex2p having been removed from the protein (approximately
100K; Fuller etal., 1989a), whereas the same antibody recognises the full size protein
in the same material prior to protease treatment. Protease treatment of ImAd-bound
material carried out in the presence of detergent completely removes the protein
recognised by anti-Kex2N from the sample.
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Figure 5-3.
Recovery of intravesicular cargo protein using ImAd
An ImAd-bound fraction was prepared from a homogenate of JRY188 cells
harbouring the plasmid pYJS50, as was a control bound fraction using Pansorbin
alone. These cells secrete the bacterial enzyme (3-lactamase. The two bound fractions
were each split into two aliquots, one of which was resuspended in 50pl
homogenisation buffer and the other in 50|ll PBS containing 0.1% Triton X-100.
ImAd was removed from each of these samples by centrifugation and the resultant
supernatants were assayed for the presence of p-lactamase activity. The results are






The luminal domain of immunoisolated Kex2p is inaccessible to
proteinase K
Five aliquots of material bound by Kex2-ImAd from an NBY10 homogenate were
resuspended in 50p.l homogenisation buffer containing 2mM CaCl2. Proteinase K
was added to a final concentration of 50|ig/ml as indicated (Triton X-100 was added
to a final concentration of 0.1% prior to this where appropriate). The samples were
placed on ice for 60 mins after which PMSF was added to a final concentration of
3mM. ImAd was removed from the samples after they had been boiled in SDS
sample buffer for 5 mins. The samples were then subjected to 10% SDS-PAGE prior
to transfer to nitrocellulose to allow immunoblot analysis using an affinity purified
antibody which recognises the luminal, N-terminal domain of Kex2p. Included on
the gel was a sample of the NBY10 homogenate, to ascertain the mobility of the full
length Kex2 protein.
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5.4. Composition of ImAd bound material
5.4a. Immunoblot analyses of the Kex2-ImAd bound fraction
The composition of the material bound by Kex2-ImAd was investigated in order to
further characterise this fraction. This was done in two ways. Firstly, the material was
tested for reaction with antibodies that had been raised against proteins known to reside
in specific yeast organelles; and secondly, proteins recovered using ImAd that are not
bound by Pansorbin were identified.
Immunoblot analyses of a Kex2-ImAd-bound fraction prepared from an NBY10
homogenate with antibodies prepared as described in the appendix to Chapter 3 were
used to assess the composition of the fraction. The ImAd-bound material shows no
reaction with the antiserum that was raised against Hmglp even when extracted with
detergent as described in the appendix to Chapter 3 (data not shown). This result is as
expected, from the NADPH cytochrome c oxidoreductase assay results (see 5.2.) and
provides additional evidence to suggest that the ImAd-bound fraction contains little, or
no, contamination with membranes derived from the ER. Similarly, ImAd-bound
material (prepared from an NBY10(pIH2-4) homogenate) does not demonstrate any
reaction with the affinity-purified anti-Ste2p antibody (data not shown) which may be
taken to suggest that the fraction does not contain any material derived from the plasma
membrane. However, Figure 5-5a shows that a supernatant taken from the cell line
B/lA1 (which recognises the Pgal-Pmalp fusion protein (but not the pgal-Kex2p
fusion protein), as well as a protein taken to be Pmalp in a P100 prepared from
NBY10 - see the appendix to Chapter 3) reacts slightly with material bound by Kex2-
ImAd from an NBY10 homogenate, but not with material bound from the same
preparation by Pansorbin alone. This apparent contradiction over whether plasma
membrane proteins can be detected in the material bound by the ImAd may be explained
by the different abilities of the two antibodies used to detect their antigens in
immunoblot analysis. To detect a signal relating to the recognition of Ste2p by the
affinity-purified anti-Ste2p antibodies, it is necessary to expose x-ray film to a filter that
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had been treated with ECL reagent (following immunoblot analysis) for 10 minutes,
whereas, under the same conditions, a signal relating to the detection of Pmalp in a
similar fraction by the B/1A1 supernatant can be detected after an exposure of
approximately 10 seconds. An exposure of 2 hours was required to detect the reaction
of B/l A1 supernatant with the ImAd bound material, demonstrating that the level of
Pmalp contained within the fraction is very low. Although this may be taken to
suggest that the ImAd bound fraction contains some membrane derived from the plasma
membrane, the presence of Pmalp in the ImAd bound material can be explained as
protein traffic travelling through the Kex2p-containing compartment en route to the
plasma membrane.
The Kexlp carboxypeptidase acts in the processing of a-factor after Kex2p, but before
DPAP A (Fuller et al., 1988). Since the two enzymes which act immediately before
and after Kexlp have been shown to reside in the same cellular compartment (see 5.2.),
it seems highly likely that Kexlp will also reside in this compartment. To investigate
this, an antibody that recognises Kexlp (supplied by Dr. H. Bussey, University of
Montreal) was used in an immunoblot analysis of Kex2-ImAd bound material prepared
from an NBY10 homogenate. Figure 5-5b shows that, as expected (H. Bussey -
personal communication: Dmochowska et al., 1987) the Kexlp antibody recognises a
protein with an apparent molecular weight of approximately 60K in an NBY10
homogenate which is present in an ImAd-bound fraction prepared from such a
homogenate, but not in material bound from the same preparation by Pansorbin alone.
This result provides direct evidence that the compartment in which Kex2p resides inside
the cell, contains Kexlp, as well as DPAP A, and that the material bound from a yeast
cell homogenate resembles the compartment in which Kex2p resides inside the cell.
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Figure 5-5.
Immunoblot analyses of the Kex2-ImAd bound material
Material was recovered from an NBY10 homogenate using both Kex2-ImAd and
Pansorbin alone. Both of these fractions (Kex2-ImAd bound and Pansorbin bound)
were tested for reaction with supernatant from the cell line B/lA1 (Figure 5-5a),
which recognises Pmalp, by immunoblot analysis, following electrophoretic
separation on a 10% polyacrylamide gel. A similar analysis was performed on the
same material using an anti-Kexlp antibody (supplied by Dr. H. Bussey) - Figure
5-5b. A PI00 prepared from the same volume of NBY10 homogenate from which





















5.4b. Polypeptide composition of Kex2-ImAd bound material
Kex2-ImAd was used to recover a bound fraction from a homogenate of NBY10 cells
containing proteins that had been radiolabelled using 35S-methionine. This material
was compared to that bound by Pansorbin alone. It can be seen from Figure 5-6 that
the Kex2-ImAd recovers a number of radiolabelled proteins from an NBY10
homogenate that are not recovered from the same sample by Pansorbin alone. In an
attempt to accentuate the differences between the fraction bound by ImAd and that
bound by Pansorbin alone, the two bound fractions were prepared from a radiolabelled
NBY10 homogenate that had previously been cleared using Pansorbin. It was hoped
that this would lead to no, or little, material binding to Pansorbin in the second round of
binding, but as can be seen from Figure 5-6, this does not appear to be the case. This
may be due to the fact that the binding experiments are carried out over a long period of
time (3 hours), during which proteins in the homogenate may denature, such proteins
may tend to form aggregates, which would sediment during recovery of the bound
fraction. Although this attempt to clean-up the control bound fraction has been only
partly successful, it can be seen that some proteins that are unique to the ImAd bound
fraction prepared from the uncleared homogenate are also found in the ImAd bound
fraction prepared from the cleared homogenate (but not in the fraction bound by
Pansorbin alone from either sample). Five proteins that are present in both of the ImAd
bound fractions, but in neither of the control bound fractions are indicated on Figure
5-6. It is likely that these proteins are resident to the same compartment as Kex2p, and
their characterisation would provide further insight into the function(s) of this
organelle.
It is worth noting that no band on the autoradiogram relating to Kex2p has been
identified specifically to material bound by Kex2-ImAd, even though this material is
known to contain the protein. This may demonstrate some technical limitation of using
such an approach to identify proteins recovered using Kex2-ImAd.
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Figure 5-6.
Identification of proteins specific to the Kex2-ImAd bound fraction
An ImAd bound fraction was prepared from an NBY10 homogenate containing
proteins that had been radiolabeled using 35S-methionine. This (Kex2-ImAd bound-
LYSATE) was electrophoretically separated on a 10% polyacrylamide gel. Material
recovered from the same homogenate using Pansorbin alone was processed on the
same gel (Pansorbin bound - LYSATE). The gel was processed by fluorography, and
the resultant autoradiogram is shown here.
An ImAd bound fraction was prepared from the same homogenate that had been
exposed to 100(ll Pansorbin for three hours at 4°C on a rotating wheel. This material
was analysed as described above (Kex2-ImAd bound - CLEARED LYSATE), as was
that recovered from the same sample using Pansorbin alone (Pansorbin bound -
CLEARED LYSATE).
Included on the gel was 3(0.1 of the homogenate (equivalent to 1% of that from which
the bound fractions were prepared -1% lysate).























5.5. Kex2-ImAd bound fraction can function as an acceptor
compartment in a protein transport assay
A yeast cell that is actively secreting a protein will contain that protein, in some form, in
each compartment of its secretory pathway, and therefore theoretically, a lysate of such
a strain can act as the donor fraction in a protein transport assay to follow delivery of
the protein to any acceptor compartment (providing that the delivery can be assayed). A
protein transport assay was devised using a Kex2-ImAd bound fraction prepared from
NBY10 as the acceptor fraction and a cell homogenate prepared from yeast cells
secreting the bacterial enzyme P-lactamase (JRY188(pYJS50)) as donor. After
incubation of acceptor with donor under various conditions the ImAd-bound fraction
was re-isolated and assayed for the presence of transported P-lactamase. It was found
to be possible to detect the delivery of P-lactamase to Kex2-ImAd bound material, and
the following conditions were found to be required for this delivery:
Figure 5-7 shows that delivery of P-lactamase from a donor fraction prepared from
JRY188(pYJS50) cells that are secreting the enzyme, to an acceptor fraction, consisting
of material recovered from an NBY10 homogenate (which contains no P-lactamase
activity) requires energy in the form of an ATP-regenerating system. The delivery does
not occur if the reaction mixture is incubated at 0°C instead of 25°C. It was also found
necessary that the homogenate used as the donor fraction was more concentrated than
the homogenate routinely used throughout this study (equivalent to 500 OD units/ml as
oppose to 100 OD units/ml was required - data not shown)
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Figure 5-7.
A protein transport assay following the delivery of a soluble cargo
protein to Kex2-ImAd bound material
Material bound to either Kex2-ImAd, or Pansorbin alone, from an NBY10
homogenate, was reusupended in 90|il of a homogenate prepared from
JRY188(pYJS50) on ice (the homogenate contained the equivalent of 500 OD
units/ml). Either 10|il homogenisation buffer (-ATP), or 10(il of a 10 x ATP
regenerating system (final concentration ImM ATP, 8mM creatine phosphate,
30units/ml creatine phosphokinase: +ATP) was added, as indicated. These reaction
mixtures were either left on ice (0°C), or incubated at 25°C for 15 mins, as indicated.
After this time, the ImAd (or Pansorbin) was recovered by centrifugation, washed
twice with homogenisation buffer, and then resuspended in PBS containing 0.05%
Triton X-100. Material released from the ImAd (Pansorbin) by the detergent was
assayed for [3-lactamase activity. This is shown opposite, with the results expressed
as a percentage of the highest value recorded.
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To dissect the transport being followed in the transport assay described above an
experiment in which membranes prepared from NBY10 were added to the assay
mixture was performed. It was found that the addition of these membranes caused a
decrease in the amount of (3-lactamase delivered to the ImAd bound fraction. If
membranes prepared from an NBY10 homogenate that have been depleted of Kex2p-
compartment by incubation with Kex2-ImAd are added to the assay mix, this
competition effect was reduced. This supports the hypothesis that the assay measures
the transport of cargo protein to the Kex2p-compartment, since an inhibition by the
presence of membranes containing Kex2p-compartment is partially reduced by identical
membranes which lack the Kex2p-compartment (Figure 5-8). One criticism of this
experiment may be that the effect observed is merely due to the 'depleted membrane'
fraction containing less material than the membranes which compete with the acceptor
fraction in this assay. Such an explanation can be discounted, since it can be seen from
Figure 5-6 that the ImAd bound material is made up of less than one percent of the total
amount of protein found in a homogenate. The most generous of estimates might say
that membrane proteins account for, say 10% of this, so at the very least the 'depleted
membrane' fraction contains 90% of the amount of membrane material found in the
membrane preparation which inhibits the assay (and probably more than this).
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Figure 5-8.
Kex2-ImAd partially depletes yeast membranes of the ability to
compete with Kex2-ImAd bound material as an acceptor compartment
in a protein transport assay
Material bound to Kex2-ImAd, from an NBY10 homogenate, was resuspended in
90|il of either a JRY188(pYJS50) homogenate (no competition), or an identical
homogenate that had previously (immediately prior to resuspension of the ImAd-
bound fraction) been used to resuspend either;
a P100 prepared from an NBY10 homogenate (membranes);
or a P100 prepared from an NBY10 homgenate that had been exposed to Kex2-ImAd
for three hours, and now contained only 20% of its original Kex2p activity (depleted
membranes).
10|il of an 10 x ATP regenerating system (described in Figure 5-7) was added to each
of these reaction mixtures prior to incubation at 25°C for 15 mins. After this time the
ImAd-bound fraction was recovered and treated as described in Figure 5-7. The
results of the ^-lactamase assays that were carried out in this experiment are
expressed as a percentage of the activity delivered to an ImAd bound fraction by the
JRY188(pYJS50) homogenate that had not had any membranes added to it.
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Delivery of proteins from a donor fraction to an acceptor fraction can be divided into
two stages: Docking, whereby transport vesicles which have budded from the donor
membrane attatch to, but do not fuse with, the acceptor compartment; and fusion,
whereby the contents of the transport vesicles are delivered to the acceptor
compartment, following a membrane fusion event. When a transport vesicle docks
onto its acceptor membrane its contents remain physically separated from those of the
acceptor compartment, whereas a membrane fusion event causes the contents of the two
compartments to become mixed. To ascertain whether the assay described above
follows the fusion of transport vesicles with the Kex2p-compartment bound to the
ImAd, the form of the protein delivered to the bound fraction was examined. For this
experiment, the donor fraction was prepared from PWYS3(pYJS50) cells (which lack
Kex2p, and therefore cannot cleave the gene product of pYJS50). Delivery of the
P-lactamase encoded by pYJS50 to a compartment containing Kex2p will result in a
change in its electrophoretic mobility following cleavage by the peptidase. As can be
seen from Figure 5-9 the area of the immunoblot where the expected Kex2p-cleaved
product would be expected to be found (bacterially expressed (3-lactamse was included
on the immunoblot as a marker) demonstrates high reactivity with the anti-P-lactamase
antibody used and the expected change in the electrophoretic mobility of the
P-lactamase has not been detected. However, it can be seen that the material recovered
from an assay carried out in the presence of an ATP regenerating system contains high
molecular weight forms of P-lactamase that are not present in material recovered from
an assay carried out in the absence of such an energy supply. Preliminary analysis of
the different forms of P-lactamase detected in Figure 5-9 identify this material as being
characteristic of that found in the Golgi (by comparison with an immunoblot shown in
Graham and Emr, 1991) and the observation that the delivery of this material to the
Kex2-ImAd bound fraction requires energy suggests that protein transport to the
Kex2p-compartment is indeed being followed. Obviously, further work is required to
determine the meaning of this result, but the preliminary work presented here provides
strong evidence that material recovered from yeast cells by Kex2-ImAd, will be of use
in the study of function(s) of the Kex2p-compartment.
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Figure 5-9
Examination of p-lactamase delivered to ImAd bound material
ImAd bound material, prepared from an NBY10 homogenate, was resuspended in
90|ll of a PWYS3(pYJS50) homogenate. 10|il of either homgenisation buffer, or a
10 x ATP regenerating system (described in Figure 5-7) was added prior to incubation
at 25°C for 15 mins (+ATP/-ATP). The ImAd-bound material was recovered, washed
three times in homogenisation buffer, and then boiled for 5 mins in SDS sample
buffer. These samples (pellets; P on figure), as well as the supernatant (S on figure)
remaining following the removal of the ImAd-bound material, were subjected to
electrophoretic separation on a 10% polyacrylamide gel before being transferred to
nitrocellulose to allow immunoblot analysis using an anti-p-lactamase antibody.
Indicated on the figure is the position at which bacterially produced p-lactamase
migrated to (29K), this is where Kex2p processed form of the protein expressed from
pYJS50 would be expected to migrate to.
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Chapter 6
Immunoisolation of material from
yeast using a Kex2-protein A
hybrid protein
6.1. Introduction
Following the successful use of Kex2p in the immunoisolation of the compartment in
which it resides (discussed in Chapters 4 and 5), it was decided that the protein should
be used to investigate the use of the affinity of protein A for IgG to isolate specific
membrane fractions from yeast using protein A fusion proteins. This was to be
undertaken by constructing a gene fusion to encode a protein consisting of protein A
IgG-binding domains fused onto the extreme C-terminus of Kex2p. It was envisaged
that, if this fusion protein had the same subcellular localisation as Kex2p, it should be
possible to use it to isolate the same membrane fraction that was isolated using Kex2-
ImAd, by using the Fc portion of IgG molecules attached to a matrix. This possibility
was investigated since, if such an approach was found to be successful, it could be
adapted to isolate other membrane fractions (by choosing appropriate proteins with
which to construct protein A fusion proteins). Such an approach may be advantageous
over obtaining antibodies for the chosen proteins since the affinity of protein A for IgG
is known to be high, whereas there is an element of chance involved in obtaining
antibodies with a high affinity for a specific antigen.
6.2. SpaK; the Kex2p-protein A fusion protein
The oligonucleotides described in Figure 6-1 were used to generate a 3.6kb fragment of
DNA, containing the entire coding region of the KEX2 gene, by PCR using genomic
DNA prepared from NBY10 as a template. The product from this reaction, which
consists of DNA from 1200bp upstream of the KEX2 gene (and is thought to contain
the promoter region of the gene) was used to construct a KEX2-spa gene fusion,
contained within the plasmid pNB66, as described in Figure 6-1. The gene fusion is
predicted to encode a protein with a molecular weight of 107K (968 residues)
consisting of 813 residues encoded by the KEX2-derived portion of the gene followed
by 7 encoded by polylinker DNA and 148 residues encoded by DNA from the spa gene
(as contained within pKpraSH; Figure 6-1). pNB66 was transformed into the yeast
strain JRY188 to create JRY188(pNB66). Lysates from this strain were screened for
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the presence of a protein A fusion protein by immunoblot analysis using a rabbit IgG-
HRP conjugate. Figure 6-2 demonstrates that JRY188(pNB66) produces a protein
recognised by rabbit IgG that has an apparent molecular weight of approximately 150K
(no such protein is produced by JRY188). The predicted molecular weight of Kex2p is
90K but it has an apparent molecular weight of 135K due to the high net negative
charge that it carries in its C-terminal domain (Fuller etal., 1989). The portion of
protein A fused to Kex2p in the construction of SpaK is predicted to add approximately
16K onto the molecular weight of Kex2p and therefore it is concluded that the protein
detected in Figure 6-2 is the expected SpaK fusion protein encoded by the gene fusion
harboured by pNB66. Figure 6-2 also shows that the fusion protein expressed by
NBY10(pNB66) fractionates to the P100 prepared from a cell lysate, with none being
found in the soluble SI00. This result is consistent with the protein being associated
with membranes.
To demonstrate that SpaK exhibits Kex2 protease activity pNB66 was transformed into
a kex2 mutant strain (PWYS3). Extract prepared from the transformant
PWYS3(pNB66) vvas found to contain levels of Kex2 protease activity comparable to
those found in a similar extract prepared from JRY188 cells whereas extract prepared
from PWYS3 cells contains little of this activity (Figure 6-3).
The results presented so far in this chapter, that SpaK is produced by JRY188(pNB66)
cells at a level comparable to that at which JRY 188 cells produce Kex2p, and that the
protein is associated with membranes, were as predicted, and therefore the investigation
of the use of SpaK to recover the Kex2p-containing compartment was continued.
162
Figure 6-1.
Creation of the KEX2-spa gene fusion
The oligonucleotides 5' -GCGGATCCGTCGATCGTCCGGAAGATGG-3' and
5'-CGGGATCCGGTACCTCCAGTGCAACCAAACG-3' were used as primers for
the PCR using genomic DNA prepared fron NBY10. This gave rise to a 3.6kb product
which, following digestion with BamHl and Kpnl, was cloned into similarly digested
pK19 to create pNB64. The gene fusion was created by cloning a 0.5kb piece of DNA
encoding IgG-binding domains of protein A from pKpraSH into pNB64 using Sail and
Hindlll to create pNB65.
pKpraSH was created from pKpra using a two step strategy. A self-complementary
linker oligonucleotide (5'-AGCTGGTCGACC-3') was cloned into the Hindlll site of
pKpra, destroying the Hindll site and introducing a Sail site, to create pKpraSB. The
BamHl site in pKpraSB was destroyed and a Hindll site was introduced in its place by
digesting the plasmid with EcoRl and BamHl and inserting the oligonucleotides
5' -AATTGTAAGCTTG-3' and 5'-GATCCAAGCTTAC-3' into the digested plasmid to
create pKpraSH.
pNB65 carries the KEX2-spa gene fusion flanked by BamHl sites. The gene fusion
was inserted into the BamHl site of YCplac22 (in the orientation which gives rise to its
expression from the lacZ promoter) to create pNB66.
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Figure 6-2.
SpaK; the Kex2p-protein A fusion protein
Glass bead extracts were prepared from 100ml cultures of JRY188 and
JRY188(pNB66) that had been grown in minimal media to an ODgQQ of 0.5. The
extract prepared from JRY188(pNB66) was fractionated by centrifugation at
100 OOOg for 1 hour giving rise to a crude preparation of membranes (PI00) and a
soluble fraction (S100). The samples were separated on a 10% SDS-polyacrylamide


























SpaK has Kex2 protease activity
pNB66 was transformed into the kex2 mutant strain PWYS3. Glass bead extract was
prepared from these cells, PWYS3(pNB66), as well as from untransformed PWYS3
and JRY188. The level of Kex2 protease activity was assayed in each of these




6.3. Recovery of SpaK-containing membranes
Using the protocol established for the recovery of Kex2p-containing membranes
(Chapters 4 and 5) IgG-Sepharose was used in place of Kex2C-ImAd in an attempt to
recover SpaK-containing membranes from an JRY188(pNB66) homogenate.
Suprisingly, it was found that no SpaK was recovered from such a preparation using
IgG-Sepharose (data not shown). Subsequent analysis of the homogenate revealed that
the fusion protein was found in the pellet resulting from the low speed centrifugation
that is performed following homogenisation of the cells (Figure 6-4). Kex2p is found
in the supernatant that results following this centrifugation (Figure 6-4). This result
suggests that SpaK does not reside in the same cellular compartment as Kex2p.
The possibility that SpaK is localised to the vacuole was considered following two
recent reports which suggest that the C-terminal tail of Kex2p is important for its
retention in its compartment and that the vacuole may be the default compartment for
membrane proteins in yeast (Roberts et al., 1992: Seeger and Payne, 1992). In order
to investigate this, IgG-Sepharose was used to recover SpaK-containing membranes
from a glass bead lysate prepared from JRY188(pNB66). The fusion protein did not
appear in the pellet obtained following low-speed centrifugation of such a preparation
(Figure 6-4), presumably because this method of lysis is harsher than homogenisation
so that organellar membranes become more fragmented (see Chapter 5) and remain in
the supernatant of a low-speed centrifugation.
Figure 6-5 shows that it is possible to recover all the fusion protein produced by
JRY188(pNB66) from a glass bead lysate of such cells using IgG-Sepharose. If SpaK
resided in the Kex2 compartment such a result would led to the prediction that all of the
Kex2p of the cell would also be recovered. This was found not to be the case (Figure
6-5). Analysis of the bound fraction obtained from JRY188(pNB66) using IgG-
Sepharose revealed that it contained over a third of the total amount of DPAP B (a
vacuolar membrane protein: Bordallo etal., 1984; Roberts etal., 1989) found within
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the lysate and also a significant amount of a luminal vacuolar enzyme, CPY (Figure
6-5). The fact that CPY is a soluble enzyme (Wiemken et al., 1979) may explain why a
smaller proportion of the total amount of CPY is found in the fraction recovered using
SpaK (smaller than the proportion of the membrane protein DPAP B found in the same
fraction); it is likely that CPY escapes from the vacuole during lysis of the cells (the
organelle will become broken up into vesicles and not all of the vacuolar contents will
be incorporated into these).
The results presented above are consistent with the idea that the fusion protein is located
to the vacuole. One finding that appears initially to be inconsistent with this conclusion
is that PWYS3(pNB66) cells process pro-a-factor (as determined by a halo assay; data
not shown) suggesting that the fusion protein is located in a compartment encountered
by pro-a-factor as it travels through the secretory pathway. However, an assay which
allows a more reasonable analysis of the levels of a-factor production was carried out
on these cells (Figure 6-6) and it was found that although PWYS3(pNB66) cells do
process the pheromone they do not do so to the same extent as cells that contain an
intact KEX2 gene. It may be that SpaK processes pro-a-factor as it travels through the
Golgi on its way to the vacuole. This would explain why PWYS3(pNB66) cells
secrete less processed pheromone than JRY188 cells since the levels of SpaK in the
Golgi at any one time will be considerably lower than the levels of Kex2p in the same
compartment of cells producing Kex2p.
Although it was not possible to use SpaK to immunoisolate the same material that was
recovered using Kex2-ImAd, it has been demonstrated here that the attachment of
protein A domains onto an integral membrane protein to construct a fusion protein
allows the use of IgG-Sepharose to recover the membrane in which the fusion protein
resides. The experiments described here demonstrate the importance of thorough
characterisation of hybrid proteins. It was assumed here that SpaK would adopt the
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same cellular localisation as Kex2p, but this does not appear to be the case. Further
characterisation of SpaK, and the material isolated using its affinity for IgG, may





A 100ml culture of JRY188(pNB66) was divided in half. Cells from one half of this
culture were lysed using glass beads and the remainder were lysed using
homogenisation following removal of their cell wall by zymolyase. The preparations
yielded by both of these procedures were subjected to centrifugation at 4000g for
2 mins giving rise to a pellet (P4) and a supernatant (S4).
Two aliquots of each of the various samples thus obtained (total extract, P4 and S4)
were subjected to electrophoretic separation on a 6% SDS-polyacrylamide gel, and
then were transferred to nitrocellulose. One portion of this filter was tested for
reactivity with a rabbit IgG-HRP conjugate (which will recognise SpaK), shown as
the top immunoblot. Another portion of the filter was tested for reactivity with anti-
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Figure 6-5.
Recovery of SpaK-containing membranes
50|J.l (slurry volume) aliquots of IgG-Sepharose were used to recover material from
300|J.l (equivalent to 30OD units) of an S4 prepared from a glass bead lysate of a
culture of JRY188(pNB66) in the following way: The IgG-Sepharose was washed 6
times with lysis buffer before being resuspended in the S4. Following incubation on
a rotating wheel at 4°C for 3 hours the IgG-Sepharose was recovered by
centrifugation at 2000g for 2 mins. The IgG-Sepharose was washed 3 times with
lysis buffer (this washed sample was taken as the bound material) and was then either
boiled in SDS sample buffer prior to immunoblot analysis using either a rabbit IgG-
HRP conjugate (Figure 6-5a) or anti-Kex2C (Figure 6-5b) following electrophoretic
separation on a 10% SDS-polyacrylamide gel and transfer to nitrocellulose, or was
assayed for the activities of various enzymes (Figure 6-5c).
The same procedure was carried out using extract prepared from JRY188 as a control
and the material remaining in the extract following removal of the IgG-Sepharose was
also analysed (unbound material). All of the analyses described here were also
carried out on a sample of each of the glass bead extracts (lysate), and the enzyme
activity assays are expressed as a percentage of that found in the lysate from which
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Figure 6-5c
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Figure 6-6.
Pro-cx-factor processing by SpaK
The ability of the yeast strain RC631 (whose growth is sensitive to the presence of ce¬
faclor) to grow in the presence of supernatants from various yeast cultures (taken at
00500=0.5) was tested in order to ascertain whether these cells were processing pro¬
a-factor. The growth of RC631 in the presence of sterile YPD was also measured.
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The product of the Saccharomyces cerevisiae KEX2 gene is a Ca2+ dependent, neutral
serine protease that cleaves peptide substrates at the carboxyl side of Lys-Arg and
Arg-Arg sites. Kex2p is required for maturation of pro-a-factor, a process that occurs
before fusion of secretory vesicles with the plasma membrane, in the Golgi apparatus.
Kex2p can accurately process the mammalian precursors proinsulin and pro¬
opiomelanocortin in vivo, and its similarity to proteases that carry out these processing
events in mammalian cells is one piece of evidence that has led to the conclusion that
Kex2p resides in a compartment in yeast cells that is functionally equivalent to the
trans Golgi network of mammalian cells (Wilcox and Fuller, 1991: others are discussed
in Chapter 1).
During the course of this project I set out to develop a procedure to use Kex2p to isolate
the cellular compartment in which it resides so that this organelle may be characterised.
To this end, bacterially-produced hybrid proteins consisting of the, normally
cytoplasmically-disposed, C-terminal 100 amino acids of Kex2p fused to either protein
A or Pgal, were used to raise, and affinity purify polyclonal antibodies that specifically
recognise this region of the protein (anti-Kex2C: Chapter 3). These antibodies were
attached to S. aureus cells, to form a Kex2-ImAd, which was subsequently used to
recover material, based on the affinity of anti-Kex2C for Kex2p, from yeast cells
(Chapter 4). Conditions were found that led to the recovery of Kex2p contained within
intact membrane vesicles. As well as being highly enriched for the Kex2 protease, the
immunoisolated material also contains the two pheromone processing enzymes which
act after Kex2p in the maturation of pro-a-factor (Kexlp and DPAP A: Fulleret ah,
1988). From this work, it seems that all three of the enzymes involved in the
maturation of pro-a-factor to a-factor reside in the same cellular compartment. This
provides further evidence that the yeast Kex2p-containing compartment is analogous to
the TGN of mammalian cells, since if Kexlp and DPAP A did not reside in the same
compartment as Kex2p, then the mating pheromone would have to encounter at least
one other cellular compartment after leaving the Kex2p-containing compartment prior to
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secretion in order to be fully processed, but the finding that Kex2p, DPAP A and
Kexlp all reside in the same compartment means that it is possible (and likely) that the
pheromone does not encounter any other Golgi compartment after the Kex2p-
compartmenL The immunoisolated material does not contain any activity associated
with enzymes that are associated with the ER (NADPH-cytochrome c oxidoreductase)
or the vacuole (DPAP B or CPY). This apparent lack of contamination of the
membrane fraction has been confirmed by immunoblot analysis using an antiserum
which recognises a second ER membrane protein (HMG-CoA reductase), and it is
envisaged that immunoblot analysis of the same fraction with an antibody that
recognises the vacuolar enzyme CPY would detect the protein in its inactive precursor
form en route to the vacuole. The ImAd recovered material has been shown to contain
a plasma membrane protein (Pmalp), believed to be recovered in association with the
Kex2p-compartment as traffic en route to its cellular location. From the results
presented in Chapters 4 and 5, it seems reasonable to conclude that the material
recovered by immunoisolation, based on the affinity of a polyclonal antibody for the
cytoplasmically-disposed C-terminal domain of Kex2p, is representative of the yeast
Kex2p-compartment, the yeast counterpart of the mammalian TGN.
An interesting finding from the experiments designed to optimise the recovery of
Kex2p-containing membranes from yeast cells, was that the co-recovery of DPAP A
with Kex2p was dependent on the method used to lyse the yeast cells, with such co-
recovery only being achieved following gentle lysis of the cells. A model to explain
this finding is suggested here; if the membrane of the Kex2-compartment is divided into
domains, with Kex2 being found in one domain, and DPAP A in another. In such a
model, when harsh lysis conditions disrupt the compartment, the resultant vesicles are
unlikely to contain both of the enzymes (since they are spatially separated), whereas
gentle cell lysis will cause less fragmentation of the compartment so that the liklihood of
recovering the intact organelle is higher.
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A second approach that was taken to isolate the Kex2p-compartment involved the
construction of a gene fusion which, when transformed into yeast cells, caused them to
produce a hybrid protein, consisting of IgG-binding domains of the protein A, fused to
the extreme C-terminus of Kex2p (SpaK: Chapter 6). Material recovered from yeast
cells using this protein's affinity for IgG does not contain normal Kex2p (also present
in these cells JRY188(pNB66)), and is therefore believed not to be the Kex2p-
containing compartment. Analysis of this material suggests that it is vacuolar in origin.
This suggests that the fusion protein does not take up residence in the Kex2p-
compartment as was expected, but is located in the vacuole. While this work was being
carried out, it was reported that mutations in the C-terminal domain of Kex2p cause the
protein to be transported to the vacuole (Roberts et al., 1992: Seeger and Payne,
1992). This could be explained by speculating that these mutations cause changes to a
protein's structure and it is these changes that cause the cell to transport the abnormal
protein to the vacuole to be degraded (by an unknown mechanism). However, it has
been suggested that transport to the vacuole is the default pathway for yeast membrane
proteins, and changes in the C-terminus of Kex2p (and indeed in the cytoplasmic
domain of other yeast Golgi membrane proteins) destroy a signal (as yet unidentified)
that serves to retain the protein in the Golgi (Fuller et al., 1989^. Further evidence for
this hypothesis came from experiments designed to identify target signals that cause
proteins to be transported to the vacuole. These involved the construction of various
gene fusions and partial deletions using the genes that encode the two yeast integral
membrane DPAPs; A (which resides in the Golgi) and B (which resides in the vacuole)
(Roberts et al., 1992). Removal or replacement of either the cytoplasmic,
transmembrane, or lumenal domain of DPAP B does not affect its localisation to the
vacuole, whereas the C-terminal domain of DPAP A is both necessary and sufficient to
retain the protein in the Golgi. Overproduction of DPAP A results in some of the
protein becoming localised to the vacuole, suggesting the saturation of a retention
mechanism. One observation which seems to be inconsistent with the idea that the
vacuole is the default pathway for yeast membrane proteins, is that chcl cells (which
lack the heavy chain of clathrin) mislocalise Kex2p to the cell surface (Payne and
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Schekman, 1989). This appears to suggest that the default pathway for the protease
leads to its localisation here, but it may be that it is not a direct interaction of Kex2p
with the clathrin heavy chain that prevents its transport to the vacuole. Kex2p could
interact with another protein which, in turn, could interact with the clathrin heavy chain,
and thus retain Kex2p in its rightful location. If this were the case, then in chcl
mutants, the protein that interacts with the C-terminal domain of Kex2p would still
serve to direct it away from the vacuole, but could not keep it in the Golgi due to the
lack of clathrin heavy chain.
If the hypothesis described above is correct, and SpaK is localised in the vacuole, it is
perhaps suprising that the protein is not degraded (a protein A fusion protein of the
expected apparent molecular weight is produced by cells harbouring the gene fusion).
It has been proposed that there is an organelle which is an intermediate between the
Golgi complex and the vacuole (Seeger and Payne, 1992) which, if it exists, SpaK
would encounter en route to the vacuole. This would be consistent with observations
that have been made following the treatment of mammalian cells with the drug brefeldin
A which suggest that some proteins encounter an endosomal compartment en route to
the lysosome (Lippincott-Schwartz et al., 1991). It may be that the material recovered
throught SpaK's affinity for IgG is derived, not only from the vacuole, but also from
this putative intermediate compartment. It is possible that the SpaK which reaches the
vacuole its lumenal domain is degraded, leaving its trans-membrane and cytoplasmic
domains remaining intact. The full length fusion protein detected in material recovered
from cells expressing the gene fusion would, using this hypothesis, be resident to the
intermediate compartment, and the vacuolar markers (e.g. the active, and therefore
mature CPY) will have been recovered through the truncated SpaK in the vacuolar
membrane (the polyacrylamide gels used in this work were of such a composition that
would not allow the detection of such a small polypeptide; this may explain why no
protein A fusion protein of a molecular weight consistent with this theory was detected
here).
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Such a scheme can also be used explain the observation that SpaK-producing kex2
mutant cells process pro-a-factor to some extent, which seemed contradictory to the
fusion protein's apparent localisation to the vacuole, but was explained in Chapter 6 as
being due to SpaK in the Golgi en route to the vacuole processing the pheromone. If
there is an organelle encountered by proteins after the Kex2p-compartment, before they
reach the vacuole, which is also encountered by proteins en route to the plasma
membrane, then pro-a-factor will encounter SpaK (which has Kex2 protease activity)
in this organelle and thus become processed.
This work has led to the immunoisolation of a membrane fraction consisting of vesicles
derived from the Kex2p-containing compartment of the yeast Golgi, and it is hoped that
this material will be used to develop protein transport assays which reconstitute some of
the in vivo functions of this organelle. Obviously, for such assays to be established, it
is necessary that the immunoisolated Kex2p-containing compartment is 'functional', or
'competent' with regards to reconstituting protein trafficking events as they occur in
vivo and preliminary experiments that reconstitute the delivery of a soluble cargo
protein to the immunoisolated Kex2p-compartment (Chapter 5) go some way to
demonstrating that this is the case. The detection of Pmalp in the isolated material may
enable the process of budding from the Kex2p-compartment to be studied. This could
be assayed for by following the appearance of this cargo protein in a supernatant that
would result following the removal of immunoisolated Kex2p-containing compartment
from the assay (by centrifugation). It would be important to distinguish between
budding of membranes and fragmentation of the immunoisolated material, and this
could be achieved by demonstrating that the appearance of Pmalp in the supernatant
had an energy requirement. Such an assay could be used to identify proteins that are
important in the budding of membrane vesicles from the Kex2p-containing
compartment. For example, a number of sec mutants are thought to be defective in the
budding of vesicles from the yeast ER (Kaiser and Schekman, 1990) and the proposed
assay may be of use in determining whether the proteins involved in this process are
also required for the budding of vesicles from the Kex2p-compartment.
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This work demonstrates the power of the technique of immunoisolation, and has
created a number of possible openings which may now be taken to study the
function(s) of the hitherto poorly understood Kex2p-continaing compartment.
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A-2. Table 2. Plasmids used in this study
Table 2a. Plasmids obtained from others
pGA714 G. Ammerer 5kb yeast genomic KEX2
fragment cloned in YEpl3
pK19 R.D. Pridmore Derivative of pUC 19: KmR
replaces Ap1* (Pridmore, 1987)
YCplac22 D. Geitz CEN4/TRP1 plasmid
(Geitz and Sigino, 1988)
pKpra A. Boyd spa fusion vector
(Zueco and Boyd, in press)
pEXll, 12 & 13 J.G. Kusters lac Z fusion vectors
(Kusters et al., 1989)
pAXll, 12 & 13 J. Zueco spa fusion vectors
(Zueco and Boyd, in press)
pAB510 M. Egerton pBR322 carrying a 4.3kb BamHl
fragment containing STE2 gene
pIH2-4 M. Egerton URA3, YEp plasmid with STE2




pYJS50 A. Boyd LEU2, YEp plasmid carrying an








pKpraKex2C P. Whitley 1.25kb EcoRI/BamHI ffagment
from pGA714 cloned into
similarly digested pKpra
Table 2b. Plasmids constructed in this study
pKpraSB self-annealed oligonucleotide AGCTGGTCGACC cloned into the
HindlU site of pKpra
pKpraSH a linker formed from the two oligonucleotides AATTGTAAGCTTG &
GATCCAAGCTTAC cloned into EcoRJ/BamHl digested pKpraSB
pNBl 1.6kb HindUI fragment, containing STE2, cloned into the Hindlll site
of pK19, orientated to give a 1.6kb fragment upon digestion with
Hindm
pNB2 0.8kb HaeIII ffagment from pNBl cloned into the Smal site of pUC18,
in such orientation that yields a 0.6kb HindlTl fragment
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pNB3 0.8kb KpnlJBamHl fragment from pNB2 cloned into similarly digested
pKpra
pNB4 Cohesive ends created following Sail digestion of pNB3 were made
blunt using Klenow fragment, prior to re-ligation
pNB13 0.8kb Haein fragment ffompNBl cloned into Smal site of pEXll, in
orientation that gives 500bp Sail fragment
pNB21 1.25kb EcoRl/BamHl fragment from pKpraKex2C cloned into
similarly-digested pEXl 1
pNB64 3.6kb PCR product obtained using the two oligonucleotides
GCGGATCCGTCGATCGTCCGGAAGATGG &
CGGGATCCGGTACCTCCAGTGCAACCAAACG as primers and
genomic DNA prepared from NBY10 as template cloned into
BamHl/Kpnl digested pK19
pNB65 0.5kb Sall/HindUl fragment encoding protein A IgG binding domains
cloned into SallJHin&lll digested pNB64, placing this fragment
downstream of KEX2
pNB66 3kb BamHl fragment containing KEX2 -spa gene fusion cloned into the
BamYK site of YCplac22
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pNB72 1,6kb PCR product (encodes from Ile524 to Ser1054 of HMG-CoA
reductase) obtained using the oligonucleotides
GAATGCTGCTAGAATTCATACCAG &
CGGGATCCAATGACGTATGACTAAGTTTAGG as primers and
genomic DNA prepared from NBY10 as template DNA cloned into
EcoRI/BamHl digested pAX12
pNB73 1.6kb EcoRl/BamHl fragment from pNB72 cloned into similarly
digested pEX12
pNB75 0.54kb fragment (encoding from Ala354 to Asp534 of the yeast plasma
membrane H+ ATPase, Pmalp) obtained by PCR using the
oligonucleotides CTCTTGGTGGATCCATACATGG &
TGGCCCGGGCTAAGAAAACAAGCCATTGTTC as primers and
genomic DNA prepared from NBY10 as template DNA cloned into
Smal/BamHl digested pAXl 1
pNB76 0.54kb Smal/BamHI fragment from pNB75 cloned into similarly
digested pEXl 1
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A-3. Creation of the yeast strain NBY10
To create the strain NBY10, JRY188 was transformed with the pGAL-HO (a plasmid
harbouring a copy of the HO gene under GAL1 control carrying the URA3 marker). The
resultant transformants were grown on YPG plates to induce expression of the HO gene.
Expression of this gene causes cells to change mating type from a to a and vice versa
nearly every cell division (Herskowitz and Jensen, 1991). Any single colony on a YPG
plate is therefore likely to, at any given time, contain haploid cells of both mating types
and siblings of opposite mating types will be able to mate with each other to form a/a
diploids.
A single colony, putatively containing a, a and a/a diploids, was streaked from YPG
onto YPD in order to seperate the three possible cell types and switch off expression of
the HO gene. Ten single colonies were then replica patched from this plate onto YPD
and sporulation media plates. After a weeks incubation at 30°C, cells from the
sporulation media plates were scored for asci. Although no asci could be seen the cells
appeared larger and rounder than cells which had not been subjected to sporulation
conditions and therefore further steps were taken to analyse the cells.
Figure A-l shows that cells from all of the ten colonies picked do not secrete a-factor,
this would be the expected result had an a/a diploid been picked. However this result
would also be obtained if a haploid cell of the 'a' mating type had been picked, such a
stable 'a' type cell could arise had a cell lost the plasmid harbouring the HO gene while
on rich media.
It was important that the strain obtained had lost the plasmid harbouring the HO gene
after a/a diploid formation, during its time on rich media. This is partly because the
plasmid carries the URA3 marker, as does pIH2-4 so in order for positive transformants
from the transformation of NBY10 with pIH2-4 to be selected it was necessary for the
strain to be Ura-. The ten patches from the YPD plate were patched onto minimal media
that had been supplemented with /-
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1. His, Ura, Tip and Leu.
2. His, Ura and Trp.
3. His, Ura and Leu.
4. His, Trp and Leu.
5. Ura, Trp and Leu.
All of the patches grew on all five plates with one exception, 'patch number 8' did not
grow on the plate that had not been supplemented with uracil (i.e. plate number 4).
These cells have lost the HO containing plasmid.
Cells from 'patch number 8', taken from YPD, were mixed seperately with DC 14
(MATa) and DC 17 (MA Ta) cells on minimal media plates. Both of these strains were
also mixed with JRY188 (MATa) and S1502B (MATa) as positive controls (with DC14
mating with JRY188 and DC 17 mating with S1502B). Neither DC 14 nor DC 17 mated
with 'patch number 8' and this was taken as a final conformation that the a/a diploid
had been formed, and the new strain was labelled as NBY10.
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Figure A-l.
Screening for a/a diploid formation by loss of a-factor production.
Ten JRY188(pGAL-HO) colonies that had been grown on galactose containing
media (SD+his, trp and leu) to ionduced expression of the HO gene, and then
moved to glucose containing media (YPD - as described in the text) were assayed
for the production of a-factor using the strain RC631, whose growth is sensitive to
the presence of the mating pheromone. Also assayed for secretion of the
pheromone here are the strains JRY188 (a) and S1502-B (a), as well as the
transformant JRY188(pGALHO) which has never expressed the HO gene
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